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INTRODUCTION 
This thesis describes the use of immunophenotyping of lymphocytes in healthy 
as well as immunodeficient children. Part I describes the applied techniques 
(Chapters 2 and 3). The experimental work in healthy children is described in Part II 
(Chapters 4-7) and Part III describes the experimental work in immunodeficient 
children (Chapters 8-13). A summary and discussion of the work is given in Part IV. 
Chapter 2 shortly describes some technical aspects of flow cytometric 
immunophenotyping of lymphocytes. The advantages of using the lysed whole 
blood technique with directly conjugated monoclonal antibodies are discussed. 
In Chapter 3 a microassay for immunophenotyping of neonatal and infant 
lymphocytes is described. This microassay was developed for the study of healthy 
children during their first year of life, to enable detailed immunophenotyping in a 
small volume of blood (0.5 to 1.0 ml). In neonatal cord blood samples, 
contamination of the flow cytometric "Iympho-gate" wHh erythroid cells leads to 
underestimation of lymphocyte subpopulations. This erythroid contamination can 
be easily identified with the GpNCD71/CD45 triple immunostaining, which allows 
correction for the presence of erythroid cells wHhin the "Iympho-gate". 
Chapter 4 constitutes the introduction to the immunophenotyping stUdies in 
healthy children. Problems and pHfalis encountered in the study of the developing 
pediatric lymphocyte system are discussed, and literature data on the current 
knowledge of lymphocyte development in neonates and infants are summarized. 
The age-related differences in lymphocyte subpopulations and function imply that 
the available adult reference values cannot be used in children. 
In Chapter 5 the actual sizes (Le. the absolute counts) of the "naive" and 
"mature" blood lymphocyte subpopulations are compared between preterm 
neonates, term neonates, and adults. Unexpectedly, "mature" blood lymphocyte 
subpopulations appeared to be present in comparable absolute counts in term 
neonates and adults. However, "naive" lymphocyte subsets occurred in essentially 
higher absolute counts in term neonates, suggesting that a large pool of "naive" 
(untriggered) cells is standby in neonates, ready for partiCipation in primary immune 
responses. This pool of "naive" lymphocytes was not so large in some preterm 
neonates, which may partly explain their higher susceptibility to infections. 
Chapter 6 presents the longitudinal follow-up study of T-Iymphocytes, 8-
lymphocytes, and NK-cells in ten healthy children from birth to one year of age. T-
and B-Iymphocytes increased at one and six weeks of age, respectively, whereas 
NK-cells showed a sharp decline directly after birth. These data show that the 
changes in size of the lymphocyte subpopulations that are found in cross-sectional 
studies are confirmed in longitudinal studies of individual children. 
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In Chapter 7 the longitudinal follow-up of several subpopulations of T-
lymphocytes, B-Iymphocytes, and NK-cells during the first year of life is shown. 
Unexpectedly, the CD45RO+ T -lymphocyte count did not change during the first 
year of life, whereas the CD45RA+ T -lymphocyte count increased markedly, 
providing a large pool of cells for participation in primary immune responses. 
CD38 (T- and B-Iymphocytes) and CD1c and CD5 (B-Iymphocytes) are discussed 
as possible markers of peripheral immaturity. Finally, NK-cell subpopulations and 
their possible role before and after birth are discussed. 
Chapter 8 gives an introduction to the immunophenotyping studies in 
immunodeficient children. A stepwise protocol for the diagnosiS of 
immunodeficiency is presented, including an immunophenotyping protocol for 
clinical use. The role and interpretation of immunophenotyping results in the 
diagnostic process are discussed. 
In Chapter 9 the use of immunophenotyping in studying the slow reconstitution 
of lymphocyte subpopulations after pediatric bone marrow transplantation is 
illustrated. Especially the CD4+ helper T-Iymphocytes recovered slowly and 
reached the p, of age-matched reference values at a late stage (> 6 months 
posttransplant). The unexpected acceleration of the reconstitution of CD4+ helper 
T -lymphocytes in patients with CMV-reactivation is discussed. The posttransplant 
development of the absolute counts of CD45RA+, CD45RO+, and CD7- T-
lymphocyte counts are discussed in relation to normal ontogeny and the possibility 
of peripheral expansion of previously primed donor-derived "memory" T-
lymphocytes versus newly processed T-Iymphocytes via T-Iymphopoiesis in the 
thymus. 
In Chapter 10 the use of immunophenotyping is described for the identification 
of an unusual F,yReceptor lila (CD16) on NK-cells in a patient with recurrent 
infections. Loss of the epitope for the CD16 (B73.1) monoclonal antibody led to 
the identification of F,yRIIIA-48H/H homozygosity. The combined use of CD16 and 
CD56 monoclonal antibodies labeled with the same fluorescent dye, as is often 
applied in routine immunophenotyping procedures, will leave these homozygotes 
undiagnosed. This might explain why the F,yRIIIA-48H/H phenotype was not 
recognized earlier, despite the 8% frequency of the 230A allele in the Caucasian 
population. The potential causal relation between the unusual F,yReceptor lila 
and the clinical problems in the patient is discussed. 
Chapter 11 describes the use of immunophenotyping in the characterization of 
the T-cell defect found in two siblings with recurrent infections. TCRaj3+ T-
lymphocytopenia was found, particularly affecting CD4+/CD45RA+ "naive" helper 
T -lymphocytes. Potential causes for this T-cell defect are discussed. The 
importance of comparing immunophenotyping results with age-matched controls 
is illustrated: Vy and Vo usage in the patients were normal in comparison with an 
age-matched control, but not in comparison with an adult control. 
In Chapter 12 the use of immunophenotyping in the diagnosis of X-linked 
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hyper IgM syndrome is shown: the activated T-Iymphocytes did not show 
expression of CD40 ligand. Analysis of the underlying mutation in the CD40 ligand 
gene and genetic screening of the family are illustrated. The relationship between 
genotype and clinical phenotype in patients with X-linked hyper IgM syndrome is 
discussed. 
Chapter 13 describes a girl with agammaglobulinemia and absence of blood 
B-Iymphocytes. Immunophenotyping of the patient's bone marrow cells enables 
characterization of the blockade in B-Iymphocyte development. Potential causes 
for the severe B-cell defect are discussed. 
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INTRODUCTION 
Lymphocytes can easily be recognized morphologically, but 
immunophenotyping with specific antibodies is needed to identify the major types 
of lymphocytes and the various lymphocyte subpopulations. Modern flow 
cytometers in combination with specially designed software programs for analysis 
of the antibody staining results enable rapid and accurate multiparameter 
evaluation of large numbers of cells in a short period of time."""w'dlo 1.2 
SAMPLE PROCESSING 
In the lysed whole blood technique (LWB), a fixed volume of anticoagulated 
blood is incubated with antibodies, red blood cells are lysed, and the sample is 
washed before it is analyzed on the flow cytometer. This LWB technique is 
currently most commonly used for flow cytometric immunophenotyping, because it 
requires fewer preparation steps and less sample handling than the previously 
used methods for staining of mononuclear cells (MNC) obtained after separation 
over a Ficoll density gradient. Furthermore, the LWB technique in principle does 
not result in differential loss of specific lymphocyte subpopulations, which has 
been observed in case of cell separation via density gradients.3 
Nowadays, virtually all routinely used antibodies are monoclonal antibodies 
(McAb) directly coupled to fluorochromes, such as fluorescein isothiocyanate 
(FITC), phycoerythrin (PE), peridin chlorophyll protein (PerCP), or the duochrome 
PE-cyanin 5 (PE-Cy5). It is important to minimize aspecific binding of McAb 
through F, receptors which are expressed on monocytes, granulocytes, NK-cells, 
and some T- and B-Iymphocytes' The LWB technique is less sensitive to 
aspecific binding, probably because immunoglobulin (I g) molecules present in the 
plasma block the F, receptor binding sites. These Ig molecules are washed away 
during the density centrifugation procedure for isolation of MNC. Dead cells show 
increased autofluorescence, potentially leading to incorrect interpretation of 
staining results. This can be minimized by using fresh samples. 
THE FLOW CYTOMETER 
Within the flow cytometer (Figure 1) the cells pass one by one through a laser 
beam. This laser beam excites the fluorochromes, which then emit light of a 
specific wave length. Photodetectors collect these fluorescent signals via several 
lens and filter systems. The laser beam is also reflected (scattered) by the cells. 
The forward scatter (FSC) and side scatter (SSC) are measures of size and 
irregularity of the cells, respectively, and are also collected by photodetectors. The 
light signals are then converted into electronic signals, which can be stored and 
analyzed with a computer using specialized software programs. 
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Figure 1. Schematic diagram of a flow cytometer. 
DATA ANALYSIS 
Data analysis is performed by isolated evaluation of the population of interest, 
e.g. lymphocytes. This is achieved by electronic gating: the so· called "Iympho-
gate" is set around the small and regularly shaped lymphocytes in an FSC versus 
SSC dot plot (Figure 2a). This gating is confirmed with analysis of the CD45 and 
CD14 staining: lymphocytes are CD45brightlCD14-, whereas monocytes are 
CD45brightlCD14bright, and granulocytes are CD45intermediate/CD14intermediate. 
Negative controls are performed with irrelevant McAb of the appropriate class 
(e.g. IgG1). The staining pattern of the McAb of interest is then analyzed within 
this "Iympho-gate", resulling in data on the intensity of staining as well as the 
percentages of lymphocyte subpopulations. 
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Figure 2. Immunophenotyping of blood T-Iymphocytes A, FSC versus SSC dot plot with 
"Iympho-gate". B, CD3 expression presented in a histogram. C, CD3 versus CD4 
fluorescence intensity presented in a dot plot. 
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Figure 3. Immunophenotyping of precursor-B-cells in normal bone marrow_ A, FSC versus 
SSC dot lot with "Iympho-gate". B, Histogram of CD19 expression within the "Iympho-
gate". C, CD10 versus CD20 expression within the CD19+ "Iympho-gate"_ The arrow 
indicates the B-cell differentiation pathway from immature CD19+/CD10++/CD20-
precursor-B-cells, to mature CD19+/CD10-/CD20+ B-Iymphocytes. 
DATA PRESENTATION 
A single parameter can be presented with a histogram displaying the 
fluorescence intensity on the X-axis, and the number of cells on the Y-axis (Figure 
2b)_ Two parameters can be presented simultaneously in a dot plot with the 
fluorescence intensity of each parameter depicted on the X- and Y-axes; each cell 
is represented by a single dot (Figure 2c). The positive and negative populations 
are then discriminated electronically by the operator of the system_ This might be 
difficult when the positivity and negativity for particular markers form a continuous 
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Figure 4. Analysis of 
TCRy1i+ T-
lymphocytes. A, After 
gating on CD3+ T-
lymphocytes a second 
gate is placed on the 
TCRy1i+ T-
lymphocytes. B, 
Detection of Vy9 
expression within the 
TCRy1l+ T-Iymphocyte 
gate. 
spectrum, such as CD10 and CD20 expression during B-cell differentiation in the 
bone marrow (Figure 3). When more then two fluorochromes are used, it is 
possible to perform an extra gating step on a subpopulation. This enables analysis 
of markers within small subpopulations, e.g. Vy and \f gene usage can be 
analyzed within the TCRyi5+ subpopulation of T-Iymphocytes after setting a 
second gate around the TCRyi5+ cells within the "Iympho-gate" (Figure 4). Using 
the total lymphocyte count obtained with a separate leukocyte count and 
differentiation, absolute counts of lymphocyte subpopulations can then be 
calculated. 5 
CHOICE OF REAGENTS FOR IMMUNOPHENOTYPING STUDIES 
Flow cytometric immunophenotyping enables quantification of lymphocyte 
subpopulations, e.g. for diagnosis of CD3+ T-Iymphocytopenia in "severe 
combined immunodeficiency" (SCID), or for follow-up of CD3+/CD4+ helper T-
lymphocyte counts in HIV-infected individuals. Alternatively, the presence or 
absence of a specific antigen can be tested with or without prior activation of the 
cells, e,g, the absence of CD18 in "leukocyte adhesion deficiency" (LAD), or the 
absence of CD40 ligand (CD40L) on activated T-Iymphocytes in X-linked hyper 
19M syndrome (XHIM). Maturation of lymphocytes can be studied with reagents 
specific for precursor markers such as in studies of precursor-B-cell differentiation 
in normal bone marrow (Figure 3), which are important for understanding the B-
cell differentiation blockade in patients with e.g. X-linked agammaglobulinemia 
(XLA). Furthermore, "naive" and "memory" markers can identify the maturational 
status of blood lymphocytes in comparative studies between infants and adults. 
Flow cytometric immunophenotyping is also used in the diagnosis and 
classification of leukemias and malignant lymphomas, the differential diagnosis of 
inflammatory conditions, the isolation of CD34+ cells for stem cell transplantation, 
and in certain routine measurements like HLA-B27 detection and red blood cell 
antigen determinations. This thesis focusses on the application of 
immunophenotyping of lymphocytes in healthy and immunodeficient children. 
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TABLE 1. Lymphocyte surface antigens studied in this thesis. 
CD no. 
COl 
C02 
C03 
C04 
C05 
C07 
C08 
COW 
C014 
C015 
CD15s 
C016 
COla 
C019 
CD20 
C02l 
C025 
C027 
C028 
CD29 
CD34 
C037 
C038 
CD40 
C045 
C045RA 
C045RO 
C058 
CD57 
C069 
C07l 
CD79a 
C079b 
CD154 
Antigen 
common thymocyte antigen 
E·roselte receptor 
TCR associated anUgen 
MHC class·1I receptor 
T1 snligen 
Tp41 pan-T -cell antigen 
MHC class-' receptorfT8 antigen 
common All antigen 
monocytic antigen 
lewls-X 
sfatyl-Lewis-X 
FeY receptor ilia 
Integrin P2 chain 
pan B-cell anUgen 
mature B-cell antigen 
a·cell antlgenfEBV receptor 
a chain of the IL2 receptor 
T-cell anUgen 
COBO(B7IBB1}/COB6(B7-2) receptor 
Inlegrin III chain 
precursor antigen 
mature B-cell antigen 
T10 antigen 
B-cell antigen 
leukocyte common antigen (LeA) 
restricted LeA, Isoform of CD45 
restricted lCA,lsoform of CD45 
neural cell adhesion molecule 
human NK-cell antigen 
activation Inducer molecule 
transferrin receptor 
mb-1; Iga; Ig associated molecule 
B29; IgJl; Ig associated molecule 
CD40 ligand; gp39 
J32 mlcroglobulln (light chain of HLA 
class-I molecule 
GpA 
HLA-DR; MHC class-II molecule 
pseudo light chaIn (VpreB/'\14.1) 
Smfg 
TCRaJl ("classlca'" T-cell receptor) 
TCRyll ralternative~ T-celJ receptor) 
Expression patternf 
cortlcallhymocytes (CD1a), subpopulalfon of B-Iymphocytes 
(COle) 
expressed on all T-Jymphocytes and most NK-cells 
mature TCR+ T-Iymphocytes 
helper T-tymphocytes; subpopulalfon of thymocytes; 
subpopufalion of monocytes 
thymocyles; mature T-Iymphocyles; subpopulallon of B-
lymphocytes 
almost all T-Iymphocytes and NK-celJs 
cytotoxic/suppressor T -lymphocytes; subpopufaUon of 
thymocytes and NK-celJs 
subpopulaUon of precursor 8-cells 
monocytes 
granlocytes; weak expression by monocytes 
granulocytes, monocytes, a nd other myeloId cells; absent in 
LAD2 patients 
granulocytes; subpopulallon of NK-cells 
mosllymphoid and myeloid cells; absent or defect In LAD1 
paUents 
precursor-B-cells and mature B-Iymphocytes 
B-Iymphocytes; subpopulaUon of precursor-B-cells 
subpopulaUon of B-Iymphocytes 
activated T- and B-Iymphocytes and NK-cells 
mature and activated T -lymphocytes 
subpopulation of T -lymphocytes 
mature CD45RO+ T-Iymphocytes 
early precursor cells (lymphoid and myeloid) 
a-lymphocytes 
Ihymocytes; activated lymphocytes; subpopulaUons of T - and B-
Iymphocyles 
mature B-Iymphocytes 
all leukocytes 
~naive~ T-Iymphocytes; B-Iymphocytes; NK-cells 
~memory" T-Iymphocytes; subpopulation of NK-celJs 
subpopulations of T-Iymphocytes and NK-cel1s 
subpopulallons of T-Iymphocyles and NK-cells 
early activated T- and B-Iymphocytes 
Ihymocytes; activated lymphocytes; erythrOid precursors 
precursor-B-cells (Cy expression); B-Iymphocytes (Sm 
expression) 
precursor-B-cells (Cy expression); B-Iymphocytes (Sm 
expression) 
activated T-Iymphocytes; absent or defect In XHIM patients 
all nucleated cells 
all erythroid cells 
hematopoietic precursors; B-Iymphocytes; activated T-
lymphocytes 
precursor B·cells; expressed with CD79a1b + J.1 heavy chaIn as 
preBCR 
B-Iymphocytes 
almost all blood T -lymphocytes 
small subpopulation of blood T-Iymphocytes 
Abbreviations used: All = acute lymphatic leukemIa, (pre}BCR = (pre) B-cell receptor, Cy = cytoplasmIc, EBV = 
Epstein-Barr virus, GpA = glycophorln A, HLA = human leukocyte anUgen, Il-2 = Interleukln-2, LAD = leukocyte 
adhesion deficiency, LCA = leukocyte common antigen, MHC = major histocompatibility complex, Smlg = surface 
membrane Immunoglobulin, TCR = T-cell receptor, XHtM = X-finked hyper IgM syndrome. 
j As relevant to the dIscussion In this thesis. 
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TABLE 2. Intracellular lymphocyte antigens studied in this thesis. 
CD no. Antigen 
C03 CyC03 
C079a COC079a(Cymb-l; Cy Iga) 
C079b CyC079b (Cy 8-29; Cy 19P) 
Cy Ig~ (heavy chain) 
K167, early Intracellular proliferation marker 
Expression pattern1 
precursor T -cells (cortical thymocytes) 
precursor B-cetls 
precursor 8.cells 
precursor B-ceUs of pre-B-ceU type 
proliferating cells during lale G1, S, G2, and M phases 
of the cell cycle 
pseudo Ught chain (VpreBI)"14.1), part of precursor B--cells 
preBCR 
TdT (Inserts nuc/eotJdes at junction sites In 19 precursor B-cefls and thymocytes 
and TCR rearrangement) 
Abbreviations used: (pre)BCR" (pre) 8-cefl receptor, Cy" cytoplasmic expression, 19 .. Immunoglobulin, TCR = T -cel! 
receptor. TdT = terminal deoxynuc!eotldyl transferase. 
t As relevanl to the discussion In this thesis. 
It is obvious that the choice of reagents is dependent on the specific diagnostic 
or research question(s) being asked. Combined staining with CD45 and CD14 
McAb and the appropriate conlrol reagents is necessary to enable accurate 
setting of the "Iympho-gate". Enumeralion of total T-Iymphocytes, B-Iymphocytes, 
and NK-cells provides an important internal control, because taken together this 
"Iympho-sum" should equal the total lymphocyte count. The selection of other 
markers is directed by the questions studied. 
The markers studied in this thesis, the antibodies used for detection, the CD-
codes, and the reactivity patlerns of the antibodies are summarized in Tables 1 
and 2. During six "Leukocyte Typing" conferences, the unique CD ("cluster of 
differentiation") codes have been assigned to well-characterized McAb to enable 
comparison of data between laboratories from all over the world. In this thesis the 
McAb are indicated with their CD-code, supplemented with the hybridoma clone 
code, and, if applicable, the fluorochrome they are conjugated to. The McAb used 
in this thesis are listed in the respective chapters. 
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ABSTRACT 
Immunophenotyping of blood lymphocyte subpopulations in neonates and 
young infants is hampered by the limited amount of blood that can be collected. 
Contamination of the flow cytometric "Iympho-gate" by normoblasts and unlysed 
erythrocytes and therefore the underestimation of the relative frequencies of 
lymphocyte sub populations interferes with the precise calculation of absolute 
counts. 
A microassay was developed by adapting the lysed whole blood technique. 
Triple immunostaining in a single antibody staining step was used to reduce 
washing steps and cell loss. Introduction of a triple staining for CD71 (expressed 
by erythroid precursors), glycophorin A (GpA, expressed by all erythroid cells), and 
CD45 (expressed by all leukocytes) permitted the relative frequencies of 
normoblasts (CD71+/GpA+/CD45- population) and unlysed erythrocytes (CD71-
/GpA+/CD45- population) to be identified and measured. Particularly high frequen-
cies of erythroid cells were found (median: 31%) in cord blood samples from 
preterm neonates. These erythroid cells disappear rapidly by 1 week of age, also 
in pre term neonates. The relative frequencies of erythroid cells can be used to 
calculate correct lymphocyte subpopulation values. Using only O.5-0.Bml of blood, 
this microassay would also be suitable for rapid prenatal immunodiagnosis of 
congenital immunodeficiencies. 
INTRODUCTION 
Immunophenotyping of blood lymphocyte subpopulations is an important tool in 
the diagnosis and follow-up of children with congenital immunodeficiencies, HIV-
infection or other immune disorders. Detailed analysis and quantitation of 
lymphocyte subpopulations is also needed for investigation of age-related 
maturational processes within the immune system in childhood. 
Immunophenotyping of blood lymphocytes used to be performed after density 
gradient separation, but the lysed whole blood technique is preferred now because 
it prevents selective cell loss, requires smaller amounts of blood, and results in 
more accurate determination of absolute lymphocyte counts.'-' 
In neonates and young infants, several problems are encountered in flow 
cytometric immunophenotyping of blood lymphocytes. The limited blood volume in 
these children and technical difficulties in venepuncture restrict the amount of 
blood that can be collected. In neonates the flow cytometric "Iympho-gate" can be 
contaminated with normoblasts and unlysed erythrocytes (Figure 1).' Normoblasts 
are comparable in size and sUrface membrane to lymphocytes and thus have 
similar flow cytometric forward scatter (FSC) and side scatter (SSC) 
characteristics. Neonatal erythrocytes are relatively resistant to osmotic lysis and 
some of them are sufficiently large to localize in the flow cytometric "Iympho-
gate".' The erythroid cell contamination hampers the determination of the relative 
frequencies of lymphocyte subpopulations and thus calculation of absolute counts 
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from the total white cell count, which is generally determined as the total nucleated 
cell count. 3 In neonates, the presence of normoblasts can also interfere with the 
determination of the white cell count, because normoblasts are nucleated, and are 
therefore included in the total count. 
To overcome these difficulties, we developed a lysed whole blood microassay 
with triple immunostaining for the identification of erythroid cells and correction for 
erythroid cell contamination within the "Iympho-gate". 
MATERIALS AND METHODS 
Twenty-one neonatal cord blood samples were' collected by venepuncture 
immediately after clamping of the cord. The blood was kept at room temperature 
until labeling with monoclonal antibodies was performed within 12 hours of sam-
pling. Peripheral blood was drawn by venepuncture from nine healthy adult 
volunteers between 20 and 40 years of age, and at 1 week of age from 14 
neonates whose cord blood had been studied previously. Ethylene-diamino-tetra-
acetate (EDTA) was used as an anti-coagulant. 
Informed consent was obtained according to the guidelines of the Medical 
Ethics Committee of the Erasmus University Rotterdam I University Hospital 
Rotterdam in all cases. 
The following monoclonal antibodies were used: CD3 (Leu-4a), CD4 (Leu-3a), 
CD8 (Leu-2a), CD16 (Leu-11c), CD19 (Leu-12), CD56 (Leu-19), CD71 (anti-trans-
ferrin receptor), CD45 (HLE1), IgG1 and IgG2 (isotype controls) (Becton Dickin-
son, San Jose, CAl, CD14 (My4), CD19 (B4) (Coulter, Hialeah, FL), CD3 (Hit3a), 
glycophorinA (GpA) (GA-R2), (Pharmingen, San Diego, CAl, CD15 (CLBgran2) 
(Central Laboratory of the Blood Transfusion Service, Amsterdam, Holland). All 
monoclonal antibodies were conjugated with fluorescein isothiocyanate (FITC), 
phycoerythrin (PE), or the duochrome PE-Cyanin5 (PE-Cy5). 
Blood samples (100, 40, 20, or 10 tJl) were incubated with titrated monoclonal 
antibodies for 10 minutes at room temperature. After two washes with phosphate 
buffered saline containing 0.1% NaN3 and 0.5% bovine serum albumin, 
erythrocytes were lysed with Lysing Solution (Becton Dickinson) according to the 
manufacturer's instructions. Before lysis the cell pellet was loosened to prevent 
incomplete lysis of erythrocytes. 
The samples were analyzed using a FACScan flow cytometer (Becton 
Dickinson). Instrument settings were determined with cells labelled with FITC, PE, 
and PE-Cy5 conjugated monoclonal antibodies and unstained cells. After gating of 
lymphocytes on the basis of FSC and SSC (checked by CD14, CD15, and CD45 
monoclonal antibody staining), 8000 events were acquired. The data were 
analyzed using FACScan software (Becton Dickinson) in dot plots, with optimal 
quadrant setting checked by histogram analysis, if necessary. 
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Leukocyte count and differentiation 
The total nucleated cell count was determined on an H1 Technicon hemocyto-
meter (Bayer, Tarrytown, NY). The relative frequency of normoblasts was carefully 
determined by manual differentiation of at least 400 nucleated cells. The total 
leukocyte count was determined according to the following formula: 
total nucleated cell count x (100-percentage of normoblasts) x 10.2 
The relative frequencies of lymphocyte subpopulations were calculated according 
to the following formula: 
percentage of population within the "Iympho-gate" x 10 2 
100 - (percentage of normobtasts plus percentage of unlysed erythrocytes within the "Iympho·gate") 
The Wilcoxon rank sum test or Friedman's test were used to compare two or 
more than two different techniques used in one blood sample, respectively (0 = 
0.05). 
RESULTS 
Development of microassay 
We incubated 100, 40, 20, and 10 IJI of blood with monoclonal antibodies. 
When using 20 IJI of blood, at least 100,000 nucleated cells remained available 
after completion of the staining procedure in all samples tested, as determined by 
use of a cell counter (Coulter Counter; Hialeah, FL). However, when using 10 IJI of 
blood, major and variable cell loss was observed. Relative frequencies of 
lymphocyte subpopulations determined in parallel with either 100 IJI or 20 IJI of 
blood per test tube gave fully comparable results in five separate neonatal blood 
samples. Therefore, 20 IJI of blood incubated with 20 IJI of each monoclonal 
antibody per test tube was used in all further experiments. 
The determination of the relative frequencies of lymphocyte subpopulations by 
either double or triple immunostaining was compared in one adult and six cord 
blood samples - for example, triple CD4/CD8/CD3 vs double CD4/CD8, CD4/CD3 
and CD8/CD3 immunostaining. When using triple immunostaining, monoclonal 
antibodies were incubated consecutively, with each incubation followed by two 
washes, or all together. No significant differences were found between the relative 
frequencies of lymphocyte subpopulations, as determined by the different staining 
methods. Therefore, in all further experiments only triple immunostaining was 
used with incubation of all three fluorochrome conjugated monoclonal antibodies 
simultaneously to speed up the microassay and minimize cell loss due to multiple 
washes. 
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Table 1. Composilion of "Iympho-gate" In neonatal and adult blood samples. 
'Lympho-gate' Preterm neonates Term neonates The same Adults (n=9) 
populations (n=6) (n=15) neonates at one 
week of age (one 
preterm and 13 
term neonates) 
Mean Median Range Mean Median Range Mean Median Range Mean Median Range 
"lympho-sum" b 57' 61 24·78 85 86 67-95 95 96 92-96 96 96 97-100 
CD14+ monocytes 2 2 1-2 1 1 0-3 1 1 0-2 1 1 0-2 
C01S+ granulocytes 1 1 0-1 1 1 0-1 1 1 0-1 0 0 0-1 
CD71+/GpA.+/CD45- 31 29 6-57 10 7 3-28 0 0 0-1 0 0 0-0 
normoblasls 
CD71-/GpA+/CD45- 4 3 2-5 2 0-11 2 0-6 0-2 
unlysed erythrocytes 
• All numbers represent percentages 
b "lympho-sum = C019+- +- CD3+ +- CD3-ICD16/56+ (8 + T +- NK) without correction for the erythroid cell contamination 
of the "Iympho-gale·. 
TABLE 2. Illustration of erythroid cell contamination bias In two cord blood samples. 
Gestational age Erythroid cells CD3+ CD19+ 
within the T -lymphocytes B-Iymphocytes 
'Iympho-gate' 
N«mob/asts Unly$e<I Uncorrected Conected Unconected Corrected 
erythrocytes 
29 weeks 44' 5 26 54 18 36 
35 weeks 40 3 24 43 10 17 
• All numbers represent percentages 
b Without correction for the erythroid contamination of the "lympho-gate", 
C With correction for the erythroid contamination of the "Iympho-gate"_ 
Detection of erythroid cell contamination 
CD16156+CD3- "Lympho-sum· 
NK-cells 
UllCO(recte<i Comcted UflCOITec!ed Collected 
10 20 56 110 
17 30 51 69 
When a scatter gate is set around the lymphocyte population, it is generally not 
possible to exclude fully other contaminating cells without excluding lymphocytes. 
However, as long as the sum of the relative frequencies of B-Iymphocytes, T-
lymphocytes, and NK-cells (the so-called "Iympho-sum") is at least 95% (or 0.95), 
the "Iympho-gate" is often considered to be placed correctly_ The remaining 
events within the "Iympho-gate" are monocytes, granulocytes, and unidentified 
events, which generally consist of dead cells and debris. In our neonatal cord 
blood samples the "Iympho-sum" rarely reached 95% of the "Iympho-gate" (Table 
1). In preterm neonates, in particular, the "Iympho-sum" seemed to be far too low. 
This was caused by a relatively high frequency of unidentified events (Figure 1). 
Normoblasts express CD71 and GpA, whereas erythrocytes express only GpA. 
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In contrast, leukocytes express CD45, unlike normoblasts and erythrocytes. 
Therefore, CD71 +/GpA+/CD45-celis within the "Iympho-gate" can be regarded as 
normoblasts, whereas unlysed erythrocytes have the CD71-/GpA+/CD45-
immunophenotype.5 By triple immunostaining with CD71-FITC, GpA-PE, and 
CD45-PE-Cy5, these unidentified events could be identified as contamination by 
normoblasts and in some samples by unlysed erythrocytes as well (Figure 2; 
Table 1). The FSC and SSC of these normoblasts and unlysed erythrocytes was 
checked ("back-gating"), and was found to be relatively low, as expected for these 
cells (Figures 2c and 2d). 
A small percentage of events remained unidentified - that is, they were neither 
CD45+ leukocytes, nor CD71 +/GpA+/CD45- normoblasts, nor 
CD71-/GpA+/CD45- un lysed erythrocytes (left lower quadrant of dot plot in 
Figure 2b). These events may represent dead cells and debris. 
Erythroid cell contamination in neonatal blood 
CD71/GpAlCD45 staining was used to determine the relative counts of normo-
blasts and unlysed erythrocytes and to calculate the relative counts of lymphocyte 
subpopulations. The differences in relative frequencies of lymphocyte 
sub populations in neonatal cord blood with and without a correction for 
normoblasts and unlysed erythrocytes are shown in Table 2 for two samples. 
Normoblasts were not found by manual differentiation or flow cytometric 
immunophenotyping in blood samples from the same neonates at 1 week of age 
nor in blood samples from adults, but unlysed erythrocytes were still present in 
some samples at 1 week of age (Table 1). 
DISCUSSION 
We have developed a microassay for flow cytometric determination of blood 
lymphocyte sub populations in neonates and young infants by adapting the lysed 
whole blood technique using one step triple immunostaining. When only double 
immunostaining is available, more blood is needed and less detailed results are 
obtained - for example, double-positive CD45RA+/CD45RO+ CD3+ T-
lymphocytes cannot be identified. This microassay needs only about O.4ml of 
blood to determine T-Iymphocyte subpopulations for monitoring HIV-infected 
infants, and 0.5 to 0.8ml of blood is sufficient for detailed evaluation of infants with 
suspected congenital immunodeficiencies. Extensive protocols for research 
purposes can also be performed, because 1.0ml of blood is sufficient for more 
than 40 triple immunostainings. These are acceptable volumes in infants and even 
in preterm babies. 
Normoblasts and unlysed erythrocytes can be present in considerable 
numbers in neonatal samples.' The presence of normoblasts cannot be prevented 
by technical measures, but strict adherence to a rigorous lysing protocol can 
minimize the number of unlysed erythrocytes in a sample. Therefore, 
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Figure 1. Flow cytometric immunophenotyping of neonatal cord blood lymphocytes 
reveals a high frequency of unidentified events within the "Iympho-gate". A, "Iympho-gate" 
setting in neonatal cord blood, based upon FSC/SSC characteristics. B, Composition of 
the "Iympho-gate" in neonatal cord blood: many unidentified events and relatively high 
numbers of NK-cells were observed. C, "Lympho-gate" setting in adult blood. D, 
Composition of the "Iympho-gate" in adult blood: virtually no unidentified events and 
relatively low numbers of NK-cells were observed. Quadrant 1: CD14+ contaminating 
monocytes, and CD3-ICD16+ICD56+ NK-cells. Quadrant 2: CD3+ T-Iymphocytes, CD19+ 
B-Iymphocytes, and CD15+ contaminating granulocytes. Quadrant 3: Unidentified events. 
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Figure 2. Triple staining for CD71, GpA, and CD45 identifies normoblasts and unlysed 
erythrocytes within the "Iympho-gate". A, "Lympho-gate" setting. B, CD71 +/GpA+ICD45-
population of normoblasts and the CD71-/GpA+ICD45- population of unlysed erythrocytes 
within the CD45- "Iympho-gate". C, "Back-gating" of CD71+/GpA+ICD45- normoblasts 
into the "Iympho-gate". D, "Back-gating" of CD71-/GpA+ICD45- un lysed erythrocytes into 
the "Iympho-gate". 
identification of both cell populations is of interest. Using triple immunostaining for 
CD71, GpA, and CD45, we were able to identify both normoblasts 
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(CD71+/GpA+/CD45- cells) and unlysed erythrocytes (CD71-/ GpA+/CD45- cells) 
within the "Iympho-gate", and to measure their relative frequencies. When only 
double immunostaining is available, the GpA+/CD45- cells can be used to 
measure the relative frequency of erythroid cells, but normoblasts and unlysed 
erythrocytes cannot be identified separately. The relative frequencies of erythroid 
cells can be used to calculate the correct relative frequencies of blood lymphocyte 
subpopulations. This is especially important in preterm neonatal and prenatal 
blood samples, where the relative frequencies of normoblasts and unlysed 
erythrocytes can be high (Tables 1 and 2),· and the frequencies of lymphocyte 
subpopulations can be underestimated. This can be confusing if a congenital 
immunodeficiency is suspected. The erythroid cell contamination of the "Iympho-
gate" rapidly disappears after birth and is virtually absent by 1 week of age (Table 
1). 
In conclusion, we have developed a fast and easy to use lysed whole blood 
microassay for immunophenotyping neonatal and infant blood lymphocyte 
subpopulations. It requires only a small volume of blood (20 ~I per test tube), and 
offers a method to correct for the presence of normoblasts and unlysed 
erythrocytes in neonatal samples. It would also be suitable for rapid prenatal 
immunodiagnosis of congenital immunodeficiencies when genetic markers are not 
available.' 
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ABSTRACT 
Technical developments in immunophenotyping and function testing have 
greatly facilitated studies on the developing lymphocyte system in the past decade 
and contributed to a better interpretation of the data obtained in these studies. 
This is important for the correct interpretation of data obtained in pediatric patients 
with possible immunological diseases. The age-related differences in lymphocyte 
subpopulations and function imply that the available adult reference values can 
not be used in children. 
In this review we give an outline of the technical developments, their influence 
upon the interpretation of data, and the available literature about age-related 
changes in the developing lymphocyte system. . 
INTRODUCTION 
Immunophenotyping of blood lymphocyte subpopulations and assays of 
lymphocyte function are important tools in the diagnosis and follow-up of children 
with immunodeficiencies and other immune disorders. Correct interpretation of the 
results obtained in patients requires knowledge of the normal development of the 
immune system during the first years of life. In this review we give an outline of 
this rapidly evolving field. 
Several differences between lymphocyte subpopulations obtained by 
immunophenotyping in healthy neonates, infants and adults have been 
reported."" In addition, in neonates and infants, lower levels of lymphocyte 
function as compared to adults have been described." This implies that the 
available adult reference values cannot be used in children. 
The decreased levels of lymphocyte function in neonates and infants should 
not be regarded as a deficiency. Healthy neonates and infants are 
immunocompetent, but, because of the virgin status of their immune system, they 
do react differently to antigens and are less efficient in coping with some 
pathogens." Their lymphocytes undergo maturational changes that are essential 
for normal development: the virgin immune system is being educated. 
In the past decades, many reports have been published on the development of 
the lymphocyte system during the first years of life. Over time, it has become clear 
that several problems and pitfalls are encountered in the analysis of lymphocytes 
in neonates and infants, which have led to erroneous conclusions. Therefore, 
interpretation of the obtained results has been adapted gradually. 
PROBLEMS ENCOUNTERED IN PEDIATRIC STUDIES 
Most stUdies on the human immune system have been performed in adults, 
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and many questions concerning lymphocyte development in children are not yet 
(fully) answered. This is mainly due to the fact that it is more difficult to obtain 
blood from healthy children than from healthy adults. Also, the volume of blood 
that is needed for these studies can pose a practical problem. Therefore, most 
pediatric studies have been performed on neonatal cord blood, which can easily 
be obtained in larger quantities. However, results from cord blood are of limited 
value for understanding lymphocyte development at later time points in infancy 
and childhood. Another problem when using cord blood for flow cytometric 
immunophenotyping is the presence of normoblasts in the circulation before and 
shortly after birth (see below)." 
TECHNICAL DEVELOPMENTS 
Initially, immunophenotyping of blood lymphocyte sub populations was only 
performed on mononuclear cell (MNC) fractions obtained after separation of the 
blood samples over a Ficoll density gradient; such MNC fractions mainly contain 
monocytes and lymphocytes. Currently, absolute counts of lymphocyte 
subpopulations can be determined more accurately by means of the flow 
cytometric lysed whole blood technique, which allows analysis of unseparated 
blood samples after osmotic lysis of the erythrocytes. This technique also prevents 
selective cell loss in some subpopulations, as seen in Ficoll density gradients.2• 
Furthermore, virtually all polyclonal antisera have been replaced by well-defined 
monoclonal antibodies (McAb), many of which can be obtained as fluorochrome 
conjugates. This minimizes aspecific binding and allows easy immunostaining for 
detailed analysiS of lymphocyte sub populations by multiparameter flow cytometry. 
Generally, in flow cytometry the staining pattern of combinations of two to three 
fluorochrome-conjugated antibodies are analyzed within the "Iympho-gate", set 
according to the lymphocytes' forward scatter (FSC) and side scatter (SSC) 
characteristics, which are regarded as measures for size and irregularity of the 
cells, respectively (Figure 1)." Recently, reference values for relative frequencies 
and absolute counts of the main lymphocyte subpopulations were obtained with 
this technique for all pediatric age groups.· 
The determination of lymphocyte activation and proliferation after mitogen 
stimulation has developed from overall measurement of radioactively labeled 
thymidine uptake in MNC fractions (a measure of DNA-synthesis) to non-
radioactive flow cytometric methods, such as calcium influx measurement," 
detection of activation-induced molecules like cluster of differentiation (CD) 69.' 
and measurement of expression of intracellular proliferation antigens like Ki67 at 
the single cell level (Figure 2).20.22 Furthermore, tests using interleukins (IL) (e.g. 
IL2), specific antigens (e.g. tetanus toxoid), and antibodies which recognize 
specific co-stimulatory molecules on T- and B-cells (e.g. CD3, C02, CD28, and 
CD40 proteins), have been developed for lymphocyte stimulation, enabling a more 
detailed analysiS of defects in lymphocyte function." These tests all show great 
variability and reference values for children have not yet been established. 
Therefore, cautious interpretation of results is warranted, preferably with age-
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matched controls run in parallel. 
The determination of soluble cytokines has improved as well, because most 
cytokines can nowadays be measured directly in ELISA systems instead of 
indirectly via functional assays," Even intracellular detection of cytokines can now 
be performed by flow cytometry, which allows the determination of "cytokine 
profiles" of lymphocyte subpopulations, such as T-helper 1 (IL2, IFNy) and T-
helper 2 (lL4, IL5, IL 10), or T-naive (IL2) and T-memory (IFNy) profiles",34,5o 
Furthermore, many cytokines are now available in recombinant forms, allowing 
more precise in vitro functional studies for specific research purposes, 
These technical improvements have greatly facilitated studies on the 
lymphocyte system, and contributed to beUer interpretation of the data obtained in 
these studies, 
FORMER PITFALLS IN THE INTERPRETATION OF PEDIATRIC 
IMMUNOPHENOTYPING DATA 
In the past, restrictions in technical possibilities have impeded the opportunities 
to test the interpretation of data from pediatric immunological studies, A clear 
example is the assumption that immature "thymocyte-like" lymphocyte precursors 
are present in the neonatal circulation, as suggested by studies on the distribution 
of blood lymphocyte subpopulations in the 1980's, ",18,'9,31,33,",<4 E-rosetting 
lymphocytes (i.e, lymphocytes binding to sheep erythrocytes) were considered to 
be equivalent to T-Iymphocytes, Consequently, cord blood cells with a low affinity 
E-roseUe receptor causing lower relative counts of E-rosetting lymphocytes as 
compared to adult cells were initially assumed to be T-cell precursors,"'" This 
idea of immature "thymocyte-like" precursors in the neonatal circulation was 
further strengthened by the finding of CD8+/CD3- cells" and CD4+/CD3- cells,15,'9 
as well as CD1+ cells,15,'9,'9,31,33,<4 CD38+ cells,,,,18,'9,33 and CD71+ cells'9,<4 in cord 
blood MNC fractions, CD8+/CD3- and CD4+/CD3- cells were assumed to be 
thymocytes in a specific developmental stage, whereas CD1, CD38, and CD71 
were known to be expressed by thymocytes, Also, the sum of CD4+ and CD8+ 
lymphocytes often exceeded the CD3+ lymphocyte count, which suggested that an 
appreciable number of CD4+/CD8+ "double-positive" thymocytes was 
present. 15,18, 19,31-33,44 
Recent studies using double and triple immunostaining have revealed that no 
such immature "thymocyte-like" lymphocyte precursors exist in the neonatal 
circulation, CD8+/CD3- lymphocytes (Figure 1 b) are in fact CD8+ natural killer 
(NK) cells (Figure 1c), which also have a low affinity E-roseUe receptor.',38,39 The 
presence of relatively high numbers of CD8+ NK-cells explains the difference 
between the sum of CD4+ (= CD4+/CD3+) and CD8+ (=CD8+/CD3+ + CD8+/CD3-) 
lymphocytes and the number of CD3+ lymphocytes, Furthermore, "double-
positive" CD4+/CD8+ lymphocytes were never found in significant numbers in cord 
blood with double immunostaining studies (Figure 1 d)",38,39 CD4+/CD3- cells 
42 CHAPTER 4 
~ 
----j ~ " ... .>. -". .' 
'MNC-gata" 
CQ4';COI4' 
"""'<>:y!.' 
C;br.~w.;r~ 8",.",··':",":cdL""'''-''''''',31<.',;''FfT'''-C'--..J 
Figure 1, In neonatal cord blood, the difference between the sum of CD4+ and CD8+ cells 
and total CD3+ cells is caused by CD8+/CD3- NK-cells and by small CD4+/CD3-
monocytes within the "Iympho-gate". A, FSC versus SSC dot plot with "Iympho-gate" and 
"MNC-gate"; the "MNC-gate" contains lymphocytes as well as monocytes. B, Relatively 
high frequencies of CD8+/CD3- lymphocytes are found, C, CD8 expression is found on 
CD3-/CD16.CD56+ NK-cells. D, Hardly any CD4+/CD8+ "double-positive" lymphocytes 
are present E, A population of CD4+/CD3- cells is present within the "MNC-gate"; this 
population is partly included in the "Iympho-gate" if the gate is set too wide, F, The 
CD4+/CD3- cells are CD4+/CD14+ monocytes. 
(Figure 1e) are in fact small CD14+ monocytes with the same size as 
lymphocytes, thereby "contaminating" the "Iympho-gate" (Figure 1f). The CD1+ 
lymphocytes were found to be CD1c+ B-Iymphocytes (=CD1c+/CD19+), which 
occur at relatively high frequencies in cord blood (Figure 3)." CD71+ cells can be 
found in large numbers in cord blood, but most of them are not CD71 + 
lymphocytes, but CD71+/GlycophorinA(GpA)+/CD45- normoblasts (Figure 4). 
These normoblasts are mainly located within the "Iympho-gate", because their 
size and surface irregularity are similar to those of lymphocytes, resulting in similar 
scatter characteristics. The presence of these normoblasts within the "Iympho-
gate" leads to underestimation of the size of lymphocyte subpopulations. lO This 
can interfere with accurate prenatal or early neonatal diagnosis of possible 
congenital immunodeficiency. 
CURRENT VIEWS 
Because neonates and infants are more susceptible to infections, it is likely 
that their lymphocytes are functionally immature in comparison with adults. 
However, these lymphocytes are not "thymocyte-like", as was previously thought. 
Recent studies have shown that CD45RA+ "naive" T-cells occur at high relative 
frequencies in neonates and infants, whereas CD45RO+ "memory" T-cells occur 
day 0 day 0 day 0 day 0 day 0 
.. , .... 
FSC Ki-67-FITC Ki-67-FITC Ki-67~F1TC Ki-67-F1TC 
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Figure 2. Evaluation of in vitro lymphocyte proliferation of various lymphocyte subpopulations by staining for the nuclear Ki67 
proliferation antigen. Blood MNC were stimulated with Staphylococcus aureus protein A and evaluated for the expression of Ki67 by 
CD3+ T-Iymphocytes, CD4+ T-Iymphocytes, CD8+ T-Iymphocytes, and CD19+ B-Iymphocytes at day 0 (upper part) and at day 5 
(lower part) of culture. This figure illustrates that Staphylococcus aureus protein A especially stimulates CD4+ T-Iymphocytes, whereas 
CD8+ T-Iymphocytes prOliferate at much lower rates and CD19+ B-Iymphocytes are virtually absent on day 5 of culture. 
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Figure 3. C01+ cells in 
neonatal cord blood are 
B·lymphocytes, not T-
lymphocytes. A, C03+ 
T ·Iymphocytes in 
neonatal cord blood 
hardly express the 
C01a antigen (T6, 
Coulter, Hialeah FL). 8, 
C01c expression (7C6, 
dr. W. Knapp and dr. O. 
Majdic, Vienna, Austria) 
is found on 
approximately 87% of 
C019+ B·lymphocytes 
(median of 15 neonatal 
cord blood samples). 
:. ',.". 
CD7f+/GpA+/CD4S-
normoblasls 
,"' . 
~;>'I:~.: 
CD71(66IGl0)·FITC 
Figure 4. Most C071+ cells within the "Iympho-gate" of neonatal cord blood samples are 
normoblasts. A. C03+ T-Iymphocytes hardly express the transferrin receptor C071. 8, 
Only a small subpopulation of C019+ B-Iymphocytes in neonatal cord blood expresses 
C071 (median 7% in 15 neonatal cord blood samples). C, Most (50 to 98% in 15 neonatal 
cord blood samples) of C071 + cells within the "Iympho-gate" of neonatal cord blood are 
C071 +/GpA+/C045- normoblasts. 
at lower relative frequencies.'·'·14,,,,,, Functional differences fit in with this 
C045RNCD45RO distribution: decreased proliferation of T-cells after stimulation 
with McAb, decreased T-helper function, and the cytokine profile all belong to the 
IInaiveu CD45RA+ phenotype. 2,4, 12, 17,27,28,42,45,47·50 
Tables 1 and 2 summarize recent literature data about the relative frequencies 
of lymphocyte subpopulations in neonates and infants as compared to 
adults.",,5,', •.•. 11.14.,.,21'''''',36.''.'' It is important to realize that relative frequencies of 
lymphocyte sub populations may be smaller than in adults, but that absolute 
numbers are higher due to the increased number of lymphocytes in neonates and 
infants,' Also, unidentified normoblasts in the neonatal circulation may have 
influenced the outcome of the studies performed in cord blood." 
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TABLE 1. Literature data on the relative frequencies of T-Iymphocyte 
subpopulatlons in the first years of life as compared to adults. 
Pan-T·eell Helper! Activation markers Naive/memory TCR Other 
markers suppressor markers molecule 
markers 
41. 
CD2wCD3 CD4 and cos ratio G02S HLA-OR C069 CD40L CD45RA CD45RO e029 TCR:i6 C038 
Neonatal conlra· II II 
cord blood dietary 
rasulls 
Infant blood contra-
dictory 
results 
Literature Refs. 1,2,4, Refs. 1,2,4,24, Refs. 1,8,24,46,47 Refs. 2, 24. 28, Refs. Refs. 
24,26,28, 26. 28·30. 43-46 29.44.48 24,44 24,28 
30,43-46 
I: higher compared to adults, 1': much higher compared to adults, I: lower compared to adults, =: sImilar to adults, 
__ : Increase during Infancy, ,,: decrease during Infancy; TCR = T-cell receptor. 
TABLE 2. Literature data on the relative frequencies of B-Iymphocyte and NK-cell 
subpopulations in the first years of life as compared to adults. 
Pan-B·cell mT -cell associated~ F<;y receptor NK-cell markers 
markers markers 
CD19 and C020 CD' CDle CD16 CD56 CDS7 
Neonatal cord blood absent 
Infant blood 
" 
literature Refs. 1. 2, 4, 24, Refs. 2, 27, 44 Refs. 1,2.24,28, Refs. 1, 2, 4, 24, 44, 
27.28.44-46 46.50 46,50 
!: higher compared to adults, I: lower compared 10 adults 
,.: increase during Infancy, ,: decrease during Infancy, ,.,: first increase, than decrease during infancy 
Table 3 summarizes the current knowledge about lymphocyte 
function.'·'·12.17.27.,,,,,,,,.,,.,. The information in this table indicates that T-
lymphocytes, S-Iymphocytes, and NK-cells in neonates and infants are indeed 
functionally immature. 
The age-related changes summarized in Tables 1-3 clearly underline the 
importance of using age-matched controls and reference values when analyzing 
the pediatric lymphocyte system. 
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TABLE 3. Literature data on lymphocyte function in the first year of life. 
Lymphocyte subsets and functions Literature 
r·lymphocytes 
Helper function of T·lymphocytes for immunoglobulin (Ig) produclion by B· Refs. 36. 37. 49 
lymphocytes is lower in neonatal cord blood than in adult blood; adult B· 
lymphocytes produce less Ig when helped by neonatal T·lymphocytes 
instead of by adult T-Iymphocytes or their respective culture supernatants. 
Neonatal T-Iymphocytes cannot induce neonatal B-Iymphocytes to produce 
IgG. whereas adult T·lymphocytes can. 
Proliferation after stimulation with mitogens is similar in neonatal cord blood Refs. 6, 31-35 
and adult blood. Proliferation is lower after stimulation with McAb in neonatal 
cord blood, which can be overcome by adding another stimulus. 
The production of IL2 is similar in neonatal cord blood and adult blood; the Refs. 6. 31·35. 
production of IFNy Is lower in neonatal cord blood; the production of IL4 is 38·41 
virtually absent in neonatal cord blood. 
a·lymphocytes 
Ig production is restricted to the IgM isotype during the first month of life; IgG Ref. 36 
and IgA appear later. 
19 production after Epstein-Barr virus stimulation of neonatal cord blood cells Ref. 36 
in vitro is restricted to the IgM isotype as welL 
NK·cells 
NK cytotoxicity is lower in neonatal cord blood than in adult blood in some Ref. 50 
but not all infants; limited information is available. 
FUTURE PERSPECTIVES 
Although nowadays much is known about the development of lymphocyte 
phenotype and function in healthy neonates and infants, many questions remain. 
Extensive knowledge of the normal development of the immune system during the 
first years of life and the availability of reliable tests wilh proper reference values 
for neonates and infants is of ulmost importance to optimize our care for children 
wilh immune disorders like HIV·infection and congenital immunodeficiency 
disease, and for children after bone marrow transplantation, or children with 
cancer during and after intensive courses of chemotherapy. 
The development of microassays for immunophenotyping as well as for 
functional testing of lymphocytes will make iI possible to undertake more extensive 
studies in neonates and young infants, and to obtain adequate reference values. 
Precise identification and enumeration of normoblasts within the "Iympho·gate" will 
Analysis of the developing lymphocyte system 47 
enhance the value of results obtained from neonatal cord blood. Preferably, 
longitudinal studies should be performed to assess the course of lymphocyte 
development during the first years of life in relation to factors like nutrition, 
infections, and vaccinations. This will lead to a better understanding of the 
interaction between the pediatric immune system and the pathogens with which it 
is challenged. 
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ABSTRACT 
We compared the absolute counts of lymphocyte subpopulations in 5 preterm 
neonates, 15 term neonates, and 9 adults using the whole lysed blood technique 
with 15 different triple immunostainings. To obtain accurate absolute lymphocyte 
counts in neonatal cord blood samples, the flow cytometric "Iympho-gate" was 
corrected for the erythroid cell contamination by normoblasts and unlysed 
erythrocytes. 
In contrast to earlier studies where relative frequencies were reported, we 
found that the major difference between neonatal and adult lymphocyte 
subpopulations concerned the much larger pool of naive "untriggered" cells in 
neonates, standby for participation in primary immune responses. In some 
preterm neonates this pool of "naive" untriggered cells was smaller than in term 
neonates, which might explain their higher susceptibility to infections, due to a 
slower or less efficient primary immune response as compared to term neonates. 
INTRODUCTION 
Neonates have an increased susceptibility to infections due to a functional 
immaturity of their immune system 1 which has not yet been challenged by 
antigens. Detailed flow cytometric analysis of blood lymphocyte subpopulations in 
preterm and term neonates in comparison with data obtained in adults can 
contribute to a better understanding of this functional immaturity. This is most 
easily performed in neonatal cord blood which is available in large quantities 
without the need for venipuncture of the child itself. Neonates have higher blood 
lymphocyte counts than adults?" Therefore, the actual differences in size of 
lymphocyte subpopulations between neonates and adults are better reflected by 
comparison of their absolute counts than by comparison of their relative 
frequencies. ' 
However, it is difficult to obtain accurate absolute counts of lymphocyte 
subpopulations by flow cytometric immunophenotyping of neonatal cord blood. 
This inaccuracy is caused by erythroid cell contamination of the so-called "Iympho-
gate". Blood lymphocytes have a relatively homogeneous size and surface 
membrane morphology which give characteristic forward scatter (FSG) and side 
scatter (SSG) patterns in flow cytometric immunophenotyping that can be used for 
defining the "Iympho-gate" (Figure 1 a).' Normoblasts are erythroid precursors, 
which can be present in considerable quantities in neonatal cord blood?" They 
have comparable size and scatter characteristics as lymphocytes, and are mainly 
located within this "Iympho-gate". Furthermore, neonatal erythrocytes are relatively 
resistant to lysis,' and are sometimes large enough to be located within the 
"Iympho-gate" as well.' This erythroid contamination of the "Iympho-gate" disturbs 
the determination of lymphocyte subpopulations.' The transferrin receptor GD71 is 
expressed on erythroid precursors, and glycophorin A (GpA) is expressed on all 
erythroid cells. GD45 is expressed on all leukocytes. Therefore, we used the 
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CD71/GpNCD45 triple immunostaining for recognition of the erythroid cell 
contamination of the "Iympho-gate"; this prevents underestimation of the relative 
frequencies of the various lymphocyte subpopulations and allows accurate 
calculation of absolute counts" 
We studied the absolute counts of lymphocyte subpopulations in fifteen term 
neonatal cord blood samples and five preterm neonatal cord blood samples, and 
compared the results with data obtained in nine adult peripheral blood samples. 
We especially studied markers that have been reported to be present in different 
relative frequencies on neonatal as compared to adult lymphocytes,·" to see 
whether comparing the actual numbers of these subpopulations would yield a 
different insight in the neonatal immune system. 
MATERIALS AND METHODS 
Cell samples 
Neonatal cord blood was collected by venipuncture immediately after clamping 
of the cord from fifteen healthy term infants born after an uncomplicated 
pregnancy and delivery (gestational age 37-41 weeks), and from five preterm 
infants (gestational age of 29, 30, 33, 34 and 35 weeks). All preterm infants 
showed an uncomplicated course in the neonatal period, except the child born at 
29 weeks, who was ventilated for presumed bacterial infection. The blood was 
kept at room temperature until immunostaining was performed within 12 hours 
after sampling. Adult peripheral blood was drawn by venipuncture from nine 
healthy adult volunteers, aged 20 to 40 years. Ethylene-diamino-tetra-acetate was 
used as anti-coagulant. Informed consent was obtained according to the 
guidelines of the Medical Ethics Committee of the Erasmus University Rotterdam I 
University Hospital Rotterdam. 
Flow cytometric analysis 
The monoclonal antibodies (McAb; listed in Table 1) were conjugated with 
fluorescein isothiocyanate (FITC), phycoerythrin (PE), or the duochrome PE-
Cyanin5 (PE-Cy5). The same set of fifteen triple immunostainings was used in all 
samples to measure T-Iymphocytes (CD3+), B-Iymphocytes (CD19+), NK-cells 
(CD16+ andlor CD56+ I CD3-), and their various subpopulations. 
The lysed whole blood technique was used for all stainings as described 
previously" Briefly, 20 ~I of blood was incubated with three optimally titrated McAb 
for 10 minutes at room temperature. Erythrocytes were lysed with Lysing Solution 
(Becton Dickinson, San Jose, CAl. The CD71/GpNCD45 triple immunostaining 
was included to identify normoblasts and unlysed erythrocytes within the "Iympho-
gate". Samples were analyzed with a FACScan flow cytometer, using FACScan 
Research software (Becton Dickinson). 
TABLE 1. Immunostainings used in the study. 
FITC-<:onjugated McAb PE-<:onjugated McAb PE-Cy5-<:onjugated McAb Recognized lymphocyte subpopulation 
"''''M Mc:Ab clone" Marker McaAbclone Marker McAb clone 
IgGl IgGl (BO) IgG2 IgG2 (BO) IgG1 679.1 Me7 (IT) lsotype controls 
C01S ClB-gran2 (ClB) CD14 My-4 (CT) CD45 HI30 (PH) "Lympho-gate~ contents control 
CD71 66IGl0 (MS) GpA 02.10 (PH) CD45 HI30 (PH) Correction for "erythroid contamination~ of "lympho-gate~ 
COS leu-1 (SO) C019 Leu-12 (SO) C03 Htttla (PH) CD5+/C019+ and COS--/CD19+ subpopulations 
C01c 7C6 (KM) CD19 Leu-12 (SO) C03 Htttla (PH) CD1C+/CD19+ and CD1c-tCD19+ subpopulations 
CD71 66IGl0 (MS) C019 Leu-12 (Bo) C03 Httl3a (PH) Control of CD71 expression on lymphocytes 
C1)4 Leu-3a (BO) COB Leu-2a (Bo) C03 Hitt3a (PH) C04+/C03+ and C08+/CD3+ subpopuJations 
C1)4 Leu-3a (SO) C045RA 2H4 (CT) C03 Httl3a (PH) C04+/CD3+ and CD45RA+/CD3+ subpopulation 
COB Leu-2a (80) C045RA 2H4 (CCT) C03 Httl3a (PH) COS+/CD3+ and CD45RA+/CD3+ subpopulation 
C04 Leu-3a (SO) CD45RO UCHl·l (OK) C03 H_(PH) C04+/CD3+ and CD45RO+/CD3+ subpopulation 
COB Leu-2a (80) C045RO UCHl·l (OK) C03 H_(PH) C08+/C03+ and C045RO'"/CD3+ subpopulation 
C045RO UCHl-l (OK) CD45RA 2H4 (CT) C03 Htttla (PH) CD45RA+/CD3+ and Co45RO+/C03+ subpopulations 
COB leu·2a (BO) C016/C056 Leu~11c1Leu-119(BO) C03 Httl3a (PH) C08+ and CDS- NK-cells (C016 and/or C056+ and CDS-) 
CD45RO UCHl·l (OK) C016/C056 Leu-11c1 Leu~19 (BO) C03 Httl3a (PH) C045RA,+/CD3+ and CD45RO+/C03+ subpopulations 
CD45RA Leu-18 (BD) CD16/C056 Leu-11c1 Leu-19 (SO) C03 Httl3a (PH) CD45RA+/C03+ and CD45RO+/C03+ subpopuJations 
• Companies: SO = Becton Dickinson, San Jose, CA: CLB = Central Laboratory of the Blood Transfusion Service, Amsterdam, the Netherlands: MS = Monosan Sanbio, Uden, 
the Netherlands; IT = Immunotech, Marseille, France; KM = Dr. W. Knapp and dr. O. Madjic, Vienna, Austria: OK = Dakopatts, Glostrup. Denmark.; CT = Coulter Clone, 
Hialeah, FL: PH = Pharmingen. San Diego. CA. 
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TABLE 2. Relative frequencies ofT- and B-Iymphocyte and NJ(-cell (sub)populations in neonates and adults.' 
CD3+ T-Iymphocytes 
CD4+ subpopulation per CD3+ 
CDS+ subpopulation per CD3+ 
CD4/CD8 ratio 
CD4SRA+ subpopulation per C03+ 
CD45RO+ subpopulation per C03+ 
CD19+ B-Iymphocytes 
CDS+ subpopulation per CD19+ 
CD1 c+ subpopulation per C019+ 
CD71 + subpopulation per CD19+ 
C016+/56+/C03- NK-cells 
COS+ subpopulation per CD16+/56+/CD3-
Preterrn neonates Term neonates p-valueb Adults 
preterm vs term 
(n=5) (n=15) (n=9) 
52(44-<>5) 64 (46-76) NS 72 (60-83) 
75 (68-88) 73 (62-83) NS 58 (52.09) 
20 (13-26) 27 (16-35) NS 33 (27-46) 
3.8 (2.6-6.7) 2.7 (1.8-52) NS 2.0 (1.2-2.7) 
54 (38-90) 72 (44-95) NS 60 (46-71) 
28(1'~1) 21 (10-76) NS 56 (46-71) 
17 (8-31) 14 (9.21) NS 12 (7-18) 
38 (31-83) 42 (25-s2) NS 23 (13-30) 
75 (59-93) 86 (65-92) 0.041 25 (21-29) 
14 (8-45) 7 (2·20) NS 8 (3-27) 
17 (8-31) 22 (9-33) NS 14 (4-18) 
22 (19-38) 37 (24-03) 0.017 29 (11-44) 
TABLE 3. Absolute counts oftotallymphocytes and T- and B-Iymphocyte and NK-ceU (sub)populations in neonates and adults:: 
Total lymphocyteS 
C03+ T-Iymphoeytes 
CD4+/CD3+ subpopulation 
CD8+/C03+ subpopulation 
CD45RA+/CD3+ subpopulation 
CD45RO+/CD3+ subpopulation 
C019+ B-Iymphocytes 
COS+/CD19+ subpopulation 
C05-/CD19+ subpopulation 
CD1 c+/CD19+ subpopulation 
C01NC019+ subpopulation 
CD1G+/S6+/C03- NK-cells 
CD8+/CD16+/S6+/CD3- subpopulation 
Preterm neonates Term neonates p-valueb Adults 
preterm vs term 
(rr-5) (rr-15) (n=9) 
4.5 (1.3-6.4) 
2.3 (1.0-3.3) 
1.6 (0.S·2.9) 
0.4 (0.2-0.6) 
1.0 (0.4-3.0) 
0.6 (0.3-1.2) 
0.9 (0.3-1.0) 
0.3 (0.2-0.3) 
0.6 (0.1-0.7) 
0.5 (0.2-0.7) 
0.2 (0.0-0.4) 
0.7 (02-1.9) 
0.1 (0.1-0.7) 
4.9 (3.5-6.3) 
3.3 (1.9-4.4) 
2.3 (1.4-3.5) 
0.7(0.4-1.1) 
1.9 (1.2-3.9) 
0.6 (0.3-2.2) 
O.S (0.3.1.0) 
0.3 (0.1-0.4) 
0.4 (0.2-0.6) 
0.6 (0.3-0.9) 
0.1 (0.0-0.3) 
1.2 (0.4-1.5) 
0.4 (0.1-0.5) 
NS 
NS 
NS 
O.OOS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
2.1 (1.1·2.4) 
1.5 (0.7.1.8) 
1.0 (0.4-1.1) 
0.5 (0.3-0.8) 
0.9 (0.3-1.1) 
0.8 (0.5-1.0) 
0.2 (0.1-0.4) 
0.1 (0.0-0.1) 
0.2 (0.1-0.3) 
0.1 (0.0-0.1) 
0.2 (0.1-0.2) 
0.2 (0.1-0.4) 
0.1 (0.0-0.1) 
• Median percentage fon~ by minimal and maximal percentages between parentheses. 
~ Only Significant differences are listed (0:=0.05); NS = not significant 
'Median absolute count (x 10 811) followed by minimal and maximal absolute count (x 10 9/1) between p,arentheses. 
01 
'" p-valueb 
term vs adult 
0.023 
<0.001 
0.002 
0.001 
NS 
<0,001 
NS 
<0.001 
<0.001 
NS 
0.016 
NS 
(') 
~ 
p-valueb "0 ;;j term vs adult :u 
'" 
<0.001 
<0.001 
<0.001 
0.004 
<0.001 
NS 
<0.001 
<0.001 
<0.001 
<0.001 
NS 
<0.001 
<0.001 
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Lymphocyte count and differentiation 
The total nucleated cell count was determined on an H1 Technicon hemocyto-
meter (Bayer, Tarrytown, NY). The relative frequency of normoblasts was 
determined by manual differentiation of 400 nucleated cells. The total lymphocyte 
count was determined according to the following formula: 
total nucleated cell count x (100 - % of normoblasts) x (% of lymphocytes) x 104 • 
Lymphocyte subpopulations were calculated according to the following formula: 
percentage of lymphocyte subpopulation within the "Iympho-gate" 
1 00 - (percentage of normoblasts plus un lysed erythrocytes within the "Iympho·gate") 
Statistics 
After logarithmic transformation, the Student t-test for independent samples 
with either equal or inequal variance (tested by Levene's test for equality of 
variance) was used to evaluate the differences in the relative frequencies and 
absolute counts of lymphocyte subpopulations between preterm and term 
neonates and between term neonates and adults (a=0.05). 
RESULTS 
1. Technical aspects 
Erythroid cell contamination 
Within the "Iympho-gate", we found a median of 9% (range 4-29%) 
GpA+/CD45- erythroid cells in term neonates and 27% (range 11-49%) in preterm 
neonates. Most of these erythroid cells were CD71+/GpA+/CD45- normoblasts, 
which were present in all neonatal samples. More than 1 % unlysed erythrocytes 
(CD71-/GpA+/CD45-) were present in 7 out of 15 term neonatal samples and in all 
five preterm neonatal samples. 
CD71+: erythroid cells, not lymphocytes 
Most CD71 + cells (50-98%) within the "Iympho-gate" of neonatal cord blood 
were CD71+/GpA+/CD45- normoblasts (Figure 1). The relative frequencies of 
CD71+/CD19+ B-Iymphocytes in term neonates and adults were similar (Table 2); 
hardly any CD71+/CD3+ T-Iymphocytes (median 0.5%) were observed in neonatal 
or adult blood. 
Pitfalls in McAb analysis 
In neonatal cord blood as well as in adult blood, CD3, CD4, and CD19 showed 
homogeneous expression patterns, resulting in dot plots with clear positivity and 
negativity (Figure 2a); the CD8 expression pattern was different on CD3+ T-
lymphocytes (CD8high) and CD3- NK-cells (CD8intermediate) (Figure 2b). These 
markers are easy to analyse by flow cytometry. However, the CD45RA and 
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Figure 1. Most 
CD71-positive cells 
within the "Iympho-
gate" of neonatal 
cord blood samples 
are normoblasts. 
Neonatal cord blood 
sample. A, FSC 
versus SSC dot plot 
with "Iympho·gate" . 
B, Most CD71-
positive cells within 
the "Iympho-gate" of 
neonatal cord blood 
are CD71+/GpA+/ 
CD45- normoblasts. 
C, CD3+ T-
lymphocytes in 
neonatal cord blood 
hardly express the 
transferrin receptor 
CD71. D, A minor 
subpopulation of 
CD19+ B-
lymphocytes in 
neonatal cord blood 
expresses CD71. 
CD45RO isoforms showed heterogeneous expression patterns, ranging from 
negativity to high levels of expression (Figure 2c-h). This is in accordance with 
data from the literature.'·· In addition, we found a clear difference in density of 
expression of CD45RO, and to a lesser extent of CD45RA, between neonates and 
adults (Figure 2c/d); a large population of CD45RArow/CD45ROIow T-Iymphocytes 
was present in the neonates, as has been described before,· Furthermore, the 
intensity of staining was influenced by the used antibody as well as by the 
fluorochrome conjugation (FITC or PEl: PE-conjugated McAb showed a greater 
intensity of staining, as has been discribed before.' This difference was most 
pronounced with CD45RA and CD45RO McAb in the neonatal cord blood samples 
(Figure 2e-h). 
2, Lymphocyte subpopulations 
The main lymphocyte populations 
Although the relative frequencies of T-Iymphocytes were lower, S-Iymphocytes 
similar, and NK-cells higher in term neonates as compared to adults (Table 2), the 
absolute counts of T- and S-Iymphocytes and NK-cells were all higher in the term 
neonates as compared to adults, due to their higher absolute lymphocyte counts. 
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32% 
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H 3% 
"Iympho·gate" 
(adult) 
19% 
11% 
Figure 2. Pitfalls in 
the analysis of 
CD45RA and 
CD45RO 
expression by T-
lymphocytes. All 
analyses were 
performed in 
neonatal cord blood 
samples (unless 
stated otherwise) 
within the flow 
cytometric "Iympho-
gate". A. Clear 
positivity and 
negativity in CD3 
versus CD4 dot plot. 
B. Heterogeneous 
CDB expression 
analyzed separately 
on T-Iymphocytes 
(CD3+) and NK-
cells (CD3-): T-
lymphocytes are 
either CDBhigh or 
CDBnegative. CDB+ 
NK-cells show an 
intermediate 
fluorescence 
intensity. C. 
Heterogeneous 
expression pattern 
of CD45RA and 
CD45RO within the 
CD3+ T-Iymphocyte 
subset; large 
subpopulation of 
CD45RAlowi 
CD45RO low T-
lymphocytes in 
neonates. D. Idem; 
higher level of 
CD45RO 
expression in adult 
sample. E. Dot plot 
with FITC-
conjugated 
CD45RA McAb. F. 
Dot plot with PE-
conjugated 
CD45RA McAb 
(same sample as 
E). G) Dot plot with 
F I TC-conj ugated 
CD45RO McAb. H. 
Dot plot with PE-
conjugated 
CD45RO McAb 
(same sample as 
G). 
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Figure 3. Comparison of absolute counts (geometrical mean and range) of several 
Iymphocyle subpopulations in preterm neonates, term neonates, and adults. A, The 
CD45RO+ "memory" T-Iymphocyte subset has a similar size in neonates and adults, but 
the CD45RA+ "naive" T-Iymphocyte subset is much larger in the term neonates. B, The 
CD5+ B-Iymphocyte subpopulation is roughly twice as large in neonates as compared to 
adults. C, The CD1c+ B-Iymphocyte subpopulation is much larger in the neonates than in 
the adults. 
The absolute counts of T- and B-Iymphocytes and NK-cells in the preterm 
neonates were similar to those in the term neonates (Table 3). 
T-Iymphocyle subpopulalions 
The CD4/CD8 ratio was higher in term neonates as compared to adults, due to 
their high absolute counts of CD4+ T-Iymphocytes. The CD4/CD8 ratio was 
highest in the preterm infants, due to their lower absolute counts of CD8+ T-
lymphocytes (Tables 2 and 3). 
The relative frequencies of CD45RO+ "memory" T-Iymphocytes were lower in 
term neonates than in adults (Table 2), as has been described before."'" 
However, the absolute counts of the CD45RO+ "memory" T-Iymphocyte population 
were similar in both groups, whereas the absolute counts of the CD45RA+ "naive" 
T-Iymphocyte population were larger in the term neonates as compared to the 
adults (median in Table 3; geometrical mean in Figure 3a). Three out of 5 preterm 
neonates (29, 30 and 34 weeks) did not have such a large population of CD45RA+ 
"naive" T-Iymphocytes (Table 3; Figure 3a). However, the difference between the 
CD45RA+ "naive" T-Iymphocyte counts between preterm neonates and term 
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neonates was not statistically significant (Table 3). 
B-Iymphocyte subpopulations 
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Like others,"" we found that the relative frequencies of CD1c+ and CD5+ B-
lymphocyte subpopulations were larger in neonates than in adults (Table 2). The 
geometrical mean of the CD1c+ as well as the CD5+ B-Iymphocyte subpopulation 
absolute counts was larger in neonates than in adults (Figures 3b and 3c). The 
median absolute counts of both the CD5+ and the CD5- B-Iymphocyte 
subpopulation were roughly twice as large in the pre term and term neonates as 
compared to the adults (Table 3). The median absolute counts of the CD1 c+ B-
lymphocyte subpopulation were larger in preterm and term neonates than in 
adults, whereas the CD1c- B-Iymphocyte subpopulation was similar in size in 
preterm neonates, term neonates and adults (Table 3). 
NK-cel/ subpopulations 
Despite similar relative frequencies of CD8+ NK-celts in neonates and adults 
(Table 2), the absolute counts of both the CD8+ and the CD8- NK-cell 
subpopulations were larger in neonates than in adults, due to the higher absolute 
counts of NK-cells in neonates (Table 3). 
DISCUSSION 
The considerable erythroid contamination of the "Iympho·gate" we found in 
neonatal cord blood samples leads to a high relative frequency of CD71 + cells 
within this "Iympho·gate". If single instead of double or triple immunostaining is 
used, it is impossible to distinguish these CD71 + normoblasts from CD71 + 
lymphocytes.' Appropriate correction for this erythroid cell contamination of the 
"Iympho·gate", e.g. with the CD71/GpAlCD45 triple immunostaining as we did 
here, prevents underestimation of the relative frequencies of lymphocyte 
subpopulations, and allows accurate calculation of absolute counts.' 
Markers with heterogeneous expression patterns within particular lymphocyte 
subsets, like the CD45RA and CD45RO isoforms on T-Iymphocytes, are difficult to 
analyze with flow cytometric immunophenotyping without strict guidelines for 
reproducible quadrant settings." In addition, we found differences in the intensity of 
expression between the various CD45RA and CD45RO McAb conjugated to 
different fluorochromes, which were more pronounced in the neonatal cord blood 
samples. We prefered usage of PE-conjugated CD45RA and CD45RO McAb, 
because their greater intensity of staining enabled more accurate dot plot 
quadrant setting. 
After addressing the technical problems described above, we were able to 
obtain accurate absolute counts for comparison of the actual sizes of blood 
lymphocyte subpopulations in preterm neonates, term neonates, and adults. 
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Because the neonatal immune system is truly "naive", I.e. not challenged with 
antigens, it is likely that the dominant lymphocyte subpopulations in neonates 
represent "untriggered" cells, recently emigrated from the bone marrow (B-
lymphocytes) or thymus (T-Iymphocytes). The higher absolute counts of T- and B-
lymphocytes and NK-cells in neonates imply that 8ubpopulations of these cells 
which have lower relative frequencies in neonates than in adults can actually be 
similar or larger in size (I.e. have the same or higher absolute counts) in neonates. 
The importance of comparing the actual numbers of neonatal and adult 
lymphocyte subpopulations to determine which subpopulations are predominant in 
neonates, is illustrated by CD45RA and CD45RO expression on T-Iymphocytes,' 
and CD1c and CD5 expression on B-Iymphocytes.' 
We found clear differences in the relative frequencies of CD45RO+ "memory" 
T-Iymphocytes between neonates and adults, which is in line with previous 
reports."·12 However, the absolute numbers of the CD45RO+ "memory" T-
lymphocyte population were similar in both groups, albeit with a lower intensity of 
staining in the neonates, whereas the absolute numbers of the CD45RA+ "naive" 
T-Iymphocyte population were much larger in neonates as compared to adults. 
So, the differences in relative frequency of CD45RA+ "naive" and CD45RO+ 
"memory" T-Iymphocytes between neonates and adults are not caused by a 
smaller CD45RO+ "memory" T-Iymphocyte subpopulation, but by a larger 
CD45RA+ "naive" T-Iymphocyte subpopulation in neonates as compared to adults. 
In addition, the differences we found in the intensity of staining of CD45RA and 
CD45RO McAb between neonates and adults, render the interpretation of 
comparative studies between neonates and adults difficult: the 
CD45RA1ow/CD45ROIow T-Iymphocytes found in neonates, have no counterpart in 
adults. They have been presumed to be truly naive "untriggered" recent thymic 
emigrants.9 
CD5+ B-Iymphocytes are assumed to represent a more primitive lineage than 
"conventional" CD5- B-lymphocytes;lOthe role of CD1c+ B-Iymphocytes is not yet 
clear. CD1 c as well as CD5 are expressed on a higher relative frequency of B-
lymphocytes in neonates than in adults,' which suggests they could be 
"untriggered" bone marrow emigrants. CD1c+ as well as CD5+ B-Iymphocyte 
subpopulation absolute counts were larger in neonates than in adults; CD1c+ and 
CD5+ B-Iymphocytes might indeed represent such "untriggered" B-cell subsets. 
Our findings suggest that a large pool of naive "untriggered" cells is stand-by in 
term neonates for participation in primary immune responses. In some preterm 
neonates this pool was smaller than in term neonates, which might explain a 
higher susceptibility to infections, due to a slower or less efficient primary immune 
response as compared to term neonates. Antigen-triggered cells seem to be 
present in comparable numbers in neonates and adults, but the differences in 
intensity of cell surface marker expression suggest that these cells might still be 
functionally different in neonates and adults. This issue remains to be solved in 
future studies. 
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INTRODUCTION 
Recently, we described prominent age-related changes in blood lymphocyte 
subpopulations during the first years of life, especially during the first twelve 
months. These changes were only detected when absolute counts instead of 
relative frequencies were considered.' In their editorial comment in the Journal, 
Bonilla and Oettgen remarked that the presented age-related patterns of blood 
lymphocyte subset counts were measured in populations, not in individuals. 
Therefore they argued whether to use absolute counts or relative frequencies of 
lymphocyte subpopulations for the follow up of individual patients.' 
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Figure 1. Absolule counts of lymphocyte subpopulalions in ten children followed 
longitudinally from birth to one year of age. X-axis: days after birth. Y-axis: absolute count 
of lymphocyte subpopulalion x10 'II. Each graph represents one individual child. A, 
Absolute counts of CD3+ T-Iymphocytes (-), CD3+/CD4+ (-) and CD3+/CD8+ ( .. ) T-
Iymphocyle subpopulations. B, Absolute counts of CD19+ B-Iymphocytes. C, Absolute 
counts of CD16+ and/or CD56+/CD3- NK-cells. 
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METHOD 
We investigated blood lymphocyte subpopulation absolute counts in the blood 
of ten individual children followed longitudinally from birth to one year of age by 
immunophenotyping with a lysed whole blood micro assay including a 
CD71/GpNCD45 triple immunostaining to identify normoblasts and unlysed 
erythrocytes within the "Iympho-gate". 
RESULTS AND DISCUSSION 
Blood lymphocyte subpopulation absolute counts of these ten chitdren followed 
a similar pattern (Figure 1). The T-Iymphocyte population increased in size 
immediately after birth. This increase mainly concerned the CD3+/CD4+ T-
lymphocyte subpopulation, whereas the CD3+/CD8+ T-Iymphocyte subpopulation 
remained relatively stable throughout the study period. These results are 
comparable to those obtained in our cross-sectional study.' B-Iymphocytes also 
showed a rapid increase In the first six weeks of life. However, six children 
showed a slight decrease of their B-Iymphocytes in the first week of life, before 
they increased in the weeks thereafter (Figure 1 b). This transitory decrease was 
not visible in our cross-sectional study, because children aged 1 week to 2 months 
formed one age group.' These changes in B- and T-Iymphocyte subsets reflect 
the high activity of the immune system in coping with all the antigens in the 
environment: B-Iymphocytes start to build up an extensive antibody repertoire after 
birth, guided by helper T-Iymphocytes. 
Six children had very high NK-cell counts at birth. All ten children showed a 
decrease of NK-cell absolute counts in the first six weeks to three months of life 
(Figure 1c), as previously described in the cross-sectional study.' NK-cell absolute 
counts remained stable during the remainder of the first year of life, with the 
exception of one child whose NK-cell counts remained high despite a temporary 
decrease at six weeks of age (child nr.9 in Figure 1c). She was apparently healthy 
during the entire study period (Figure 1c). These findings are intriguing, but 
difficult to explain with our current limited knowledge of NK-cell function. 
The inftuence of even minor infections on blood lymphocyte (sub)populations 
was illustrated by one child who had a very high CD3+/CD8+ T-Iymphocyte count 
at 6 weeks of age (child nr.1 in Figure 1a): she suffered from her first - probably 
viral - upper respiratory tract infection at that time. 
Our observations confirm the need to perform diagnostic immunophenotyping 
of lymphocyte subpopulations in a clinically stable phase with the use of 
appropriate age-matched reference values. 
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ABSTRACT 
Age-matched reference values for lymphocyte subpopulations are generally 
obtained via cross-sectional studies, whereas patients are followed longitudinally. 
We performed a detailed longitudinal analysis of the changes in lymphocyte 
subpopulations in a group of eleven healthy infants followed from birth up to one 
year of age, with special attention for early developmental markers, markers of 
maturation, and markers of activation. 
We found that T- and B-Iymphocytes increased at 1 and 6 weeks of age, 
respectively, whereas NK-cells showed a sharp decline directly after birth. 
CD45RA+ - mainly CD4+ - "naive" T-Iymphocytes were high at birth, and 
increased further during the first year of life; they form a large expanding pool of 
cells, ready for participation in primary immune responses. The absolute counts of 
CD45RO+ "memory" T-Iymphocytes were similar in infants and adults, albeit with a 
lower level of expression of CD45RO on infant T -lymphocytes. Almost all infant T-
lymphocytes expressed CD38 throughout the first year of life. CD38 is known to 
be present on thymocytes and activated T-Iymphocytes, but we did not find any 
evidence for a premature release of "thymocyte-like" T-cells into the circulation in 
infants, nor did we find an increased expression of other activation markers. The 
abundant expression of CD38 on infant's T-Iymphocytes might be related to a 
greater metabolic need of the large population of naive "untriggered" cells which 
are continually involved in primary immune responses during the first year of life. 
The high B-Iymphocyte counts in infants mainly concerned CD38+ B-
lymphocytes throughout the first year of life. Also, the relative frequencies of 
CD1c+ and CD5+ B-Iymphocytes were higher throughout the first year of life than 
in adults. So, CD1c, CD5, and CD38 could be markers of "untriggered" B-
lymphocytes. 
NK-cells were high at birth and declined soon afterwards; they seem to be 
more important during pregnancy than thereafter. The high NK-cell count at birth 
was for a large part accounted for by CD8+ NK-cells. Also, at birth some infants 
showed large subpopulations of CD7-, CD38-, and CD45RA- NK-cells. 
In conclusion, our longitudinal survey of T- and B-Iymphocytes, NK-cells, and 
their sub populations during the first year of life helps to complete the picture of 
lymphocyte development in infants. This information contributes to the correct 
interpretation of data from infants with possible immune disorders. 
INTRODUCTION 
Immunophenotyping of blood lymphocyte subpopulations is an important tool in 
the diagnosis and follow-up of children with immune disorders. Correct 
interpretation of the obtained results requires knowledge of the normal 
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development of the immune system during the first years of life. 
For this purpose, several sets of age-matched reference values of relative 
frequencies and absolute counts of lymphocyte subpopulations in childhood have 
been reported.'" Because of the higher blood lymphocyte counts in neonates and 
infants as compared to adults,'" differences in lymphocyte subpopulations are 
better reflected by comparison of absolute counts than relative frequencies. In 
that way, trends are observed which are missed when only relative frequencies 
are used.' These absolute lymphocyte counts are more accurately determined by 
the whole lysed blood technique than by analysis after density gradient 
separation.'" 
To date, age-matched reference values for lymphocyte sub populations were all 
obtained in cross-sectional studies. Longitudinal studies in individual children are 
more informative about the pattern of lymphocyte subpopulation development in 
time. Children with immune disorders are also followed longitudinally. Therefore, it 
is useful to compare patient data with data from studies on longitudinal 
development of lymphocyte subpopulations in healthy children. Such longitudinal 
follow-up studies can also assess the influence of factors like infection and 
vaccination on the size of lymphocyte subpopulations. This information is 
important for correct timing of lymphocyte subpopulation studies for diagnostic 
purposes as well as for disease monitoring in patients. 
We therefore performed a detailed longitudinal analysis of lymphocyte 
sub populations by immunophenotyping wilh a lysed whole blood microassay in a 
group of eleven healthy infants followed from birth to one year of age. We studied 
helper- and cytotoxic-T-Iymphocytes, B-Iymphocytes, and NK-cells, and their 
subpopulations. Because the presence of immature as well as of activated cells 
has been described in neonatal samples in the past," special attention was paid to 
the expression of early developmental markers, markers of maturation, and 
markers of activation. 
MATERIALS AND METHODS 
Subjects and cell samples 
Immediately after clamping of the cord, neonatal cord blood was collected by 
venipuncture from eleven healthy infants born after an uncomplicated pregnancy 
and delivery at gestational ages of 35 weeks (infant no. 10), 37 weeks (infant no. 
6), 38 weeks (infant no. 4), 40 weeks (infants no. 2, 3, 9, and 11), and 41 weeks 
(infants no. 1, 5, 7, and 8). At the age of 7 days, 6 weeks, 3 months, 6 months, 
and 1 year additional blood samples were collected by venipuncture from the 
same infants (infant nr.11 was lost from follow-up at 6 months of age). The blood 
was kept at room temperature until immunostaining was performed within 12 
hours after sampling. Every time a blood sample was taken, a physical 
examination of the infant was performed by the pediatrician (EV), and questions 
about infections, vaccinations, feedings, and development were answered by the 
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mother. Adult peripheral blood was drawn by venipuncture from nine healthy adult 
volunteers (age 20 to 40 years). Ethylene-diamino-tetra-acetate was used as anti-
coagulant. Informed consent was obtained according to the guidelines of the 
Medical Ethics Committee of the Erasmus University Rotterdam/University 
Hospital Rotterdam. 
Flow cytometric analysis 
The monoclonal antibodies (McAb) used in thirty triple labelings (listed in Table 
1) were conjugated wilh fluorescein isothiocyanate (FITC), phycoerythrin (PE), or 
the duochrome PE-Cyanin5 (PE-Cy5). The same set of thirty triple 
immunostainings was used in all samples, to enable accurate comparison of the 
relative and absolute sizes of the different T-Iymphocyte (CD3+), B-Iymphocyte 
(CD19+), and NK-cell (CD16+ and/or CD56+ /CD3-) subpopulations between the 
infants at the various time-points in their first year of life and the adults. 
A lysed whole blood microassay was used for all stainings as described 
previously.'· Briefly, 20 ~I of blood was incubated wilh three optimally titrated 
McAb for 10 min at room temperature. Erythrocytes were lysed with Lysing 
Solution (Becton Dickinson, San Jose, CAl. The CD71/GpNCD45 triple 
immunostaining was included to identify normoblasts and unlysed erythrocytes 
within the "Iympho-gate".'· The samples were analyzed wilh a FACScan flow cyto-
meter, using FACScan Research software (Becton Dickinson, San Jose, CAl. 
Lymphocyte count and differentiation 
The total nucleated cell count was determined on an H1 Technicon 
hemocytometer (Bayer, Tarrytown, NY). The relative frequency of normoblasts 
was determined by manual differentiation of 400 nucleated cells in all samples. 
The total lymphocyte count was determined according to the following formula: 
total nucleated cell count x (100 - % of normoblasts) x (% of lymphocytes) x 104 • 
Lymphocyte subpopulations were calculated according to the following formula: 
% of population within the "Iympho-gate" X 1 a' 
1 00 - (% of normoblasts plus unlysed erythrocytes within the "lymph a-gate") 
Statistics 
After applying logarithmic transformation to obtain approximately normally 
distributed variables, repeated measurements ANOVA was used to compare the 
various time-points. Additional specific comparisons were made for T-
lymphocytes, NK-cells and their subpopulations in cord blood versus the mean of 
these parameters at the other time-points. Also, for B-Iymhocytes and their 
subpopulations the mean of cord blood and 1 week was compared to the mean of 
the time-points thereafter. To evaluate the effecls of infection, vaccination, 
medication, and breast feeding at the various time-points the t-test was used for 
each factor. In view of the number of comparisons made, the significance level 
was set at p<0.01. 
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TABLE 1. Thirty triple immunostainings used In the longitudinal study. 
Marker FITC-conjugated Marker PE-conjugated Marker PE-Cy5 conjugated 
McAb (com~an~l McAb (comean~l McAb (comean~l 
IgG1 IgGl (80) IgG2 IgG2 (80) IgGl B79.1Mc7 (IT) 
CD15 ClB·gran2 (ClS) CD14 My-4 (CT) CD45 HI30 (PH) 
C071 66IGl0 (MS) GpA 02.10 (PH) C045 HI30 (PH) 
CD37 1081 (IT) C020 Leu-1B (80) C019 HI819 (PH) 
C05 Leu-l (80) C019 Leu-12 (80) C03 Hit3a (PH) 
CD38 108B (IT) C045RA 2H4 (CT) C019 HI819 (PH) 
C03 Leu-4 (80) COla TB (CT) C019 HIB19 (PH) 
CD1e 7CB (KM) C019 Leu-12 (80) C03 Hi13. (PH) 
CD25 2A3 (80) C019 Leu-12 (80) C03 Hit3a (PH) 
C071 66IGl0 (MS) C019 Leu-12 (80) C03 HH3. (PH) 
C04 leu-3a (80) COS leu-2a (80) C03 Hi13. (PH) 
TCRap WT31 (80) C04 Leu-3a (80) C03 Hit3. (PH) 
TCRap WT31 (80) COS Leu-2a (80) C03 Hit3. (PH) 
TCRV6 TCRM (TO) C04 leu-3a (80) C03 Hi13. (PH) 
TCRyl> TCR61 (TO) COS leu-2a (80) C03 Hit3. (PH) 
C04 leu-3a (80) C045RA 2H4 (CT) C03 Hi13. (PH) 
COS leu-2a (80) C045RA 2H4 (CT) C03 Hit3. (PH) 
C04 Leu-3a (80) C045RO UCHL-l (OK) C03 Hit3a (PH) 
COS Leu-2a (80) C045RO UCHL-l (OK) C03 Hit3. (PH) 
CD45RO UCHL-l (OK) CD45RA 2H4 (CT) C03 Hit3. (PH) 
CD38 10BB (IT) CD45RO UCHL-l (OK) C03 Hit3a (PH) 
C03S 108B (IT) C045RA 2H4 (CT) C03 Hit3a (PH) 
CDS7 leu-? (SO) CD16/CD56 leu-11cJLeu-19 (80) C03 Hil3a (PH) 
C07 CL83Al/l (CL8) CD16/CD56 Leu-11c1Leu-19 (SO) C03 Hil3a (PH) 
COS leu-2a (80) COIB/C05B leu-11cJleu-19 (80) C03 Hit3. (PH) 
CD38 108B (IT) CD16fCD56 Leu-11c1Leu-19 (80) C03 Hit3a (PH) 
CD45RO UCHL-l (OK) C016/C056 leu-11cJLeu-19 (80) C03 Hit3. (PH) 
C045RA Leu-IS (80) COIB/C056 Leu-11c/Leu-19 (80) C03 Hit3. (PH) 
CD25 2A3 (80) COIB/C056 Leu-11c1Leu-19 (SO) C03 Hit3a (PH) 
HLA-OR L243 (80) C016/CD56 Leu-11c1leu-19 (BO) C03 Hit3a (PH) 
• Companies: BO = Becton DIckinson, San Jose, CA; CLB = Central Laboratory of the Blood TransfusIon Service, 
Amsterdam, The Netherlands; MS = Monosan, Sanblo, Uden, The Netherlands; IT = Immunotech, Marseille, France; 
KM = Dr. W. Knapp and dr. O. Madjlc, Vienna, Austria; TO = T-cell Diagnostics, Cambridge, f-..-\A; OK = Dakopatts, 
Gloslrup, Denmark; CT = Coulter Clone, Hialeah, FL; PH = Pharmlngen, San Diego, CA. 
RESULTS 
Subject follow-up 
All infants were born after a normal pregnancy and delivery. All had birth 
weights appropriate for gestational age. None of the infants used medication at 
any time-point when a blood sample was taken. Several infants suffered from 
minor infections of the upper airways or gastrointestinal tract around the time a 
blood sample was taken. One infant developed atopic eczema and food allergies 
(infant nr.5), No other medical problems were noted. The infants were vaccinated 
according to the regular Dutch schedule, which consisted of diphteria toxoid, 
tetanus toxoid, pertussis, and inactivated polio virus type I, II, and III (DTP-IPV) at 
3, 4, 5, and 11 months of age at the time of the study. 
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Figure 1. T-Iymphocytes, B-Iymphocytes, and NK-cells from birth to 1 year of age. 
Each graph represents one individual infant (infants no. 1-10). 
Lymphocyte counts 
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Total lymphocyte counts and T-Iymphocyte counts increased at 1 week of age. 
B-Iymphocyte counts increased at 6 weeks of age. NK-cells followed a different 
pattern: they were highest at birth and decreased at 1 week of age (Figure 1, 
Tables 2-4). 
TCR-expression on T-Iymphocytes 
Most T-Iymphocytes expressed the ap T-cell receptor (TCR) (Table 5). 
TCRyc5+ T-Iymphocyte counts increased slightly during the first year of life (Table 
2). 
Expression of CD4 and COB on T-Iymphocytes 
CD4+ helper T-Iymphocyte counts followed the pattern of total T-Iymphocyte 
counts with an increase at 1 week of age, as did CDB+ cytotoxic T-Iymphocyte 
counts (Table 2). Although both CD4+/CD3+ and CDB+/CD3+ counts were higher 
in infants than in adults, the CD4/CDB ratio was higher in infants than in adults, 
due to the very high CD4+/CD3+ counts in infants (Tables 2 and 5). 
Hardly any "thymocyte-like" T-cel/s 
In the thymus, CD4+/CDB+ "double-positive" T-cells develop into "single-
positive" CD4+ or CDB+ T-Iymphocytes," and CD1a is a marker present on 
cortical thymocytes." Hardly any CD4+/CDB+ "double-positive" or CD1 a+ T-cells 
were present in the blood of either infants or adults (Figure 2a-d, Tables 2 and 5). 
CD45 isoform expression on T-Iymphocytes 
The relative expression of the CD45RA and CD45RO isoforms was profoundly 
different between infants and adults: the median relative frequencies of CD45RA+ 
"naive" T-Iymphocytes were higher, and the median relative frequencies of 
CD45RO+ "memory" T-Iymphocytes were lower in infants than in adults (Table 5), 
as was described before.""" However, the median absolute counts of CD45RO+ 
"memory" T-Iymphocytes were similar in infants and adults, with a slight increase 
at 1 week of age (Table 2). The changes in the absolute counts of T-Iymphocytes 
during the first year of life were mainly accounted for by changes in the size of the 
CD45RA+ "naive" T-Iymphocyte population, not by changes in the size of the 
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Figure 2. Expression of 
early developmental 
markers and markers of 
maturation by T-
lymphocytes. Hardly any 
CD4+/CD8+ "double-
positive" T-cells were 
present in neonates (A) 
and adults (8). CDl a 
was hardly expressed on 
T-cells at birth (C), or in 
adults (D). The intensity 
of staining of CD45RO+ 
"memory" T-Iymphocytes 
was lower in neonates 
(E) than in adults (F). 
CD38 was expressed by 
most T-Iymphocytes in 
neonates (G), and by 
about half of adult T-
lymphocytes (H). 
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CD45RO+ "memory" T -lymphocyte population in the course of time (Figures 3 and 
4). However, the intensity of CD45RO staining was higher in adults than in infants, 
i.e. adult T-Iymphocytes probably carried more CD45RO molecules on their cell 
surface (Figure 2e/t). 
The increase in CD45RA+ "naive" T-Iymphocytes during the first year of life 
and the slight increase of CD45RO+ "memory" T -lymphocytes at 1 week of age 
was due to an increase in CD4+ helper T -lymphocytes as well as CD8+ cytotoxic 
T-Iymphocytes (Tables 2 and 5). 
Expression of CD38 on T-Iymphocytes 
We found CD38 on ,90% (median) of T-Iymphocytes in infants, and on about 
half of adult T-Iymphocytes (Figure 2g/h; Table 5). 
The distribution of CD38 on CD45RA+ "naive" and CD45RO+ "memory" T-
lymphocytes was markedly different between infants and adults (Table 5). In 
adults, the CD38+/CD45RA+/CD3+ and the CD38+/CD45RO+/CD3+ 
subpopulations were much smaller, and the CD38-/CD45RA+/CD3+ and the 
CD38-/CD45RO+/CD3+ subpopulations were much larger than in infants. The 
changes in size of the CD45RA+ "naive" T-Iymphocyte subpopulation in the first 
year of life were mainly due to changes in size of the CD38+/CD45RA+/CD3+ 
subpopulation. The median absolute counts of CD38-/CD45RO+/CD3+ T-
lymphocytes increased only slightly during the first year of life. The slight peak of 
CD45RO+ "memory" T-Iymphocytes at 1 week of age was mainly caused by an 
increase in CD38+/CD45RO+/CD3+ T-Iymphocytes (Table 2). 
The expression of CD38 on CD4+ helper T-Iymphocytes and on CD8+ cytotoxic 
T-Iymphocytes was also different between infants and adults (Table 5). In adults, 
most CD8+ T-Iymphocytes were CD38-, whereas about half of CD4+ T-
lymphocytes was CD38+. The changes in CD4+ T-Iymphocytes in the first year of 
life were mainly caused by changes in the size of the CD38+/CD4+/CD3+ 
subpopulation, not by changes in the size of the CD38-/CD4+/CD3+ 
subpopulations (Table 2). 
Expression of CD25 and HLA-DR on T-Iymphocytes 
The absolute counts of T-Iymphocytes bearing CD25 (the IL-2 receptor a 
chain) on their surface peaked at 1 week of age. The absolute counts of HLA-DR+ 
T-Iymphocytes did not. They were lower than in adults throughout the first year of 
life (Table 2). 
Absence of CD57 + T-Iymphocytes 
The human natural killer cell antigen, CD57, is present on a subpopulation of 
T -lymphocytes. It has been suggested that these cells represent previously 
activated T -lymphocytes, which have returned to a state of rest." CD57 + T-
lymphocytes were virtually absent at birth, and very low up to 6 months of age, 
except for two infants who had higher values at some, but not all, time-points 
(Tables 2 and 5). 
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Figure 3. Absolute 
counts 
(geometrical mean 
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deviation) of 
CD45RA+ and 
CD45RO+ T-
lymphocyte 
subpopulations x 
10 '/I in 11 infants 
during the first year 
of life and in 9 
adults. Left bars 
represent 
CD45RA+ T-
lymphocytes and 
right bars 
represent 
CD45RO+ T-
lymphocytes. 
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Figure 4. CD45RA+ and CD38+ T-Iymphocytes followed the pattern of total T-
lymphocytes in the infants, but CD45RO+ T-Iymphocytes did not. Each graph represents 
one individual infant (infants nrs. 1-10). 
Hardly any precursor-B-cells 
There was no indication that B-Iymphocytes leave the bone marrow at an 
earlier developmental stage in infants than in adults: hardly any CD37-/CD20-
ICD19+ precursor-B-cells15 were present in the samples of either infants or adults 
(Tables 3 and 6). 
Expression of CD1 c, CD5 and CD38 on B-Iymphocytes 
The relative frequencies of CD1c+ and CD5+ B-Iymphocytes were higher in 
infants than in adults. CD1c+ and CD5+ B-Iymphocyte absolute counts followed 
the pattern of total B-Iymphocytes during the first year of life with high values from 
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6 weeks of age onwards. The same was observed for CD1c- and CD5- B-
lymphocyte absolute counts, although this was not statistically significant in the 
latter (Figure 5, Table 3). CD38 was present on a median of >90% of B-
lymphocytes throughout the first year of life, and on a median of 82% of B-
lymphocytes in adults (Table 6). CD38- B-Iymphocyte absolute counts were low in 
both infants and adults (generally <0.1 x 10 'II) (Table 3). 
Expression of C025 on B-Iymphocytes 
CD25 is a marker of activation in B-Iymphocytes.'· The relative frequencies 
and absolute counts of CD25+ B-Iymphocytes were lower during the first year of 
life than in adults (Tables 3 and 6). 
Expression of CO?1 on B-Iymphocytes 
The transferrin receptor CD?1 is present on a sub population of B-
lymphocytes." It is not clear what role CD?1 has on the surface of B-Iymphocytes. 
It might be present as a marker of activation as well. The absolute counts of 
CD?1. B-Iymphocytes were the same in infants throughout the first year of life and 
in adults (Table 3). It is important to note that most CD?1. cells (66-95%) within 
the "Iympho-gate" of the neonatal cord blood samples were normoblasts, as we 
described before. '0 
CO?-, C038-, and C045RA- NK-cells 
At birth, some infants showed large subpopulations of NK-cells that were not 
expressing CD?, CD38 and CD45RA. At 1 week of age 5 out of 11, 4 out of 11, 
and 3 out of 11 infants still did not express CD?, CD38, and CD45RA on >20% of 
their NK-cells, respectively. However, the CD?-, CD38-, and CD45RA- NK-cells do 
not account for the high absolute NK-cell counts during the first week of life (Table 
?). Only CD8. NK-cells were significantly higher at birth than thereafter (see 
below). 
Absence of C05? NK-cells 
CD5? is a well-known marker of a subpopulation of NK-cells, which role is not 
yet known. It is rapidly lost after NK-cell aclivation.'· Interestingly, CD5? was 
hardly expressed by NK-cells until 3 months of age (Figure 6a). From 3 months 
until 1 year of age a growing number of infants showed a CD5? NK-cell 
subpopulation of up to around 20% (median) of NK-cells. Adults always showed a 
CD5? NK-cell subpopulation (Figure 6b, Tables 4 and ?). 
Absence of C045RO. NK-cells 
The CD45RA- NK-cells in neonatal cord blood must express another isoform 
of the CD45 molecule, such as CD45RB or CD45RC, as almost none of these 
NK-cells were expressing the CD45RO isoform either (Figure 6c, Tables 4 and ?). 
Possibly, the small but clearly present population of CD45RO. NK-cells in adults 
(Figure 6d) represents NK-cells that have encountered a stimulus, like CD45RO. 
"memory" T-Iymphocytes. 
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Figure 5. Absolute 
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Expression of Co25 and HLA-oR on NK-cells 
CD25 is upregulated in NK-cells upon activation, as is HLA-DR.19 CD25 as well 
as HLA-DR were hardly expressed by NK-cells in infants as well as adults (Tables 
4 and 7). 
Expression of COB on NK-cells 
The relative frequency of CDB+ NK-cells did not change significantly during the 
first year of life (Table 7), but the absolute counts of CDB+ NK-cells at birth and 1 
week of age were high (Table 4). These high CDB+ NK-cell counts can influence 
the determination of the CD4+/CDB+ ratio of T-Iymphocytes if single 
immunostaining is used instead of multiple immunostaining with CD4, CDB and 
CD3 McAb. 
Influence of infections and vaccinations 
Infant no. 1 suffered from her first, probably viral, upper respiratory tract 
infection at 6 weeks of age; she was not very ill, and recovered without treatment 
within a week. None of the other infants suffered from an infection in the first 6 
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A 
Figure 6. NK-cell 
subpopulations in 
neonates and adults. 
Absence of CD57+ NK-
cells shortly after birth 
(A). and a clear 
subpopulation of CD57+ 
NK-cells in adults (B). 
Hardly any CD45RO+ 
NK-cells were present in 
neonates (C). a small 
subpopulation of 
CD45RO+ NK-cells was 
present in adults (O). 
weeks of life. Infant no. 1 had a very high T-Iymphocyte count at week 6 (Figure 
1). due to an extremely high absolute count of CD8+ T-Iymphocytes (5.8 x 10'/1); 
her absolute count of CD4+ T-Iymphocytes was not different from the other infants 
(3.3 x 10 'II). Her CD45RO+ "memory" T-Iymphocytes were high at that time (6.1 x 
10 'II); there was no significant relation between the absolute count of CD45RO. 
"memory" T -lymphocytes and infection at any other time-point in our small group 
of infants. however. Interestingly. CD25+ T-Iymphocytes in infant no. 1 were not 
different from the other infants (9% of T-Iymphocytes; 0.8 x 10'/1). whereas the 
HLA-DR+ T-Iymphocyte count was very high (70% of T-Iymphocytes; 6.6 x 10 'II). 
as was the HLA-DR+ NK-cell count (40% of NK-cells. 0.5 x 10 'II). 
At no other time point a significant relation was found between recent infection 
or vaccination and the distribution of lymphocyte subpopulations in this small 
group of eleven infants. 
DISCUSSION 
After differentiation in the bone marrow and thymus. lymphocytes undergo 
further functional maturation in the periphery. This process is directed by 
numerous encounters with environmental antigens which take place from birth 
onwards. The immune system thus gradually builds up a pool of experienced 
TABLE 2. Absolute counts of lymphocytes, CD3+ T-Iymphocytes, and CD3+ T-Iymphocyte subpopulations in eleven infants 
'" .... during follow-up from birth to one year of age and in nine adults. 
neonatal cord 1 week of age 6 weeks of age 3 months of age 6 months of age 1 year of age ncb <: as compared adults 
blood to 1wk.-1yf 
Total lymphocytes 4.7 (3.5-62)' 6.9 (4.0-9.6) 7.2 (4.1-12.6) 7.1 (5.8-9.6) 6.S (5.6-9.9) 7.1 (4.1-8.9) P < 0.001 2.1 (1.1-2.4) 
CD3· T -lymphocytes 2.6 (1.9-4.4) 5.6 (2.4-8.0) 5.1 (3.0-9.5) 4.5 (3.9-7.1) 4.5 (3.7-7.7) 4.4 (2.3-5.9) P < 0.001 1.5 (0.7-1.S) 
T-cell subpopulations: 
TcRCI~·JCD3" 2.5 (1.S-4.3) 5.5 (2.2-7.7) 4.9 (2.9-8.5) 42 (3.5-7.0) 4.2 (3.3-7.5) 4.0 (2.0-5.S) p <: 0.001 1.4 (0.6-1.7) 
TcRv~"/CD3" 0.1 (0.0.(l.1) 0.1 (0.0-02) 0.1 (0.1 .(l.S) 0.2 (0.1.(l.3) 0.2 (0.1.(l.3) 0.2 (0.1.(l.3) p <: 0.001 0.1 (0.0-0.2) 
CD4·'CD3· 2.0 (1.4-3.5) 4.1 (2.0-6.1) 3.3 (22-5.4) 3.4 (2.6-6.1) 3.5 (2.4-<;.5) 32 (1 .5-5.0) p< 0.001 1.0(0.4-1.1) 
CD.'/CD3' 0.6 (0.5-1.0) 1.3 (0.4-2.4) 1.2 (0.7-5 .• ) 1.0 (0.8-1.4) 1.0 (0.5-2.2) 1.0 (0.6-1.5) P < 0.001 0.5 (O.3-0.S) 
CD4+JCDS+,CD3+ 0.1 (0.0-0.1) 0.1 (0.0-0.1) 0.1 (0.0-0.4) 0.1 (0.0-0.2) 0.0 (0.0.(l.2) 0.0 (0.0.(l.2) n.s. 0.0 (0.0.(l.1) 
CD1a+'CD3· 0.1 (0.0-0.3) 0.0 (0.0-0.3) 0.0 (0.0.(l.5) 0.0 (0.0-0.2) 0.0 (0.0.(l.0) 0.0 (0.0..0.1) n.s. 0.0 (0.0-0.1) 
CD45RA'"/CD3+ 1.7 (1.0-3.9) 4.3 (1.9-5.5) 3.6 (2.1-5.2) 3.S (2.7-5 .• ) 3.7 (2 .• -8.7) 3.S (1 .S-5.1) P < 0,001 0.9 (0.3-1.1) () 
C045RO·/CD3" 0.6 (0.3-1.S) 12 (0.7-2.4) 0.9 (0.4-6.1) 1.1 (0.6-1.9) O.S (0.6-2.6) O.S (0.5-2.1) P < 0.001 O.S (0.5-1.0) 5l: 
CD38'/CD3' 2.5 (1.8-4.3) 5.4 (2.2-7.7) 4.S (2.9-9.3) 4.1 (3.6-7.0) 4.2 (3.3-7.4) 4.0 (2.0-5.6) P <: 0.001 0.7 (0.3-0.9) 
" C04·'CD45RN/C03+ 12 (0.6-3.1) 2.4 (0.1-4.0) 2.3 (1 .3-42) 2 .• (1.9-4.S) 2.9 (1.9-4.9) 2.7 (1.1-4.3) P < 0.001 0.4 (0.1.(l.S) ~ CDS·,CD45RNICD3+ 0.6 (0.4-0 .• ) 1.1 (0.4-1.7) 1.0 (0.6-2.5) 0.9 (0.7-12) 0.9 (0.5-1.9) 1.0 (0.6-1.3) P <: 0.001 0.3 (0.1.(l.6) 
CD4+'CD45RO'"C03" 0.4 (0.2-1.2) 1.0 (0.1-1.9) 0.7 (0.3-2.2) 0.7 (0.4-1.6) 0.6 (0.5-2.3) 0.6 (0.4-1.5) p <: 0.001 0.6 (0.3-0.7) 
"" CDS'/CD45RO'/CD3" 0.1 (0.1.(l.5) 0.2 (0.1.(l.7) 0.1 (0.1-4.S) 0.2 (0.1.(l.5) 0.1 (0.1.(l.7) 0.1 (0.1.(l.5) P = 0.002 0.2 (02.(l.4) 
CD38/CD45RA'/CD3' 0.1 (0.0-0.1) 0.1 (0.0-0.2) 0.1 (0.0-0.2) 0.1 (0.1.(l.2) 0.1 (0.1 .(l.2) 0.2 (0.1.(l.3) p< 0.001 0.4 (02.(l.7) 
CD38'/CD45RA'/CD3' 1 .• (1.1~.7) 4.2 (1.9-5.4) 3.5 (2.0-5.1) 3.6 (2.4-5 .• ) 3.5 (2.7-8.4) 3.6 (1.6-4.9) P <: 0.001 0.5 (02.(l.7) 
CD38'/CD45RO'/CD3' 0.1 (0.0-02) 0.1 (0.1 .(l.2) 0.2 (0.M.3) 0.1 (0.1 .(l.3) 02 (0.1.(l.4) 02 (0.1.(l.3) p <: 0.001 0.6 (O.4-0.S) 
CD38'/CD45RO'/CD3' 0.5 (0.3-1 .6) 1.1 (0.6-2.2) a .• (0.4-8.0) O.S (0.5-1 .5) 0.7 (0.5-2.0) 0.6 (0.3-2.1) P < 0.001 0.3 (0.1 .(l.4) 
CD38'/CD4'/CD3' 0.1 (0.0-0.1) 0.1 (0.1 .(l.2) 0.2 (0.1 .(l.2) 0.2 (0.1 .(l.2) 02 (0.1.(l.2) 0.2 (0.1 .(l.2) P < 0.001 0.1 (0.0.(l.5) 
CD38'/CD4'/CD3' 1.9 (1 .3-3.5) 4.0 (1 .9-8.0) 3.1 (2.2-5.3) 3.2 (2.4-6.0) 3.4 (2.3-5.4) 3.0 (1 .3-4.S) P = 0.002 0.5 (0.2.(l .• ) 
CD38/CDS'/CD3' 0.1 (0.0-0.1) 0.1 (0.0.(l.2) 0.1 (0.0-1.2) 0.1 (0.0-0.1) 0.1 (0.0-02) 0.2 (0.0.(l.3) P = 0.001 0.1 (0.0-0 .• ) 
CD38'/CD.'/CD3' 0.6 (0.5-0.9) 1.3 (0.4-2.2) 1.0 (0.5-5.4) 1.0 (0.7-1.3) 0.9 (0.5-2.1) 0 .• (0.5-1.3) n.s. 0.1 (0.0-0.1) 
CD2S"'CD3+ 02 (02.(l.4) 0.7 (O.5-0.S) 0.5 (O.3-0.S) 0.4 (0.3-0.7) 0.4 (0.3-0.5) 0.3 (0.2.(l.5) P < 0.001° 0.4 (02.(l.5) 
HLA-DR'/CD3' 0.2 (0.0-0.9) 0.2 (0.1-1.6) 0.2 (0.1-8.6) 0.1 (0.1-1.3) 0.1 (0.1.(l.2) 0.1 (0.1.(l.3) n.s. 0.4 (O.o-o.S) 
CD57"/CD3' 0.0 (0.0-0.0) 0.0 (0.0.(l.1) 0.0 (0.0-0 .• ) 0.0 (0.0.(l.5) 0.0 (0.0.(l.3) 0.1 (0.0-0.6) n.s . 0.1 (0.0-02) 
• Median absolute count followed by minimal and maximal absolute count in parentheses x 1&11: 
bncb = neonatal cord blood. 1wk = 1 week of age, 6wk = 6 weeks of age, 3rno = 3 months of age. Smo = 6 months of age, 1yr = 1 year of age, n.S. = not significant: 
calso 1wk::> 6wk-1yr. 6wIc: > 3m().o1yr. 3rno:> 6mo-1yr. all p < 0.001. 
TABLE 3. Absolute counts of CD19+ B-Iymphocytes and CD19+ B-Iymphocyte subpopulations in eleven infants during follow-
up from birth to one year of age and in nine adults. 
neonatal cord 1 week of age 6 weeks of age 3 months of age 6 months of age 1 year of age ncb-1wk < as adults 
blood compared to 6wk.-1yf' 
CD19~ B-Iymphocytes 0.8 (0.3-1.0)" 0.6 (0.3-1.7) 1.6 (0.9·2.4) 1.7(1.4-2.0) 1.4 (1.3-2.3) 1.7 (1.2·2.8) P < 0.001 0.2 (0.1.o.4) 
B--celf subpopulations: 
C03I1CD20-JCD19~ 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.O.o.1) 0.0 (0.O.o.1) 0.0 (0.0-0.1) 0.0 (0.0-0.1) n.s. 0.0 (0.0-0.0) 
CD1c·/CD19+ 0.6 (0.3-0.9) 0.5 (0.2-1.6) 1.1 (0.7-1.9) 1.2 (0.9-1.5) 0.9 (0.6-1.3) 0.9 (0.7-1.4) P < 0.001 0.1 (0.0-0.1) 
CD1c-/CD19+ 0.4 (0.2.o.9) 0.1 (0.1.o.2) 0.4 (0.2.o.9) 0.5 (0.3-0.7) 0.5 (0.4-1.2) 0.8 (0.4-1.3) P < 0.001 0.2 (0.1.o.2) 
CDS"/CDW 0.3 (0.1.o.4) 0.3 (0.M.8) 0.9 (0.6-1.6) 0.8 (0.6-1.2) 0.7 (0.4-1.2) 0.7 (0.4-1.7) P < 0.001 0.1 (0.0-0.1) 
CDS"/CD19* 0.5 (0.2.o.6) 0.3 (0.1-1.0) 0.7(0.3-1.1) 0.8 (0.4-1.3) 0.8 (0.5-1.5) 0.8 (0.6-1.8) n.s. 0.2 (0.1.o.3) 
CD3S'·'CD19" 0.8 (0.3-1.0) 0.6 (0.3-1.7) 1.5 (0.9-2.3) 1.6 (1.3-2.0) 1.3 (1.2-2.2) 1.6 (1.2-2.6) P < 0.001 0.2 (0.1.o.3) 
CD38'JCD19- 0.0 (0.0-0.0) 0.0 (0.0-0.1) 0.0 (0.O.o.1) 0.1 (0.0-0.1) 0.1 (0.0-0.1) 0.2 (0.0-0.3) n.s. 0.0 (0.0-0.1) 
C07nCDHr 0.0 (0.0-0.4) 0.0 (0.0-0.1) 0.0 (0.O.o.1) 0.1 (0.O.o.1) 0.1 (0.O.o.2) 0.1 (0.0-0.1) n.s. 0.0 (0.0-0.1) 
CD2S-/CD19· 0.0 (0.0-0.1) 0.0 (0.0-0.1) 0.1 (0.O.o.2) 0.1 (0.O.o.1) 0.0 (0.O.o.2) 0.1 (0.0-0.2) n.s. 0.2 (0.0-0.5) 
TABLE 4. Absolute counts of CD1S+/56+/CD3- NK-cells and CD16+/56+/CD3- NK-cell subpopulations in eleven infants during 
follow-up from birth to one year of age and in nine adults. 
neonatal cord 1 week of age 6 weeks of age 3 months of age 6 months of age 1 year of age ncb > as compared adults 
blood to 1wk.-1yr" 
CD1S"'56·'CD:r NK-cells 1.0 (0.4-1.6)" 0.6(0.3-1.7) 0.4(0.2-1.1) 0.5 (0.2-1.3) 0.3 (0.2-1.4) 0.4 (0.3-0.9) P < 0.001 0.2 (0.1.o.4) 
NK...t;efl subpopulations: 
COrICD1S-/SS*,CDS" 0.6 (0.3-1.2) 0.5 (0.2-1.7) 0.4 (0.2-1.0) 0.4 (0.2-1.3) 0.3 (0.2-1.4) 0.4 (0.3-0.9) n.s. 0.2 (0.1.o.3) 
CD45RNICD1S·/SS+'CD3" 0.6 (0.3-1.2) 0.5 (0.2-1.7) 0.4 (0.2-1.0) 0.4 (0.2-1.3) 0.3 (0.2-1.4) 0.4 (0.2.o.8) n.s. 0.2 (0.1.o.3) 
CD38~JCD16"J56~/CD3' 0.6 (0.2-1.2) 0.5 (0.2-1.7) 0.4 (0.2-1.0) 0.4 (0.2-1.3) 0.3 (0.2-1.4) 0.4 (0.3-0.9) n.s. 0.2 (0.1.o.3) 
CD4SRO·/CD16"'SS·/CD3· 0.0 (0.0-0.0) 0.0 (0.0-0.1) 0.0 (0.O.o.1) 0.0 (O.O.o.O) 0.0 (0.O.o.1) 0.0 (0.0-0.1) n.s. 0.0 (0.0-0.0) 
CD8~/CD1B~/56"/CD3' 0.4 (0.1.o.5) 0.4 (0.1.o.8) 0.2 (0.1.o.3) 0.1 (0.O.o.4) 0.1 (0.O.o.2) 0.1 (0.0-0.2) P = 0.001 0.1 (0.0-0.1) 
CD5T1CD1B"J56~/CD3' 0.0 (0.0-0.0) 0.0 (0.0-0.1) 0.0 (0.O.o.1) 0.0 (0.O.o.1) 0.0 (0.O.o.2) 0.1 (0.0-0.2) n.s. 0.1 (0.0-0.2) 
CD25"JCD1B+J56~/CD3' 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (O.o.o.O) 0.0 (O.O.o.O) 0.0 (O.O.o.O) 0.0 (0.0-0.0) n.s. 0.0 (0.0-0.0) 
HLA~DR~JCD1B·"/56·"/CD3· 0.0 (0.0-0.2) 0.0 (0.0-0.2) 0.1 (0.O.o.4) 0.0 (0.O.o.1) 0.0 (0.0-0.1) 0.0 (0.O.o.1) n.s . 0.0 (0.O.o.1) 
• Median absolute count followed by minimal and maximal absolute count in parentheses x 1ot'lI; 
b ncb = neonatal cord blood. 1wk = 1 week of age, 6wk = B weeks of age, 3mo = 3 months of age. Bmo = B months of age, 1yr = 1 year of age, n.S. = not significant. 
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TABLE 5. Relative frequencies of CD3+ T-Iymphocytes and CD3+ T-Iymphocyte subpopulations in eleven infants during '" 0> 
follow-up from birth to one year of age and in nine adults. 
neonatal cord 1 week or age 6 weeks of age 3 months of age 6 months of age 1 year of age adults 
blood 
CD3- T -lymphocytes 59 (44-76)" 79 (58-89) 71 (61-80) 69 (53-76) 72 (50-78) 65 (50-73) 72 (60-83) 
T..(;ell subpopulations: 
TCRal> 94 (90-9Tf' 97 (94-99) 96 (89-97) 95 (89·97) 95 (90-97) 92 (88.98) 93 (83-97) 
TCRy~' 3(1-4) 2 (0-3) 3 (1·9) 3 (1-8) 4 (1-8) 4(2-8) 5 (2·15) 
CD4' 72 (62-82) 76 (69-87) 74 (35-84) 75 (63-86) 56 (34-84) 50 (30-82) 58 (52-89) 
CD8' 27 (17-35) 25 (13-31) 25 (15-81) 15 (10-34) 15 (8-32) 16 (8-34) 33 (27-46) 
CD4/C08 ratio 2.7 (1.8·5.0) 2.9 (2.3-6.5) 2.9 (0.6-5.6) 3.5 (1.8-8.6) 3.3 (2.0·7.8) 2.9 (1.8-7.0) 2.0 (1.2·2.7) 
CD4·lCDS· 2(1-4) 2 (1-5) 2(1-4) 1 (1-3) 1 (0-3) 1 (0-3) 1 (1-4) 
CD1a" 2 (0-7) 1 (0-5) 1 (0-5) 1 (0-4) 0(0-1) 0(0-1) 0(0·2) 
CD45RA' 72 (44-94) 79 (52-90) 69 (52-$4) 74 (67-91) 80 (64-90) 81 (72-88) 60 (46-71) () 
CD45RO' 23 (10-76) 26 (16-85) 17 (9-74) 18 (14-50) 15 (13-71) 16 (9-54) 56 (48.71) ~ 
CD38' 95 (92-98) 96 (95-98) 95 (91-98) 95 (90-98) 93 (89-96) 90 (87-95) 45 (34-82) 
" CD4"'CD45RA- 70 (37-95) 76 (41-88) 65 (57-81) 79 (64-96) 82 (72-91) 80 (65-97) 49 (35-70) ii1 
CDS·'CD45RA- 83 (59-99) 84 (67-97) 83 (42-93) 84 (73-99) 89 (64-94) 89 (81-100) 73 (55-80) :<J 
CD4"'CD45RO" 25 (9-83) 26 (17-73) 19 (10-84) 17 (14-82) 15 (13-90) 16 (11-85) 63 (47-81) " 
CDS-'CD45RO" 19 (7-58) 16 (5-43) 13 (4-83) 16 (7-34) 13 (5-65) 15 (7-41) 46 (38-59) 
CD3S-JCD45RA .. 4 (2-7) 3(1-4) 3(2-5) 3 (1-8) 4 (2.7) 5 (2-8) 43 (28-64) 
CD38'.,CD45RA .. 97 (93-98) 98 (96-99) 96 (95-98) 98 (94-98) 97 (93-98) 95 (93-98) 56 (35-72) 
CD3S·/CD45RO' 9 (4-19) 8 (5-13) 14 (2-26) 17 (9-29) 23 (14-30) 23 (13-36) 74 (58-83) 
COSS+,CD45RO' 91 (81-94) 90 (87-94) 87 (74-9S) 83 (71-92) 77 (71-85) 77 (64-93) 28 (16-42) 
CD3S-/CD4* 2 (1-5) 2 (1-4) 3 (2-8) 3 (2-5) 3(2-5) 4 (2-7) 27 (17-33) 
CD38",CD4+ 98 (94-99) 98 (94-99) 96 (93-98) 96 (92-98) 96 (92-97) 94 (90-96) 52 (42-75) 
CD38·,CD8' 2(1-4) 1 (1-3) 1 (1-3) 2 (0-7) 2 (0-4) 4 (1-7) 26 (15-33) 
CD38"CD8' 93 (90-97) 96 (92-97) 95 (90-99) 93 (85-97) 92 (84-97) 83 (77-95) 32 (21-54) 
CD25' 10 (6-15) 13 (10-21) 9 (8-12) 9 (8-11) 9 (6-11) 8 (6-10) 27 (19-36) 
HLA-DR· 9 (1-30) 3 (1-27) 4 (2-70) 3 (2-31) 3 (2-8) 3 (2-7) 28 (3-45) 
COST 0(0-1) 0(0-1) 1 (0-8) 1 (0-12) 1 (0-8) 2 (1-14) 7 (2-17) 
• Median relative frequency followed by minimal and maximal relative frequency between parentheses within the lymphocyte population; 
b% positivity of the CD3'" T-lyrnphocyte subpopulation followed by minimal and maximal values between parentheses. 
TABLE 5. Relative frequencies of CD19+ B-Iymphocytes, and CD19+ B-Iymphocyte subpopulations in eleven infants during 
follow-up from birth to one year of age and in nine adults. 
neonatal cord 1 week of age 6 weeks of age 3 months of age· 6 months of age 1 year of age adults 
blood 
C019' B·lymphocytes 16 (9-21)' 10 (6-19) 22 (16-29) 23 (18-28) 22 (18-31) 28 (19-36) 12 (7.18) 
B-cell subpopulation: 
C03,C020" 1 (0-2)1> 2 (1-7) 1 (1-6) 1 (0-3) 1 (1-4) 2 (0-6) 1 (1-3) 
CDS" 38 (25-62) 47 (40-67) 62 (48-71) 45 (34-73) 43 (30-68) 48 (29-68) 23 (13-30) 
CD1c" 85 (59-92) 87 (72·90) 75 (54-83) 69 (61.79) 64 (46-72) 55 (33-63) 25 (21·29) 
C038' 99 (98-100) 98 (90.99) 98 (95-99) 97 (94-99) 94 (91-97) 93 (82·97) 82 (62-86) 
CD7,· 7 (2-45) 9 (1-17) 2 (1-6) 3 (1·5) 3 (1-17) 3 (2-7) 8 (3-27) 
CD2S'" 2 (1·29) 6 (2-24) 4 (2·9) 3 (1-8) 3 (1-10) 4 (1·11) 13 (8·26) 
TABLE 7. Relative frequencies of CD15+/56+/CD3- NK-<:ells, and CD16+/56+/CD3- NK-<:ell subpopulations in eleven infants 
during follow-up from birth to one year of age and in nine adults. 
neonatal cord 1 week of age 6 weeks of age 3 months of age 6 months of age 1 year of age adults 
blood 
CD16'"15f)ICD~ NK-cells 24 (9..33)" 6 (3-9) 6 (3.9) 6 (3·18) 5 (3-19) 6 (3-11) 14 (4-18) 
NK-celf subpopulation: 
C07' 79 (38-93)' 94 (82·97) 94 (82·97) 93 (85-98) 91 (84-99) 93 (87.99) 93 (85-97) 
CD45RA'" 79 (40-92) 94 (86-99) 94 (86-99) 95 (92-99) 95 (83-99) 95 (87.99) 96 (93-98) 
CD3S'" 78 (38-90) 93 (84-98) 93 (84-98) 95 (86-99) 95 (81·99) 95 (87.99) 92 (79·96) 
C045RO" 0(0-3) 6 (1-12) 6 (1·12) 4 (2·7) 7 (3-14) 5 (2.12) 2 (0-17) 
CDS· 37 (19-63) 36 (16-72) 36 (16-72) 36 (6-52) 26 (4-58) 19 (5-62) 29 (11-44) 
COST 0(0·2) 0(0-5) 0(0-5) 0(0·24) 12 (0-31) 20 (9-38) 47 (20-58) 
C025' 1 (0-3) 3 (2-7) 3 (2·7) 4 (1-6) 4 (0-6) 1 (1-7) 5 (2·10) 
HLA·OR· 2 (1.18) 14 (4-40) 14 (4-40) 12 (2-22) 10 (2-22) 8 (3-17) 10 (4-21) 
"rVIedian relative frequency followed by minimal and maximal relative frequency between parentheses within the lymphocyte population; 
1>% positivity within the CD16'"/SQ/CD3' NK-cell subpopulation followed by minimal and maximal values between parentheses. 
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"memory" lymphocytes. It is to be expected that these maturational processes are 
to some extent reflected by changes in the composition of lymphocyte 
sub populations during infancy. 
Reference values for lymphocyte subpopulations obtained in cross-sectional 
studies may reflect this gradual process, but changes in the composition of 
lymphocyte subpopulations in individual children will not occur at exactly the same 
time-points in life, and will therefore be leveled off in such studies. Longitudinal 
studies in individual children are more informative about the pattern of lymphocyte 
subpopulation development in time, and about the influences of external factors 
like infections and vaccinations upon this development. Also, children with 
immune disorders are generally followed longitudinally. Therefore, we performed a 
longitudinal survey of lymphocyte subpopulations in eleven healthy infants during 
the first year of life and compared these results with those obtained in nine adults. 
We did not find a significant relation between infection or vaccination and the 
distribution of lymphocyte subpopulations - except for one time-point - in this small 
group of eleven heallhy infants, however. 
We found that T- and B-Iymphocyte counts were high throughout the first year 
of life, wilh an increase at 1 and 6 weeks of age, respectively. In contrast, NK-cell 
counts were high at birth and declined after the first week of life, but remained at 
levels of about twice those found in adulls. This is in line with previous data 
obtained in a cross-sectional study, as we reported recently.'· 
Because of these high lymphocyte counts in infants, differences in 
subpopulations of T- and B-Iymphocytes and NK-cells between infants and adulls 
are better reflected by comparison of their absolute counts than by comparison of 
their relative frequencies. This is illustrated by our findings in T-Iymphocyte, B-
lymphocyte, as well as NK-cell subpopulations. 
CD4+ as well as CD8+ T-Iymphocyte counts followed the pattern of total T-
lymphocytes with an increase at 1 week of age and high numbers - especially of 
CD4+/CD3+ T-Iymphocytes - throughout the first year of life. These were mainly 
CD45RA+ "naive" T-Iymphocytes, probably new T-cells, freshly released from the 
thymus.21 The absolute counts of CD45RO+ "memory" T -lymphocytes in infants 
during the first year of life and in adults were similar. So, the profound differences 
in relative frequencies of CD45RA+ "naive" and CD45RO+ "memory" T-
lymphocytes between infants and adults are not due to changes in the size of the 
CD45RO+ "memory" pool, but to changes in the size of the CD45RA+ "naive" 
pool of T-Iymphocytes: a large pool of naive "untriggered" cells is present at birth, 
and increases further during the first year of life, ready for participation in primary 
immune responses. 
Then how is the building of a functional "memory" pool of T -lymphocytes 
reflected in the distribution of T -lymphocyte subpopulations? Firstly, adult T-
lymphocytes probably carried more CD45RO molecules on their surface than 
infant T -lymphocytes. Secondly, the distribution of the expression of CD38 on 
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CD45RO+ "memory" (and CD45RA+ "naive") T-Iymphocytes was markedly 
different between infants and adults: it decreased from birth to adulthood, as was 
described before on total T -lymphocytes. 4.22·" CD38 is a differentiation lineage-
unrestricted cell surface molecule with a role in cellular adhesion, activation and 
proliferation, which is known to be expressed on thymocytes, on activated 
peripheral blood T - and B-Iymphocytes, and on plasma cells. It is generally 
regarded as an activation marker." However, we and others·'··30·" did not find 
other markers of activation in neonatal cord or infant blood, like increased 
expression of CD25, HLA-DR, CD69, and CD154 (CD40 ligand). Nor did we find 
an increase of "thymocyte-like" CD1 a+, or CD4+/CD8+ "double-positive" T-cells. 
We therefore presume that the abundant expression of CD38 on infant's T-
lymphocytes might be related to a greater metabolic need of the large population 
of naive "untriggered" cells, due to their continually required participation in primary 
immune responses. 
Little is known about markers expressed by naive "untriggered" B-Iymphocytes. 
Cell surface expression of CD45 isoforms is not informative in B-Iymphocytes: all 
B-Iymphocytes express the CD45RA isoform," not the CD45RO isoform. 33 We and 
others" found higher relative frequencies of CD1c+, CD5+, and CD38+ B-
lymphocytes in neonates and infants than in adults. The function of CD1c on the 
surface of B-Iymphocytes has not yet been elucidated. CD5+ B-Iymphocytes 
spontaneously produce low-affinity polyreactive IgM autoantibodies, use un mutated 
VH genes, and are presumed to represent a more primitive lineage than CD5- B-
lymphocytes." We found that CD1c+ and CD5+ B-Iymphocyte counts were indeed 
higher at birth than in adults; they increased even further during the first year of life. 
CD1c- and CD5- B-Iymphocyte counts also increased during the first year of life, 
albeit not statistically significant for CD5- B-Iymphocyte counts. However, the 
relative frequencies of CD1 c+ and CD5+ B-Iymphocytes were considerably higher 
throughout the first year of life than in adults. Therefore, CD1c and CD5 could be 
markers of "untriggered" B-Iymphocytes. CD38 is associated with the CD21/CD19 
complex on the surface of B-Iymphocytes, and probably has a role as mediator of 
extracellular signals." The relative frequency of CD38+ B-Iymphocytes was higher 
in infants than in adults. CD38- B-Iymphocyte absolute counts were low in infants 
as well as adults; the high B-Iymphocyte counts throughout the first year of life were 
due to high CD38+ B-Iymphocyte counts. The abundant expression of CD38 on 
infant's B-Iymphocytes could be related to a greater metabolic need caused by the 
many encounters with antigen in primary immune responses, analogous to the 
situation in T-Iymphocytes. 
The high NK-cell counts at birth were for a large part accounted for by CD8+ 
NK-cells. Interestingly, at birth some infants showed large subpopulations of CD7-, 
CD38-, and CD45RA- NK-cells. It could be that these findings are associated with 
the maturational status of NK-cells. However, it is more likely that the high absolute 
counts of NK-cells observed directly after birth are due to a state of NK-cell 
activation during pregnancy, which rapidly disappears during the first weeks after 
birth; these activated NK-cells are postulated to represent a fetal 'tumor response' 
to maternal antigen, or to playa role in placentation.'" This fits in with the absence 
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with the absence of CD57+ NK-cells in the first months of life: CD57 is rapidly 
downregulated upon activation. CD7 is expressed on all resting NK-cells, and is 
known to be down regulated upon activation.'· However, we did not find an 
increase in the number of NK-cells positive for other activation markers at birth. 
CD8 is involved in the recognition of HLA class I molecules, which are expressed 
by all nucleated cells. It is intriguing that CD8+ NK-cells are present in such large 
numbers at birth. Perhaps this is related to the maintenance of pregnancy at the 
immunological interface between the fetus and its mother. Interestingly, the two 
infants born at the youngest gestational age (infant nr.6 at 37 weeks, and infant 
nr.10 at 35 weeks) showed the highest relative frequencies and absolute counts of 
CD38- NK-cells, CD45RA- NK-cells, and CD7- NK-cells at birth and at 1 week of 
age. CD8+ NK-cell absolute counts were not higher in these two youngest 
children, however. 
In conclusion, we showed that a detailed longitudinal analysis of the absolute 
counts of lymphocyte subpopulations in infants contributes to the understanding of 
lymphocyte development after birth. We found that a large pool of "naive" 
CD45RA+ - mainly CD4+/CD3+ - T-Iymphocytes continues to be produced during 
the first year of life, ready to be primed in primary immune responses. With 
priming, further functional maturation is accompanied by changes in the 
distribution of lymphocyte subpopulations: adult "memory" CD45RO+ T-
lymphocytes mostly express no CD38 and probably carry more CD45RO 
molecules upon their surface. CD1 c, CD5 and CD38 are possible markers of 
"untriggered" B-Iymphocytes. NK-cells seem to be more important during 
pregnancy than thereafter, with absolute numbers falling immediately after birth. 
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ABSTRACT 
Children with recurrent infections form a large group of patients in pediatric 
practice. This frequently concerns ear-nose-throat infections and lower respiratory 
tract infections. Follow-up of these children shows that most of them have local 
obstructive problems, bronchial hyperreactivity or an allergic constitution. 
However, some of them might have a primary immunodeficiency, which needs a 
prompt diagnosis before serious infections compromise the child's general 
condition. 
We developed a multistage diagnostic protocol which allows early exclusion of 
immunodeficiency diseases by liberal use of screening tests in the first stage, 
whereas more elaborate tests are reserved for those children where an 
immunodeficiency disease becomes a more likely diagnosis. 
Particularly, flow cytometric immunophenotyping of leukocytes appears to be 
an efficient and rapid tool in the diagnosis and follow-up of immunodeficient 
patients. 
INTRODUCTION 
Immunocompromised children form an increasing group of patients in pediatric 
practice due to the expanding use of immunosuppressive drugs and aggressive 
chemotherapy as part of oncological treatment regimens, in autoimmune 
diseases, or after organ transplantation, as well as due to the increasing 
prevalence of HIV-infection.' From time to time, pediatricians are also confronted 
with children suffering from primary immunodeficiency diseases. '2 These children 
should be discerned from the relatively large group of children with recurrent ear-
nose-throat (ENT) infections and lower respiratory tract infections due to other 
causes, such as local obstructive problems, bronchial hyperreactivity, or an 
allergic constitution. 
Laboratory studies for identification and clinical follow-up of immunodeficient 
children can now be performed in many hospitals. On the one hand, this enables 
prompt diagnosis of immunodeficiency before serious infections have 
compromised the child's general condition, reducing the chances of survivaL '2 On 
the other hand, the easy availability of most laboratory tests may lead to excessive 
use of these expensive tests. The application of a multistage diagnostic protocol 
allows early exclusion (or identification) of an immunodeficiency due to a low 
threshold for the performance of simple screening tests in the first stages, 
whereas more elaborate tests can be reserved for later stages, leading to 
diagnosis and definitive classification of those cases where a primary 
immunodeficiency becomes more likely. 
In this review, we propose such a multistage diagnostic protocol and focus our 
discussion on the increaSingly important role of flow cytometric 
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immunophenotyping of leukocytes in the diagnosis and follow-up of 
immunocompromised children In pediatric practice.' Flow cytometric 
immunophenotyping allows precise assessment of relative frequencies of 
leukocyte subpopulations by detection of cell surface and intracellular markers 
with fluorochrome-labeled monoclonal antibodies (McAb). It can be performed 
within the population of lymphocytes, monocytes, or granulocytes, which are 
defined on the basis of their light scatter characteristics, such as forward scatter 
(FSC) as measure for size, and side scatter (SSC) as measure for cellular 
irregularity (Figure 1).' Leukocyte count and differential cell count are then used to 
calculate absolute counts, which can be compared with age-matched reference 
values' 
DIAGNOSING CHILDREN WITH PRIMARY IMMUNODEFICIENCY 
Three distinct clinical categories of primary immunodeficiency diseases can be 
recognized: antibody deficiencies, cell-mediated or combined (cell-mediated and 
antibody) immunodeficiencies, and granulocyte/monocyte function deficiencies. 
Children with antibody deficiency usually suffer from recurrent ENT and lower 
respiratory tract infections. Children with cell-mediated or combined 
immunodeficiency often suffer from failure to thrive, intractable diarrhea, eczema, 
and other chronic problems, or they present with an opportunistic infection. 
Children with granulocyte/monocyte function deficiency may show superficial and 
systemic infections with pyogenic bacteria or fungi. 
It is practical to analyse the possible presence of these different clinical 
categories of primary immunodeficiency diseases along separate pathways, as is 
shown in the multistage diagnostic protocol in Table 1. A mUltistage 
immunophenotyping protocol wilh "limited" and "extended" levels is shown in 
Table 2. The major types of primary immunodeficiency diseases and the 
characteristic immunophenotyping results found in patients with these diseases 
are summarized in Table 3. 
Children with recurrent ENT and lower respiratory tract infections 
Most children with recurrent ENT and lower respiratory tract infections do not 
have an antibody deficiency, but suffer from local obstructive problems, bronchial 
hyperreactivity, or an allergic constitution. If these are ruled out, or if infections 
persist despite adequate treatment of the underlying problem, the presence of a 
relatively mild antibody deficiency like IgA deficiency, IgG subclass deficiency, or 
anti-polysaccharide antibody deficiency should be evaluated."·12 
It is useful to perform immunophenotyping of lymphocytes according to the 
"limited" protocol in Table 2 in the following cases: 
- severe antibody deficiency with agammaglobulinemia, as found in X-linked 
agammaglobulinemia (XLA),'2 1911 deficiency,'· or II 14.1 deficiency; 10 
- progressive hypogammaglobulinemia with combinations of IgA deficiency, 
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TABLE 1. Multistage protocol for the exclusion or diagnosis of primary 
immunodeficiency diseases. 
Suspected antibody deficiency in children with recurrent ENT and lower respiratory tract infections 
If common underlying problems are ruled oul or adequately treated and infections persis!: 
1. Serum IgG, IgA, 19M and IgG subclass concentratfons 
2. SpeciflC antibody titers before and arter tetanus toxoid and pneumococcal vacclnaUon 
In cases of severe antibody deficiency: 
3. Immunophenotyping: tolal blood B-Iymphocytes and T-Iymphocytes ('limited" protocol) 
4. Immunophenolyplng: a-cell development In bone marrow, CD40L expressIon on activated T-Iymphocytes 
("extended" protocol, specialized/research protocols) 
5. Determlnallon of the genetic defect, If applicable 
Suspected cell-mediated or combined immunodeficiency in children with failure to thrive, intractable 
diarrhea, eczema and other chronic problems or opportunistic infections 
First diagnostic work-up: 
1. leukocyte count and differential; serum IgG, IgA and IgM concentratlons; HIV serology and HIV PCR 
2. Immunophenotyplng: the major lymphocyte populations ("limited" protocol); N.B. confounding presence of 
maternal T-Iymphocytes might occur In SCID {tests In specialized laboratories are then required} 
If abnormalities have been detected, or Immunodeficiency is hIghly suspected: 
3. lymphocyte proliferation In vitro after stimulation with mitogens 
4. Immunophenolyplng: focussing on specific diseases ("extended" protocol, specialized/research protocolS) 
5. Specific measurements for certain diseases (e.g. ADA and PNP enzyme levels, karyotype and DNA-repair, 0-
foetoproteln for AT, sk.eletal X·rays for cartilage hair dysplasia) 
99 
6. More elaborate protiferallon protocols (In vitro lymphocyte proliferatlon after stimulation with McAb or antigens: In 
vivo delayed hypersensllivityvla skin tests) 
7. Determination of the genetic defect, if applicable 
Suspected granulocyte/monocyte function deficiency in children with superficial and systemic infections 
with pyogenic bacteria or fungi 
First diagnostic work·up: 
1. leukocyte count and differenlJal 
2. Hematological assessment If Indicated 
3. ConsIder antibody deficiency, or cell·medlated or combined ImmunodefiCiency (see above) 
If other causes are excluded and the Infections persist: 
4. Granulocyte function testing (chemotaxis, phagocytosis, Intracellular killing of bacteria) 
5. Immunophenotyplng In case of granulocytosis: CD18 and CD15s expression ("extended" protocol) 
5. Determination of the genetfc defecl, if applicable 
Abbreviations: ADA = Adenosine deamlnase deficiency, AT = ataxia teleangleclasla, HIV = human Immunodeficiency 
virus, McAb = monoclonat antibody, PCR = polymerase chain reacllon, PNP = purine nucleollds phosphorylase 
deficiency. 
IgG subclass deficiency, and/or anti-polysaccharide antibody deficiency, as 
found in common variable immunodeficiency (CVID);12.14 
- severe hypogammaglobulinemia with normal or increased IgM, as found in X-
linked hyper IgM syndrome (XHIM).7 
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Figure 1. Flow cytometric immunophenotyping of lymphocytes in blood and bone marrow 
of immunodeficient patients. A, Analysis of peripheral blood of an XLA-patient. Dot plot 
with FSC and SSC showing "Iympho-gate" (left). Absence of C019+ B-Iymphocytes 
(middle), wilh CD3+ T-Iymphocytes and CD16+ and/or CD56+/CD3- NK-cells normally 
present (right). B, Analysis of bone marrow of an XLA-patient. Dot plot with FSC and SSC 
showing "Iympho-gate" (left). Very few C019+ B-lineage cells are present (middle), which 
are mostly CD1 O+/CD20-ICD19+ precursor-B-cells (right). C, Analysis of bone marrow of a 
SCIO patient. Dot plot with FSC and SSC showing "Iympho-gate" (left). Absence of CD3+ 
T-Iymphocytes (middle), leading to a relatively predominant presence of mature C01O-
ICD20+/C019+ B-Iymphocytes within the "Iympho-gate". 
If immunophenotyping of lymphocytes shows that B-Iymphocytes are absent in 
the peripheral blood compartment (Figure 1a), this strongly suggests a diagnosis 
of XLA or - less frequently - 1911 deficiency. Analysis of the maturational arrest by 
morphologic and immunophenotypic studies of bone marrow cells with an 
extensive research protocol can then direct the diagnostic analysis at the 
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TABLE 2. Flow cytometrlc Immunophenotyping protocol for the diagnosis of primary 
Immunodeficiency diseases in pediatric practice. 
-Limited" protocol (U56 absolute counts and age-matched reference values) 
T-Iymphocytes: lolal CD3t 
CD4+ICD3+ helper subset 
C08+/CD3+ suppressor/cytotoxic subset 
B·lymphocytes: tolal COt9'" or CD20+ 
NK-cells: defined as CD3· as well as C016+ andlor C056+- populalfon 
·Extendedn protocol (compare with normal age-matched controls run in paraffel if no reference values are available) 
CD40L expression on activated T-Iymphocytes if XHIM is suspected 
HLA·DR (class II) and 112 mlcroglobulin (class I) expressIon on leukocytes if BLS Is suspected 
TCRall and TeRVO expression on T-Iymphocytes If CATCH-22 Is suspected 
COts and CD15s expressIon on leukocytes if LAOt or LAD2 is suspected 
Abbrevlallons: BLS = bare lymphocyte syndrome; LAD = leukocyte adhesion deRclency; XHIM = X·llnked hyper 19M 
syndrome. 
molecular level: XLA results in the arrest of 8-cell development in the bone 
marrow at a later maturational stage than Ig[1 deficiency (Figures 1 band 2).' 
If 8-lymphocytes are found to be present in the peripheral blood compartment, 
CVID or XHIM are more likely diagnoses. Immunophenotyping of blood 
lymphocytes according to the "limited" protocol in Table 2 can show 
accompanying T-Iymphocytopenia in CVID.14 In XHIM, immunophenotyping of 
activated blood T-Iymphocytes shows absent or decreased expression of CD40 
ligand (CD40L) ("extended" protocol in Table 2).'·12 This absent or decreased 
expression of CD40L leads to disturbed CD40L-CD40 mediated T-8 cell 
communication, which is indispensable for isotype switching from IgM to IgG, IgA 
or IgE. The definitive diagnosis of XHIM can be made via mutation analysis of the 
CD40L gene. 
Children with failure to thrive, Intractable diarrhea, eczema, and other 
chronic problems, or with an opportunistic infection 
Many children with cell-mediated or combined immunodeficiency do not 
present with recurrent infections, but with failure to thrive, intractable diarrhea, 
eczema, and other chronic problems.' The differential diagnosis is extensive in 
these cases. The combination of lymphopenia and agammaglobulinemia can 
direct the search towards an immunodeficiency, but these are not invariably 
present. Opportunistic infections almost always indicate an immunodeficiency, 
either acquired (see below) or congenital. 
1, Reticular dysgenesis 
2. 'Severe Combined Immunodeficiency' (SCID) with mutations in RAG genes 
3. Omenn syndrome (oligoclonal T-cells) 
4, X~linked SCID with mutations in 'common gamma chain' 
5, SCID with mutations in JAK3gene 
6. CATCH22 or DiGeorge syndrome 
7. Purine phosphorylase (PNP)...<feficiency 
8. CD8+ T-cell deficiency with mutations in ZAPlO gene 
g, X·linked agammaglobulinemia (XLA) 
10, C)l deficiency 
11. X·Jinked hyper IgM syndrome 
12. Selective IgA deficiency 
13. IFNy receptor deficiency 
14. IL·12 receptor.B chain deficiency 
15. HLA class II deficiency 
(bare Iymfocyte syndrome type II) with 
diminished numbers CD4+ T·lymphocytes 
2,3 
10. /Pre-£3..11 cell 
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Figure 2. Hypothetical scheme of 
lymphocyte differentiation in bone 
marrow and thymus, Relevant cell 
surface and intracellular markers are 
mentioned. Dotted lines show the 
position of maturational arrests in 
various congenital immunodeficiency 
diseases. 
Cy--cytoplasmic,Sm=surface membrane, 
immature'" ~ 
thymocyte ~. 
pre-TCR 4~5 
CD44 
CD25 
TdT 
CD4 
mature 
thymocyte 
CD' 
mature thymocyte 
coa 
TCR-C03 
1l12A 
________ IL12 
helper 
T-Iymphocyte 
CD' 
IFNy 
suppressor! 
cytotoxic T-Iymphocyte 
CDS 
TCR·CD3 
H 
macrophage/El.ntigen 
presenting cell 
C080 
CD40 
Immunophenolyping in immunodeficient children 103 
The "limited" immunophenotyping protocol as shown in Table 2 can easily 
detect severe combined immunodeficiency disease (SCID): T-Iymphocytes will be 
absent or very low in number (Figure 1 c). The presence or absence of B-
lymphocytes differentiates between B+ SCID and B- SCID, as found in X-linked 
common v-chain deficiency (XSCID) or autosomal recessive JAK3 and RAG1 or 
RAG2 deficiency, respectively (Figure 1c).··" Changes in either the CD4+/CD3+ 
helper T-Iymphocyte count or the CD8+/CD3+ suppressor/cytotoxic T-Iymphocyte 
count can indicate a diagnosis of "bare lymphocyte syndrome" (BLS type II or 
MHC class-II expression deficiency) with low CD4+/CD3+ counts or a diagnosis of 
ZAP70 deficiency with low CD8+/CD3+ counts, respectively." 
However, in many cases of combined immunodeficiency (CID), like adenosine 
deaminase (ADA) and purine nucleotide phosphorylase (PNP) deficiency, WiskoU-
Aldrich syndrome (WAS) and ataxia teleangiectasia (AT), immunophenotyping 
results are less aberrant with T-Iymphocytopenia developing over time." 
Additional tests are then required to come to a diagnosis (see Table 1). 
If immunodeficiency is highly suspected, but the "limited" immunophenotyping 
protocol shows no abnormalities, an "extended" immunophenotyping protocol as 
shown in Table 2 can identify additional children with specific subtypes of cell-
mediated or combined immunodeficiency that are not accompanied by major 
changes in the main lymphocyte populations. For example, in MHC class-II 
deficiency the absence of HLA-DR surface expression is the definitive clue to the 
diagnosis;" CATCH-22 syndrome is sometimes accompanied by severe T-
lymphocytopenia with low to absent TCRall+ T-Iymphocytes and normal numbers 
of TCRVi5+ T-Iymphocytes (J.J.M. van Dongen, unpublished observation). 
In unclassifiable cases, extensive specialized protocols may be needed to 
unravel the immunodeficiency. These protocols may include the following:'·'·" 
- HLA-typing or sex-chromosome analysis of individual T-Iymphocytes in male 
patients to detect the maternal origin of T-Iymphocytes in SCID patients with 
maternal graft versus host disease; 
- markers of maturation, such as CD45RA and CD45RO; 
- markers of aclivation and/or proliferation, such as CD25, CD69, CD40L and 
Ki6?; 
- co-stimulatory and/or signalling molecules, such as CD2? ... CD?O, and CD28 
... CD80/CD86 
- intracellular cytokines, such as IL2 and IFNV (Th1 profile), and IL4, IL5, and 
IL 10 (Th2 profile); 
- specialized function tests, such as in vitro immunoglobulin production. 
These tests are generally not performed in routine laboratories, and will not be 
further discussed here. 
Children with superficial and systemic Infections with pyogenic bacteria or fungi 
Most children with superficial and systemic infections with pyogenic bacteria or 
fungi suffer from neutropenia due to hematologic disorders or iatrogenic causes 
TABLE 3. Immunophenotyping in the diagnosis of primary immunodeficiency diseases. 
DISEASES 
MILD ANTIBODY DEFICIENCIES 
(Recurrent ENT and lower respiratory trad 
infections. lambliasis. sometimes asymptomatic) 
- IgA deficiency 
- IgG subclass deficiency 
- Anti-polysaccharide antibody deficiency 
SEVERE ANTIBODY DEFICIENCIES 
(Recurrent respiratory trad and ENT infections. life--
threatening bade rial infections, enteroviral CNS 
lnfedions, lambliasis) 
- XLA (Btk enzyme deficiency, X-linked) 
-19I-I deficiency (autosomal recessive) 
-).,14.1 deficiency (autosomal recessive) 
-XHIM 
-CVlD 
COMBINED IMMUNODEFICIENCY DISEASES 
(Failure to thrive, intractable diarrhea. eczema. and 
other chronic problems. or opportunistic infections) 
- ADA deficiency (autosomal recessive) 
- PNP deficiency (autosomal recessive) 
- MHC class-II expression deficiency (BlS type II, 
autosomal recessive) 
PATHOGENESIS 
Pathogenesis unknown 
Early arrest in B-cell development 
CD40l deficiency leads to absent isotype switch of B-
lymphocytes and associated T -lymphocyte defect due to 
absent CD40 stimulation 
Probably defects in B-cell maturation and helper T-
lymphocyte fundion 
Accumulation of toxic purine metabolites due to enzyme 
deficiency 
Impaired antigen presentation 
IMMUNOPHENOTYPING 
Normal immunophenotyping results 
Absent blood B-Iymphocytes; maturational arrest reflected in 
precursor B-cell population in bone marrow 
Absent or decreased CD40l expression on activated T-
lymphocytes; blood B-Iymphocytes present 
Blood B-Iymphocytes present; sometimes T-Iymphocytopenia 
Increasing T-Iymphocytopenia with time; also 8-
lymphocytopenia in ADA- SCID 
Deficient MHC class-II expression; low numbers of CD4+ T-
lymphocytes 
- WASfXl T (X-linked) (patients also suffer from Impaired cytoskeletal reorganization of platelets and T - Increasing T-Iymphocytopenia with time; impaired CD43 
eczema, thrombocytopenia. and malignancy) lymphocytes expression 
~ 
~ 
() 
i; 
lJ 
ii1 
::0 
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DISEASE 
SEVERE COMBINED IMMUNODEFICIENCIES 
(Failure to thrive, intractable diarrhea, eczema, and 
other chronic problems, or opportunistic infections) 
- X-SCID (common y-chain deficiency, X-linked) 
- JAK-3 kinase deficiency (autosomal recessive) 
PATHOGENESIS 
Defect in T-Iymphocyte and NK.-cell development 
- RAG1 or RAG2 deficiency (autosomal recessive) Early arrest in common lymphocyte development 
- Omenn syndrome; some RAG1 deficiencies 
(autosomal recessive) 
- ZAP-70 kinase deficiency (autosomal recessive) 
- CD3 y- or e-chain deficiency (autosomal 
recessive) 
- Reticular dysgenesis 
Defective T-Iymphocyte development with B-Iymphocyte 
deficiency 
Defect in T-Iymphocyte development 
Defect in T-Iymphocyte function 
Stem cell defect leading to defective maturation of T-
and B-ceHs and myeloid cells 
MILDER IMMUNODEFICIENCIES ACCOMPANYING OTHER DISEASES 
- DiGeorge (CATCH-22 syndrome) Cardiac malformaUons, hypoparathyroidism 
-AT (autosomal recessive) Progressive ataxia, teleangiectasia 
IMMUNOPHENOTYPING 
T-lymphocytes absent, NK-cells low, and B-lymphOcytes 
present 
T- and B-Iymphocytes absent 
Oligoclonal T-Iymphocytes, very low or absent B-Iymphocytes 
T-lymphOcytes - especially CD8+ decreased; B-Iymphocytes 
present 
T-Iymphocytes decreased, CD3 expression decreased; B-
lymphocytes present 
Pancytopenia 
SomeUmes TCRa[3+ T-lymphocytopenia with normal TCRy~+ 
T-Iymphocyte counts 
Sometimes increasing T -lymphocytopenia with time 
- Chromosomal breakage syndromes (Nijmegen 
breakage syndrome, Blooms syndrome, ICF 
syndrome) 
Mental retardation, photosensitivity, abnormal physionomy ImmunoPhenotyping mostly normal 
Abbreviations: AT = ataxia teleangiectasia; ADA = adenosine deaminase; BLS = bare lymphocyte syndrome; Btk = BMon's tyrosine kinase: CNS = central nervous system: 
CVID = common variable immunodeficiency: ENT = ear-nose-throat; HLA = human leukocyte antigen; ICF = immunodeficiency-centromeric instability-facial dysmorphism; JAK 
= Janus-associated kinase; MHC = major histocompatibility complex: PNP = purine nucleotide phosphorylase; RAG = recombinase activating gene; WAS = W1skott Aldrich 
syndrome: XHIM = X-linked hyper IgM syndrome; )(LA = X-linked agammaglobulinem'la; XL T = X-linked thrombocytopenia: XSCID = common y-chain deficiency. 
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(see below). This is easily detected with a leukocyte count and differential. A 
defect in granulocyte/monocyte function, such as in chronic granulomatous 
disease (CGD) or leukocyte adhesion deficiency (LAD), is rare. In CGD, 
granulocytes show deficient microbial killing due to a defect in one of the five 
NADPH oxidase complex components. This can be investigated by function tests 
of granulocytes." In LAD1 (CD18 deficiency) and LAD2 (CD15s deficiency) 
leukocyte adhesion is impaired. This leads to leukocytosis, which is even more 
pronounced during infections." CD18 and CD15s expression can be evaluated 
with immunophenotyping. 
FOLLOWING CHILDREN WITH ACQUIRED IMMUNODEFICIENCY 
Most cases of acquired immunodeficiency are iatrogenic and can therefore be 
anticipated: as more and more children are being treated with immunosuppressive 
drugs, aggressive chemotherapy protocols, and bone marrow transplantation, 
acquired immunodeficiency becomes a more common problem in pediatric 
practice. 
During follow-up of children treated with immunosuppressive drugs or 
chemotherapy, the degree of neutropenia is easily assessed with a leukocyte 
count and differential. The slow reconstitution of Iym phocytes after bone marrow 
transplantation can be monitored by a simple immunophenotyping protocol to 
determine the numbers of the main lymphocyte populations ("Iimited" protocol in 
Table 2). It should be kept in mind, however, that these cells remain functionally 
deficient for a longer period of time than is needed for the normalization of their 
absolute counts." 
HIV-infection is generally diagnosed by serology or PCR.'s 
Immunophenotyping has a role in the follow-up of HIV-infected children with the 
determination of decreasing CD4+/CD3+ helper T-Iymphocyte counts as a 
prognostic marker for the development of AIDS, and - together with RNA 
quantification - for the timing of antiretroviral therapy.15 During antiretroviral 
therapy monitoring of CD4+ helper T-Iymphocyte counts is useful for evaluating 
the treatment effectiveness in addition to RNA quantification. 
More elaborate immunophenotyping protocols can be reserved for research 
purposes, e.g. for comparison of the immune reconstitution after bone marrow 
transplantation with normal ontogeny." Such studies are important for 
understanding the regeneration processes, but have no direct clinical relevance as 
yet. 
CONCLUSION 
A multistage diagnostic protocol as shown in Table 1 identifies 
immunodeficient children in an efficient way: simple tests applied to a larger group 
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of children with potential immunodeficiency allow early diagnosis or exclusion, 
whereas more elaborate tests are reserved for those few children where 
immunodeficiency is more probable. 
Immunophenotyping of leukocytes forms an important part of the multistage 
protocol: determination of the presence and number of the main lymphocyte 
populations ("Iimited" protocol) identifies (S)CID patients and B-Iymphocytopenia 
in agammaglobulinemic patients, and, in selected cases, a set of extra 
measurements ("extended" protocol) identifies children with immunodeficiencies 
that are not accompanied by major changes in the main lymphocyte populations 
(Table 2). However, it should be noted that not all children with an 
immunodeficiency show alterations in immunophenotyping results. 
More extensive immunophenotyping protocols used in specialized laboratories 
or research settings help to recognize new immunodeficiency diseases by 
identifying as yet undescribed staining patterns. Also, pathogenesis of known 
defects can be further elucidated: the absence of specific cell surface markers, 12 
the loss of specific epitopes defined by McAb staining patterns,'" or the 
determination of the B-cell differentiation blockade in bone marrow' can support 
the precise characterization of the defect. Therefore, it is important to use these 
more extensive immunophenotyping protocols in patients with an established 
immunodeficiency disease, as well as in patients with probable immunodeficiency 
disease that has not been proven with other methods. 
Due to the rapid developments in the field of flow cytometry and antibody 
production, it is likely that the "limited" and "extended" immunophenotyping 
protocols defined here will have to be updated in a few years time. 
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ABSTRACT 
We prospectively studied the reconstitution of lymphocyte subpopulations in a 
group of 22 children, who survived disease-free at least 6 months after allogeneic 
bone marrow transplantation (BMT) for a hematological malignancy. 
Absolute counts of lymphocytes, B-Iymphocytes, T-Iymphocytes, and CD4+ 
helper T-Iymphocytes reached the 5th percentile (p,) of age-matched reference 
values within 6 months after BMT in 15, 17, 7, and 2 patients, respectively. 
Especially CD4+ helper T-Iymphocyte reconstitution was very slow. Unexpectedly, 
CMV-reactivation had a profound positive influence upon the number of CD4+ 
helper T-Iymphocytes in the children. In 5 patients, B-Iymphocyte absolute counts 
above the 95th percentile were reached from 6 months after BMT onwards, 
mimicking normal ontogeny. 
Unlike normal ontogeny, the percentages of helper T -lymphocytes expressing 
the "naive" CD45RA isoform were low and those expressing the "memory" 
CD45RO isoform were high in the first 3 months after BMT, as was described 
before. Thereafter, the CD45RA:CD45RO ratio slowly normalized. Also, CD7 
expression was absent on up to 90% of T-Iymphocytes in the first months after 
BMT, and on a steadily decreasing percentage thereafter, as was recently 
described in adults. However, the absolute counts of CD45RO+/CD4+ and CD7-
ICD4+ helper T-Iymphocytes did not change significantly. So, we found no 
evidence of peripheral expansion of previously primed donor-derived "memory" T-
lymphocytes during the follow-up period of 1-18 months after BMT. The absolute 
counts of "naive" CD45RA+ helper T-Iymphocytes did not show a faster increase 
after BMT than was described in adults, despite the presumed presence of a non-
involuted thymus in children. 
INTRODUCTION 
Bone marrow transplantation (BMT) is increasingly used as a potential curative 
therapy for hematological and other malignancies, immunodeficiency diseases, 
and lately also for metabolic and autoimmune disorders.'" Unfortunately, 
infectious morbidity and mortality resulting from the period of immunodeficiency 
early posttransplant are an important side effect of BMT. 
Studies on the immune reconstitution after allogeneic BMT have been 
performed extensively in adults.'·9 The innate immune system (phagocytes) fully 
recovers in the first weeks to months after BMT, but complete functional 
reconstitution of the adaptive immune system (B- and T-Iymphocytes) takes much 
longer. Therefore, infectious complications continue to be a problem for many 
months after BMT.'·10 Especially, the reconstitution of CD4+ helper T-Iymphocytes 
is very slow in adults. This could be related to the decreasing thymic function with 
age. Presumably, reconstitution of the T-cell compartment shortly after BMT is 
mainly provided by a peripheral expansion of donor T-Iymphocytes present in the 
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graft, and not by donor stem cells undergoing the normal developmental pathways 
in the bone marrow and thymus.'·11 This fits in with the observation that CD45RO+ 
"memory" CD4+ helper T -lymphocytes are present at a high proportion in 
peripheral blood after BMT in adults.12 Results of studies on T-cell regeneration 
after courses of intensive chemotherapy indicate that the thymus-dependent 
repopulation of "naive" CD4+ helper T -lymphocytes occurs with a shorter delay in 
children than in adults. 13." In children, however, only limited data on immune 
reconstitution after BMT are available."·16 
Therefore, we longitudinally investigated the T - and B-cell lineages in peripheral 
blood by immunophenotyping in 22 children after allogeneic BMT for a 
haematological malignancy. Because of the low total lymphocyte counts shortly 
after BMT, changes in lymphocyte subpopulation size are better represented by 
their absolute counts than by their relative frequencies," So, we studied the 
dynamics of reconstitution by calculating the absolute counts of the different 
lymphocyte subpopulations. These results were related to age-matched reference 
values for healthy children from the literature if available,17 and otherwise to the 
values found in age-matched BMT donors. 
MATERIALS AND METHODS 
Patients 
Between October 1990 and April 1994, absolute counts and relative frequencies 
of peripheral blood lymphocyte subpopulations were determined prospectively in 
22 of 34 consecutive pediatric patients who underwent allogeneic BMT for a 
hematological malignancy at the Department of Pediatrics of the Leiden University 
Medical Centre. These 22 children survived disease-free for at least 6 months 
posttransplant and had at least 3 posttransplant samples analyzed during up to 18 
months of follow-up. Clinical data concerning these children are summarized in 
Table 1. 
Swveillance for herpesvirus-reactivation 
At weekly intervals after BMT, throat swaps were cultured for herpes simplex 
virus (HSV), and throat swaps and urine samples were cultured for 
cytomegalovirus (CMV). White blood cells were investigated once weekly from 3 
weeks after BMT onwards for the presence of the nuclear CMV-related antigen 
pp65 in seropositive recipients." Serology for HSV, varicella zoster virus (VZV), 
CMV and Epstein-Barr virus (EBV) was performed before BMT, and on indication 
after BMT (results in Table 1). Reactivation was defined as isolation of the virus 
from the throat (HSV), the throat and/or urine (CMV) or antigen detection in the 
blood (CMV). Disease was defined as reactivation combined with signs of organ 
involvement, e.g. hepatitis, pneumonitis (CMV), mucositis (HSV), skin lesions 
(VZV), and Iymphoproliferation (EBV). Eleven patients were at risk for CMV-related 
problems (positive serology pre-BMT in donor and/or recipient), 13 for HSV-, 17 for 
EBV-, and 18 for VZV-related problems (Table 1). None of the patients received 
viral prophylaxis. 
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Immunostaining of membrane antigens 
Leukocyte counting was performed on EDTA-blood using a Sysmex F800 
hematological counter (Toa Medical Electronics, Kobe, Japan), and leukocytes 
were differentiated on blood smears stained with May-Grunwald Giemsa. 
Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll density 
gradient centrifugation. Interface cells were resuspended in Iysisbuffer to remove 
the erythrocytes, followed by an incubation at 37 'c to remove immunoglobulins 
bound non-specifically to the cell membrane. 
The various cell populations present among PBMC were identified according to 
the surface expression of lineage-specific antigens after two-colour 
immunostaining (Table 2). CD3+/CD8+ suppressor/cytotoxic T-Iymphocytes were 
not measured directly in the oldest samples (25%), but estimated by the 
investigation of total CD8+ lymphocytes. In short, 50 ~I of the cell suspension 
containing 0.1-1.0 x 10 6 PBMC was incubated in the dark for 30 minutes at room 
temperature with 25 ~I of fluorochrome-conjugated monoclonal antibodies 
(MoAbs). The cells were washed once with phosphate buffered saline (PBS) 
containing 1 % (w/v) bovine serum albumin (PBS-BSA). All media contained NaN, 
to prevent antibody internalization. 
Immunostaining patterns were analyzed by flow cytometry (FACScan, Becton 
Dickinson, San Jose, CAl, and data were analyzed using the Cellquest software 
package. A gate was set around the lymphocyte population on the basis of 
forward and side scatter characteristics and staining patterns of CD45 and CD14 
MoAbs (CD45+/CD14- cells). 
Recovery of lymphocyte subpopulations 
Normalization of the absolule counts of a given lymphocyte (sub)population in 
the peripheral blood of a patient was defined as reaching the 5th percentile (P5) of 
age-matched reference values published in the Iiterature. 17 In case age-matched 
reference values were not available, a comparison was made with data from age-
matched BMT donors analyzed between September 1992 and April 1997 (1-5 
years of age, n=29; 5-10 years of age, n=30; 10-18 years of age, n=45). 
CMV-specific lymphocyte activation 
Child no. 21 suffered from CMV-reactivation wilh pp65 detectable in white 
blood cells and CMV cullured from urine from 1 to 4.5 months after BMT. CMV-
specific T-cell responses were measured at day +80, day +220, and day +264 
posttransplant. Briefly, PBMC were stimulated with CMV (AD169) infected HEL-
cells, and un infected HEL-cells as control. After 6 hours of stimulation, cells were 
analyzed by flow cytometry for surface expression of the activation marker CD69 
and the intracellular presence of interferon (IFN) V according to Waldrup et al.20 
After 5 days of stimulation 'H-thymidine was added to the cullures and 
incorporation was measured during a final 16 hours of incubation. 
Statistics 
The P5 recovery data were analyzed with life table techniques, taking into 
TABLE 1. Patient's characteristics and reconstitution data. ~ ~ 
.... 
No. Sex Age' Donor TCD Diagnosis Conditio GvH- GvHD CMII" HSV EBV vzy Reconstitution after B~ 
ning prophylaxis 
QRQI DR!.';:I DB!.':I DRQI T Th T~ B 
M 3.3 HLA-id AMLI1 TBlley CsAIMTX + + r + . + . . + . <28 28-77 <28 28-42 
+AraC 
2 F 15 HLA-id AMLI TBVCy CsAIMTX + + + 
- -
167+ 167+ <32 32-90 
+AraC 
3 M 8.8 HLA-id AMLI TBVCy CsAIMTX + r + + + + + + <28 78-239 <28 29-50 
+AraC 
4 F 1.7 HLA-id ALLI TBVCy CsAIMTX - + - - n - - n - + n - 85-167 358+ 8$.167 <57 
+VP16 
5 M 5.5 HLA-id ALL II TBVCy CsAIMTX 85-162 162-344 <27 27-58 
+VP16 
() 
6 M 13.2 HLA-id ALL II TBVCy CsAIMTX + - r 
- + - + - + + 85-225 225-414 27-62 85-225 5): 
+VP16 
"1J 
7 M 6.4 HLA-id AMLI TBVCy CsAIMTX + - 27-57 162+ <27 <57 n:: 
+AraC ::0 
<0 
8 M 7.3 HLA-id ALL II TBIiCy CsAIMTX + • . + + + 57-99 302+ 57-176 57-176 
+VP16 
9 F 7.8 HLA-id A1,...lll TBIiCy CsAIMTX + r + + + + - 27·57 176+ <27 27-57 
·VP16 
10 F 6.9 HLA-id ALL II TBlley CsAIMTX 
-
+ • + + s + + - 27-64 232+ 78-232 <64 
+VP16 
11 F 4.8 MUD +' MDS TBVCy CsAIMTX 
- + - + . - - + - 152-194 131-194 <26 <131 
+AraC 
12 M 1.3 Haplo-id + AUL BulGy CsAIMTX + + - + - 139-377 377+ 377+ 377+ 
13 M 8.3 HLA-id ALL II TBIiCy CsAlMTX a I' 
-
+ 
-
62-90 202-321 <34 <90 
+VP16 
No. Sex Age' Oonor 
14 F 1.8 MUD 
15 M 6.8 HLA-id 
16 F 9.7 MUD 
17 M 13.1 HLA~id 
18 M 9.5 HLA-id 
19 F 2.1 HLA~id 
20 F 12 MUD 
21 M 3.3 MUD 
22 M 11.8 MUD 
TCD Diagnosis Conditio GvH- GvHD CM'P 
• 
• 
• 
• 
AMLII 
MOS 
MOS 
ALL I 
AMLI 
AMLI 
AMLI 
ning prophylaxis 
TBUCy CsAIMTX 
+AraC 
TBIiCy CsAJMT)( 
·AraC 
TBIiCy CsAJMT)( 
+AraC 
TBIiCy CsAJMT)( 
+VP16 
TBl/Cy CsA!MTX 
·mC 
BuiCy CsAJMT)( 
+AraC 
TBIiCy CsAJMT)( 
·mC 
Ph'CML TBlICy CsAIMTX limchr 
+AraC 
MDS TBUCy long course -
+AraC MTX 
DRCI 
. -
• r 
n 
• 
• r 
· -
HSV EBV vz:v Reconstitution after BMr 
ORCI DRCI DRCI T Th Tslc B 
• 174-391 174-391 a3~174 a3~174 
+ - + + - · . - a5-, a8 188~356 <85 85-188 
+ ns +n-
• n 
28-63 364· <28 <63 
+ + n - • • 183-463 463+ 57-183 183-463 
• • • • • • 377-610 377+ <85 85-183 
. - • • 27-57 372+ <27 <92 
• · . - . - 27-62 356+ 27-62 197-356 
n n n • 9 94-171 94-171 <34 241+ 
n n + - n + - 307+ 307+ 62-111 <48 
, Age at SMT in years. Z Viral serology in the donor (D) and the recipient (R) scored as either positive (+), negative H, or not determined (n). and absence (-) or presence (r = 
reactivation; s = stomatitis: g ;;;; generalized skin eruption) of clinical problems (CI) related to viral reactivation and/or disease (for definition see Materials and Methods 
section). 3 T-cell depletion (~2 log) was achieved by albumin gradient centrifugation and E-rosette sedimentation [18]. Time interval in days after BMf where Ps of age-
matched reference values was crossed; < indicates that crossing occurred before this first study sample was taken; + indicates that crossing occurred after this las study 
sample was taken, so there is a censored observation. T = T-Iymphocytes, Th :;: helper T-Iymphcoytes, Tslc = suppressor/cytotoxic T.lymphocytes as estimated by T-Th, B :;: 
B-Iymphocytes. 5 a I = acute grade I; limchr = limited chronic. 
ALL = acute lymphoid leukemia; AML :;: acute myeloid leukemia; AraC = cytarabine; AUL = acute undifferentiated leukemia; Bu :;: busulphan; CMV = cytomegalovirus; CsA :;: 
ciclosporin A; Cy :;: cyClophosphamide; EBV = Epstein-Barr virus; GvH(D) = graft versus host (disease); Haplo-id = haplo-identical; HLA-id = HLA-identical; HSV :;: herpes 
simplex virus; MDS :;: myelodysplastic syndrome; MTX = methotrexate; MUD:;: matched unrelated donor; Ph'CML :;: Philadelphia chromosome positive chronic myeloid 
leukemia; TBI :;: total body irradiation; TCD = T-cell depletion; VP16 :;: etoposide; vz:v:;: varicella zoster virus. 
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TABLE 2. Immunophenotyplng protocol. 
Marker File-conJugated Marker PE-conJugated Recognized lymphocyte subpopulatlon 
MoAb (Companyl) MoAb (Companyl) 
IgGl 
COl IgGl (In IgG2 IgG2 (BO) Isotype control 
C03 leu·9 (BO) C03 leu-4 (BO) Tolal CD3+; CD3+/CD7· r-Iymphocytes 
COl leu-4 (BO) C04 OKT4 (00) Total C03+; CD3+/CD4+ helper T-Iymphocytes 
CD45RA leu-9 (BD) CD4 OKT4 (00) CD4+JCD7- T-Iymphocytes 
CD45RO leu-1B (BD) CD4 OKT4 (00) CD4+/CD45RA+ 'naive" helper T-Iymphocytes 
CD3 UCHl-l (OK) CD4 OKT4 (00) CD4+/CD45RO+ 'memory" helper T-Iymphocytes 
Leu·4 (SO) COB OKTB (00) Total CD3+; CD3+/CD8+ suppressor/cytotoxic T-
COl lymphocytes 
CD20 leu-9 (BD) COB OKTB (00) COSt/C07-lymphocytes 
OKB20 (00) CD5 leu-I (BD) Total CD20+; CD20+IC05+ B-Iymphocytes 
1 BO = Becton Dickinson San Jose, CA; OK = Dako, Glostrup. Denmark; IT = Immunotech, Marseille, France; 00 = 
Ortho DIagnostics, Raritan, NJ. 
account that only the time interval was known in Which the recovery took place, Le. 
the data were so-called interval censored." The time-intervals are shown in Table 
1: e_g. for patient no. 1, the recovery of helper T-Iymphocytes took place 
somewhere between day 28 and day 77, whereas for patient no. 2 reconstitution 
had not yet occurred at the last day of follow-up (day 167); this patient is censored_ 
The curves for the cumulative risk on reconstitution were estimated for the total 
group as well as for patients with and without CMV-reactivation (CMV+ and CMV-), 
with an HLA-identical (HLA-id) and with a matched unrelated donor (MUD), and 
with and without T-cell depletion (TCD) (TCD+ and TCD-), separately_ The 
comparison of the groups of CMV+ and CMV- patients, the groups with an HLA-id 
and a MUD donor, and the groups of TCD+ and TCD- transplants, is expressed as 
the relalive risk (RR) of reaching the Ps of age-matched reference values, and its 
95% confidence interval. The analysis of interval censored data is not available in 
standard statistical packages_ It was done using the GAUSS package and the 
Turnbull algorithm." 
RESULTS 
Clinical course (see also Table 1) 
Six children developed CMV-reactivation within 2 months posttransplant (5 HLA-
id, 1 MUD), none had overt disease_ Two children suffered from HSV-stomatitis, 
and one child developed generalized VZV-related skin eruptions; they were treated 
successfully with iv aciclovir. There were no EBV-related problems in the study 
group. Grade I acute graft versus host disease (GvHD) was observed in 1 child 
(HLA-id), limited chronic GvHD developed in another child (MUD). Due to the 
limited occurrence of complications in these 22 children, the influence of the 
development of GvHD or herpesvirus-reactivation on lymphocyte reconstitution 
after BMT could not be analyzed, except for CMV-reactivation (see below). 
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Figure 1. The influence of 
CMV-reactivation on the 
probability of CD4+ helper 
T-Iymphocyte recovery (> 
p, of age-matched 
reference values) after 
BMT in 22 children 
transplanted for a 
hematological malignancy. 
Recovery offhe main lymphocyte populations (see also Tabte 1) 
The absolute lymphocyte counts reached the p, of age-matched reference 
values within 3 months after BMT in 9 patients (41%; 7 HLA-id, 2 MUDfTCD_), 
and in another 6 patients (27%; 4 HLA-id, 1 MUDfTCD-, 1 MUDfTCD-) between 3-
6 months after BMT. The absolute counts of B-Iymphocytes reached the p, of age-
matched reference values within 3 months after BMT in 13 patients (59%; 11 
HLA-id, 2 MUDfTCD_), and in another 4 patients (18%; 2 HLA-id, 2 MUDfTCD-) 
between 3-6 months after BMT. In 5 patients (23%; all HLA-id), absolute counts 
of B-Iymphocytes above the 95th percentile (p,,) were reached from 6 months 
after BMT onwards. The absolute counts of T-Iymphocytes reached the p, of age-
matched reference values within 3 months after BMT in only 3 patients (14%; all 
HLA-id), and in another 4 patients between 3-6 months after BMT (18%; 2 HLA-id, 
2 MUDfTCD-). The absolute counts of CD8- suppressor/cytotoxic T-Iymphocytes 
(measured in 13 HLA-id and 3 MUD patients only) recovered quickly. They 
reached the p, of age-matched reference values within 3 months after BMT in 10 
patients (63%; 8 HLA-id, 1 MUDfTCD. and 1 MUDfTCD-), and in another 4 
patients (25%; 3 HLA-id, 1 MUDfTCD.) between 3-6 months after BMT. CD4. 
helper T-Iymphocytes remained very low up to 18 months after BMT, despite the 
fact that all BMT-recipJents were children. They reached the p, of age-matched 
reference values within 3 months after BMT in only 1 patient (5%; HLA-id), and in 
only 1 more patient (5%; HLA-id) between 3-6 months after BMT. There was no 
significant difference in the rate of recovery of the main lymphocyte 
subpopulations between HLA-id and MUD transplants, or between TCD. and 
TCD- transplants (Table 3). The 1 haplo-idfTCD. transplanted patient did not 
show any recovery of the main lymphocyte subpopulations in the first 6 months 
after BMT. 
The influence of CMV-reactivation 
Two patients (nos. 1 and 3; both HLA-id) showed an initial peak in their total 
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Figure 2. Follow-up of T-
lymphocyte sUbpopulations 
after BMT in 22 children 
transplanted for a 
hematological malignancy. 
A, Percentage CD45RA+ 
of CD4+ helper T-
lymphocytes. B, 
Percentage of CD45RO+ 
of CD4+ helper T-
lymphocytes. C, 
Percentage CD7- of T-
lymphocytes. 
lymphocyte counts early posttransplant (7.3 x 10 911 at +42 days and 5.3 x 10' II at 
+50 days, respectively); both were excreting CMV in their urine, and pp65 was 
detectable in their blood leukocytes at that time. They also showed an initial peak 
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Figure 3. Dot plots of representative peripheral blood samples from the study group of 22 
children who were transplanted for a hematotogical malignancy. A, Low percentage 
C045RA+ of C04+ helper T-Iymphocytes 2 months after BMT. B, High percentage of 
C045RO+ of C04+ helper T-Iymphocytes 2 months after BMT. C, High percentage of 
CD7- T-Iymphocytes 1 month after BMT. 0) Low percentage of CD7- T-Iymphocytes 6 
months after BMT. 
in their T-Iymphocyte counts (4.5 resp. 4.4 x 10 '/1), but not in their CD4+ helper T-
lymphocyte count. An additional child (no. 21; MUDffCD-) with CMV-reactivation 
had very high T-Iymphocyte levels at 8 months after BMT (4.2 x 10 '/1). In all these 
cases the peak reflects an expansion of C08+ suppressor/cytotoxic T-
lymphocytes. 
Although there was a trend towards faster quantitative T -lymphocyte recovery 
among the children with CMV-reactivation, this was not significantly different from 
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the recovery of T-Iymphocytes in children without CMV-reactivation: relative risk 
CMV. vs CMV- 2.36, 95% confidence interval 0.82-6.70. Estimated 
suppressor/cytotoxic T-Iymphocyte recovery (assessed as total T-Iymphocyte 
minus CD4+ helper T-Iymphocyte counts) was faster among the children with 
CMV-reactivation: relative risk CMV. vs CMV- 3.48, 95% confidence interval 1.12-
10.6 (Table 3). Unexpectedly, CD4. helper T-Iymphocyte recovery was 
significantly faster in children with CMV-reactivation: relative risk 12, 95% 
confidence interval 2.1-90 (Table 3 and Figure 1). To assess whether the faster 
reconstitution of T-Iymphocytes was related to CMV-specific activation, PBMC 
available from child no. 21 at different time points after BMT were in vitro 
stimulated with CMV. A clear, but low, CMV-specific proliferative response was 
only observed at +220 days posttransplant. Also, the combined analysis of cell 
surface expression of CD69 and intracellular expression of IFNy by flow cytometry 
indicates only a marginal, if relevant, presence of CMV specific T -lymphocytes at 
any of these time points. There was no influence of CMV-reactivation on B-
lymphocyte recovery (relative risk 1.01, 95% confidence interval 0.31-2.57) (Table 
3). 
CD45RA and CD45RO expression on helper T-Iymphocytes 
Early posttransplant, the percentage of helper T -lymphocytes expressing the 
"naive" CD45RA isoform was low, showing an increase (Figure 2a) from a 
median of 20% in the first blood samples at 1-2 months (Figure 3a) to a median of 
50-60% at >3 months after BMT. BMT donors (see Material and Methods) showed 
a median percentage of helper T-Iymphocytes expressing the "naive" CD45RA 
isoform of 75%, 66%, and 64% at 1-5 years, 5-10 years, and 10-18 years of age, 
respectively. The percentage of helper T-Iymphocytes expressing the "memory" 
CD45RO isoform was high, showing a decrease (Figure 2b) from a median of 
around 90% (TCD- median 84%, TCD. median 92%) in the first blood samples at 
1-2 months (Figure 3b) to a median of 30-40% at >3 months after BMT. BMT 
donors showed a median percentage of helper T-Iymphocytes expressing the 
"memory" CD45RO isoform of 18%, 32%, and 34% at 1-5 years, 5-10 years, and 
10-18 years of age, respectively. This pattern of expression of the CD45 isoforms 
after BMT is in accordance with data from the literature."" However, the absolute 
counts of CD45RO+ helper T -lymphocytes did not change significantly during the 
follow-up period from 1 to 18 months after BMT (median 0.1 x 10 9,,). The 
absolute counts of CD45RA. helper T-Iymphocytes increased tenfold, but 
remained low in number, from a median of 0.02 x 10 9" in the first 6 months after 
BMT to a median of 0.2 x 10 9" thereafter. 
Predominance of CD7- T-Iymphocytes early posttransplant 
In the first blood samples at 1 month after BMT, CD7 was not expressed on a 
median of around 70% of T-Iymphocytes (HLA-idfTCD- median 62%, MUDfTCD+ 
1 sample 77%) (Figure 3c). The percentage of CD7- cells within the T-Iymphocyte 
population decreased quickly after BMT (Figure 2c) to a median of 40% at 2-3 
months, 20% at 6 months (Figure 3d), and 10% in the second year posttransplant. 
BMT donors showed a median percentage of CD7- cells within the T-Iymphocyte 
population of 5%, 7%, and 7% at 1-5 years, 5-10 years, and 10-18 years of age, 
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TABLE 3. Influence of CMV·reactivation, donor type and TCD on lymphocyte 
recovery. 
Lymphocyte 
subpopulaUon 
T·lymphocytes 
HLA-ld4 
MUDs 
TeD.6 
TeD+1 
Helper T-Iymphocytes Total 
CMV· 
CMV+ 
HLA-id 
MUD 
TeD-
TeO+ 
Suppressor/cytotoxic Total 
T-lymphocytes8 
a·lymphocytes 
CMV· 
CMV+ 
HLA·ld 
MUD 
TCD· 
Teo+ 
Tolal 
CMV· 
CMV+ 
HLA-jd 
MUD 
TCD· 
TeO+ 
Day after BMT at which the Relative Risk of crossing the Ps -value of 
cumulative incidence of crossing the age-matched reference values of CMV+ 
p:; -value of age-matched reference versus CMV- children, HLA-id versus MUD 
values reaches 20%, 50%, and 80%, transplants, and Teo+ versus TeO· grafts, 
respectively. respectively. 
20% 
28 
47 
28 
28 
45 
28 
45 
233 
313 
168 
235 
25 
233 
194 
11 
12 
11 
9 
16 
11 
9 
36 
39 
36 
36 
37 
36 
37 
50% 
90 
90 
28 
87 
157 
88 
186 
380 
391 
234 
382 
381 
239 
383 
28 
28 
26 
23 
28 
28 
21 
42 
42 
42 
41 
87 
41 
87 
80% 
187 
380 
141 
185 
383 
99 
334 
594 
780 
237 
765 
387 
732 
388 
97 
102 
28 
94 
95 
88 
109 
90 
90 
90 
89 
286 
89 
330 
Relative Risk 95% Confidence interval 
2.36 0.82-6.70 
0.66 0.17-1.58 
0.58 0.16-1.54 
12 2.1·90 
1.32 0.28-5.17 
0.58 0.10·2.44 
3.48 1.12-10.6 
1.10 0.41-2.57 
0.40 0.10-1.12 
1.01 0.31-2.57 
0.73 0.24-1.84 
0.59 0.17·1.59 
1 All children after allogeneiC BMT.' Chltdren without CMV·reactivat!on (n=16)! Ch.ildren with CMV-reactivaUon (n=6). 
4 Children transplanted with an HLA-fd donor (n=15). sChUdren Itansplanted with a MUD donor (n=6), 
6Children transplanted with a full bone marrow graft (n=16). 
7Children transplanted with a T·celt depleted bone marrow graft (n=6). 
8 Assessed as total T-Iymphocyte minus CD4+ helper T·lymphocyte counts. 
Abbreviations: BMT = bone marrow transplantation; CMV = cytomegalovirus; HLA·id HLA·fdent1cal; MUD 
matched unrelated donor; TCD = T-cell depletion. 
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TABLE 4. CMV-speciflc in vitro stimulation of PBMC of the CMV+ patient no. 21. 
Stimulus CMV (AD169) infected HEl-cells Stimulus: unlnfecled HEl-cells 
Proliferation 
PBMC day +80 
+220 
+264 
0.3
' 
3.2 
0.1 
Percentage of CD3+ T-lymphocyt8S expressing IFNyand CD69 
PBMC day +80 
+220 
+264 
0.011 2 
0.002 
0.002 
1 counts per minute x 10 -3 of 3H-Ihymldlne Incorpora!ion after 6 days of culture 
0.1 
0.2 
0.2 
0.002 
0,003 
0.006 
2 Percentage of CD3+ T-Iymphocytes expressing Intracellular IFNy and cell surface CD69 after 6 hours of slimufalion 
Abbrevlalfons: CMV = cytomegalovIrus: IFN = Interferon; PBMC = peripheral blood mononuclear cells. 
respectively. At 1 month after BMT the median absolute count of CD7 -/CD3+ T-
lymphocytes was 0.5 x 10 'II, thereafter it did not change significantly during the 
remaining follow-up period from 2 to 18 months after BMT (median 0.1- 0.2 x 
10 'II). The median absolute count of CD7-/CD3+ T-Iymphocytes in BMT donors 
was 0.1 x 10'11 in all age groups. Six patients showed high absolute counts of 
CD7-/CD3+ T-Iymphocytes in the first 3 months after BMT (1.0-2.5 x 10 'II). Four 
of these patients suffered from CMV-reactivation. The median absolute count of 
CD7+/CD3+ T-Iymphocytes slowly Increased from 0.4 x 10 'II at 1 month after 
BMT to 1.6 x 10 'II at 12-18 months after BMT. CD7 expression on CD4+ helper 
T-Iymphocytes and on CD8+ cells followed a similar pattern (data not shown). 
C05+ B-Iymphocytes 
Although the median percentage of CD5+ cells within the B-Iymphocyte 
population decreased from 65% (median) at 1-2 months after BMT (HLA-id 
median 65%, MUDITCD+ 2 samples 46% and 48%) to 42% (median) at > 1 year 
after BMT, the absolute counts of CD5+/CD20+ B-Iymphocytes remained stable 
during the entire follow-up period (median 0.3 x 10 'II at 1-2 months after BMT to 
0.4 x 10 'II at > 1 year after BMT). 
DISCUSSION 
We prospectively analyzed the reconstitution of lymphocyte subpopulations 
after allogeneic BMT in a group of 22 children transplanted for a hematological 
malignancy. The recovery, measured in terms of crossing the p, of age-matched 
reference values,17 was slow. In one third of the children, the absolute lymphocyte 
counts still had not reached the p, of age-matched reference values 6 months 
after BMT. In addition, B- and T-Iymphocytes showed a different pattern of 
recovery. 
The absolute counts of B-Iymphocytes recovered relatively fast after BMT, 
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reaching the P. within 6 months posttransplant in 77% of the children. A quarter of 
the children, all transplanted with an HLA-id donor, reached values above the Pes, 
resembling normal ontogeny during the first year of life, as was described before.8 
CD5+ B-Iymphocytes, which are presumed to be more primitive cells," seem to 
repopulate the periphery faster than CD5- "conventional" B-Iymphocytes following 
BMT: although the median percentage of CD5+ cells within the B-Iymphocyte 
population was high early after BMT, as was described before,24 the absolute 
counts of CD5+/CD20+ B-Iymphocytes remained stable during the entire follow-up 
period. CD5- B-Iymphocytes increased only slowly, resembling normal ontogeny in 
the first year of life (E. de Vries et aI., submitted). 
The absolute counts of T-Iymphocytes recovered more slowly: in only one third 
of the children levels above the P. were reached at 6 months after BMT. At that 
time, only 2 children (9%; both HLA-id) had reached levels above the P. for CD4+ 
helper T -lymphocytes, whereas 88% of the children had reached levels above the 
P. for CD8+ suppressor/cytotoxic T-Iymphocytes. This very slow reconstitution of 
CD4+ helper T-Iymphocytes was described before in adults, • but not in children." 
However, Foot et al ,. did not apply age-matched reference values to evaluate the 
reconstitution of lymphocyte subpopulations in their study. The P. of the absolute 
counts of CD4+ helper T-Iymphocytes is higher in younger children, resulting in an 
increasing threshold for "recovery", with decreasing age. The comparatively slow 
recovery of CD4+ helper T-Iymphocytes after BMT in children and adults is in 
contrast with the conclusions of Mackall et al. 13 Their findings led to the conclusion 
that the thymus-dependent reconstitution of helper T-Iymphocytes after cytostatic 
therapy is delayed in adults in comparison with children. Maybe, the pre-BMT 
conditioning regimen initially damages the thymus to such an extent that CD4+ 
helper T-Iymphocyte development is impaired for a long period of time in pediatric 
bone marrow graft recipients as well. CD8+ suppressor/cytotoxic T-Iymphocytes 
rapidly recovered to normal absolute counts after allogeneic BMT in the children, 
despite the potential damage to the thymus of the myelo-ablative therapy, but this 
was also described in adult BMT recipients' and after intensive chemotherapy.13." 
Unexpectedly, we found a clear positive influence of CMV-reactivation on 
quantitative CD4+ helper T-Iymphocyte recovery. CMV represents a significant 
problem in the posttransplant period, with a high morbidity and mortality, especially 
in adults." In healthy individuals, primary infection results in lymphocytosis of 
CD8+ cytotoxic T-Iymphocytes (CTL's) during a mild or even subclinical illness.'· 
These CTL's are probably responsible for elimination of the active infection, and 
induction of protective immunity. A lymphocytosis of CD8+ cytotoxic T-
lymphocytes was described in children after TCD+ BMT. ,. We also found a faster 
recovery of suppressor/cytotoxic T-Iymphocytes, assessed as total T-Iymphocyte 
minus CD4+ helper T-Iymphocyte counts, in children with CMV-reactivation. The 
faster CD4+ helper T-Iymphocyte recovery we found in children with CMV-
reactivation might be related to the more benign course of CMV-reactivation in 
children than in adults: Reusser et al" found a significant association between the 
presence of CMV-specific T-helper cell proliferation and the development of CTL 
activity. We did not find a significant CMV-specific proliferation of T-Iymphocytes 
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after BMT in the one child with CMV-reactivation we tested. however. 
Our data confirm the findings by others"" of a high percentage of "memory" 
CD45RO+ helper T-Iymphocytes and a low percentage of "naive" CD45RA+ helper 
T-Iymphocytes early posttransplant. However. our data also show that a different 
picture emerges when absolute counts are considered. Actually. the "memory" 
CD45RO+ helper T-Iymphocyte counts remain stable during a follow up period 
from 1 to 18 months after BMT. and the "naive" CD45RA+ helper T -lymphocyte 
counts increase slowly. Interestingly. the few T-Iymphocytes that were present at 1 
month after BMT were also largely CD7-. as was recently described in adults." In 
normal individuals. a small subpopulation of CD7-. mostly CD4+. CD45RO+ and 
CD45RA- primed "memory" T -lymphocytes exists. which are probably destined for 
homing to the skin. This subpopulation increases in size with age.30 The absolute 
counts of CD7 + T -lymphocytes increased only slowly after BMT. whereas the 
absolute counts of CD7- T-Iymphocytes remained stable during 18 months of 
follow-up. . 
In conclusion. we found that immune reconstitution after BMT. especially of 
CD4+ helper T-Iymphocytes. is a slow process in children. as it is in adults. 
Unexpectedly. CD4+ helper T-Iymphocyte recovery was significantly enhanced in 
children following CMV-reactivation. We did not find evidence of a peripheral 
expansion (i.e. increase of blood lymphocyte subpopulation absolute counts) of 
previously primed donor-derived CD45RO+ and CD7- "memory" T-Iymphocytes 
from 1 month after BMT onward in these children. Of course. it is possible that 
those lymphocytes that appear around 1 month after BMT are the result of such a 
peripheral expansion during the first month posttransplant. It is difficult to analyse 
this with immunophenotyping. due to the extremely low numbers of lymphocytes in 
the first month after BMT. Like in adults. there was but a slow reconstitution of 
truly "naive" CD45RA+ T-Iymphocytes coming out of the thymus. 
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ABSTRACT 
We found an unusual Fcy Receptor lila (CD16a) phenotype on the natural killer 
(NK) cells of a 3-year-old boy, who suffered from recurrent viral respiratory tract 
infections since birth. He also had severe clinical problems after Bacille Calmette-
Guerin (BCG) vaccination and following Epstein-Barr virus and varicella zoster virus 
infections. His peripheral blood lymphocytes contained a normal percentage and 
absolute number of CD3-CD7+ cells, which were positively stained with the CD16 
monoclonal antibodies (MoAbs) 3G8 and CLBFcRgran1, but did marginally stain 
with the CD16 MoAb Leu11c/B73.1. FcyRllib expression on granulocytes appeared 
to be normal. NK-cell function, analyzed in vitro by direct cytotoxicity on K562 target 
cells and ADCC-activity on P815 target cells, was normal compared with an age-
matched healthy control. Sequence analysis of the FcyRillA gene, encoding CD16 
on NK-cells and macrophages, showed a T to A nucleotide substitution at position 
230 on both alleles, predicting a leucine (L) to histidine (H) amino acid change at 
position 48 in the first extracellular Ig-like domain of FcyRllla, which contains the 
Leu11c/B73.1 epitope. The combined use of CD16 and CD56 MoAbs labeled with 
the same fluorescent dye, as often applied in routine immunophenotyping proce-
dures, will leave these homozygotes undiagnosed. The pattern of infections in this 
patient is in agreement with the postulated function of NK-cells in the 
immunological defense against viruses and other intracellular microorganisms. 
Further analysis of the NK-cell function in vitro, and follow-up of the clinical course 
of FcyRIIIA-48H/H homozygotes is required to ascertain whether this genotype is 
causally related to an NK-cell immunodeficiency. 
INTRODUCTION 
Natural killer (NK) cells are generally defined as large granular lymphocytes 
that express CD16 and/or CD56, and are negative for pan-T- and B-cell markers. 
They are able to lyse sensitized target cells in vitro through the mechanism of 
antibody-dependent cell-mediated cytotoxicity (ADCC) and to kill K562 target cells 
spontaneously. Their function in vivo is not fully known. NK-cells probably playa 
role in the destruction of tumor cells and in the resistance to infections caused by 
certain viruses and other intracellular pathogens. ' 
The Fcy receptor lila (CD16) is involved in the triggering of ADCC'·2 and 
spontaneous cytotoxicity.'" Recently, an expression polymorphism of CD16 on NK-
cells derived from healthy individuals, based on a difference in the number of 
binding sites for monomeric IgG per NK-cell, has been described.' Until recently, 
no genetic polymorphism of FcyRilla had been reported.' 
Here, we describe a 3-year-old boy who suffered from recurrent viral respiratory 
tract infections since birth. He also had severe problems with Bacille Calmette-
Guerin (BCG) vaccination, and Epstein-Barr virus and varicella zoster virus 
infections. This clinical pattern might be compatible with an in vivo dysfunction of 
NK-cells. Immunophenotyping of peripheral blood mononuclear cells. (PBMC) 
130 CHAPTER 10 
indicated that NK-cells, defined as CD3-CD7+ lymphocytes, are normally present, 
but that the CD16 molecule expressed by these cells lacks the epitope recognized 
by the MoAb Leu11c/B73.1. The in vitro NK-cell function was normal compared 
with an age-matched healthy control. Sequence analysis of the FcyRlllA gene 
revealed a T to A nucleotide substitution at position 230 on both alleles, predicting a 
leucine to histidine change at amino acid position 48 in the first extracellular domain 
of FcyRllla. 
MATERIALS AND METHODS 
Patient 
The patient was born at term after an uneventful pregnancy and delivery. He 
was the first-born child of non-consanguineous parents of Turkish and Dutch-
Norwegian descent. Recently, a second son was born in this family. From 3 months 
of age onward, the patient suffered from recurrent, mainly viral, upper respiratory 
tract infections. These were accompanied by wheezing and nocturnal dyspnea, 
which reacted well to inhaled salbutamol and, later on, to inhaled steroids. BCG 
vaccination at 6 months of age resulted in local abscess formation, fever, and 
malaise, only cured 1 year later by excision of the abscess and 2 months of 
isoniazid therapy. At 18 months of age, he developed a prolonged Epstein-Barr 
virus infection with fever and malaise, which lasted about 10 months. He mounted a 
normal antibody response to Epstein-Barr virus during this period. At 30 months of 
age, he had chickenpox, Which was progressive during 2 weeks, and was finally 
cured with acyclovir therapy. Despite all this, his grow1h and development were 
normal. 
The absolute number and function of his peripheral blood granulocytes, T-, and 
B-cells were normal, as were the levels of serum Ig isotypes and specific antibodies 
following diphteria toxoid and tetanus toxoid-inactivated polio virus type I, II, and III 
(DT-IPV) vaccination. However, the CD3-CD7+ NK-cells were not stained by the 
CD16 MoAb Leu11c/B73.1. NK-cell function was tested by spontaneous cytotoxicity 
of K562 target cells and by ADCC of P815 targets, and further investigation of the 
FcyRllla (CD16) expression on the NK-cells and of the FcyRlllA gene was 
undertaken. 
Isolation of cells 
Fresh anticoagulated blood was diluted 1:2 in phosphate-buffered saline (PBS) 
and centrifuged over a Percoll gradient with a specific gravity of 1.076 g/ml 
(Pharmacia, Uppsala, Sweden). Mononuclear cells (PBMC) were harvested from 
the interphase and the pellet, containing mainly neutrophils and erythrocytes, was 
treated with ice-cold NH,CI solution (155 mmollL NH,CI, 10 mmollL KHCOa, 0.1 
mmollL EDTA, pH 7.4) to lyse the erythrocytes. 
MoAbs 
The following MoAbs were used: pan-FcyRIlI CD16 MoAbs: CLBFcRgran1 
(mlgG2a), 3G8 (mlgG1), Leu11a (mlgG1), DJ130c (mlgG1), BW209/2 (mlgG2a); 
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NA1-FcyRlllb plus FcyRllla CD16 MoAbs: B73.1 (mlgG1), phycoerythrin (PE)-
labeled Leu11c (mlgG1); NA2-FcyRlllb plus FcyRllla CD16 MoAb: GRM1 
(mlgG2a); less-glycosylated NA2-FcyRllib plus FcyRllia CD16 MoAb: PEN1 
(mlgG2a). The MoAbs Leu11c/B73.1, GRM1, PEN1 and BW209/2 recognize 
epilopes located at the first extracellular Ig-like domain of CD16, whereas the 
epitopes recognized by the MoAbs CLBFcRgran1, 3GB and Leu11a reside at the 
membrane-proximal Ig-like domain. BW209/2 was a gill from Dr R. Kurrle, Behring 
Werke, Marburg, Germany. B73.1 was kindly provided by Dr B. Perussia, Thomas 
Jefferson Universily, Philadelphia, PA. PE-Iabeled Leu11c (clone B73.1) was 
obtained from Becton Dickinson, San Jose, CA. The other CD16 MoAbs were 
obtained via the Vth Leukocyte Typing Workshop. PE- and fluorescein 
isothiocyanate (FITC)-Iabeled Leu4 (CD3; mlgG1) and PE-Iabeled Leu19 (CD56; 
mlgG1) were obtained from Becton Dickinson. Biotin-labeled CD7 (mlgG2a), FITC-
labeled goat-anti-mouse-Ig, and murine control MoAbs of the IgG1 and IgG2a 
subclass with irrelevant specificities (mlgG1 and mlgG2a, respectively) were from 
the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, 
Amsterdam, The Netherlands. 
Flowoylomelry 
PBMC and neutrophils were incubated with CD16 MoAbs for 25 minutes at 
room temperature. Aller washing with PBS containing 0.2% bovine serum albumin 
(BSA) (wVvol), the cells were incubated with FITC-Iabeled goat antimouse Ig for 25 
minutes at room temperature. In triple color experiments, the free F(ab), parts of 
FITC-Iabeled goat antimouse Ig were first blocked with a mixture of control mlgG1 
and mlgG2a. Therealler, PE-Iabeled Leu4 (CD3) and biotin-labeled CD7 MoAbs 
were added. Binding of CD7-biotin was detected with Cy-Chrome-Iabeled 
streptavidin (Pharmingen, San Diego, CAl. Immunofluorescent staining was 
assessed by flow cytometry (FACScan, Becton Dickinson). A gate was set around 
the lymphocyte population on the basis of forward and orthogonal light scatter 
characteristics and staining patterns with the combination of CD45 and CD14 M-
oAbs.' 
Cyloloxioilyassays 
Cytolytic activilies of PBMC were determined in standard 3-hour 51Cr-release 
assays.· Briefly, varying numbers of lymphocytes were seeded in triplicate in 96-
well, round-bottomed microtiter plates (150 ilL/well). A fixed number of target cells 
labeled with "Cr (200 IlCi/10 6 cells) was added in a volume of 100 ilL/well. At the 
end of the incubation period (37°C and 5% CO,), release of 51Cr into the 
supernatants was measured. The following target cells were used: for the 
assessment of NK activity, the K562 erythromyeloid leukemia line, and for ADCC, 
the PB15 mouse mastocytoma cell line coated with rabbit anti-PB15 IgG. The 
cytotoxxicity assays were performed at four different effector to target (E:T) ratios, 
ie, 50:1, 25:1, 12.5:1 , and 6.25:1. The percentage of specific lysis (SL) was 
calculated according to the formula: 
%SL = Exp.cpm - Spon.cpm x 100 
Max.cpm - Spon.cpm 
where Exp. Is the experimental number of counts obtained from target cells 
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incubated with effector cells; Spn. Is the spontaneously released counts obtained 
from targets incubated in medium alone; and Max. is the maximal counts obtained 
from targets lysed with a 1% Triton X-100 solution. 
Sequence analysis 
Messenger RNA was isolated from mononuclear cells and reversely transcribed 
into cDNA. Primers used to amplify the entire coding region" of FCYRllla-encoding 
cDNA were: Tf1 (sense; nt -5-21) 5'-CGC AAG cn TGG TGA cn GTC CAC TC-
3' and Tf2 (antisense; nt 963-988) 5'-CGC TCT AGA TCA TGG GCT Tn CCC 
n -3'. The polymerase chain reaction (PCR) amplified fragment was ligated into a 
pGEM-T vector, according to the manufacturer's instructions (Promega, Madison, 
WI). After cloning into E. coli, the insert was amplifiedand the nucleotide sequence 
was determined by cycle sequencing with "p end-labeled primers (Amersham, 
Amersham, UK), using the BRL cycle sequencing kit according to the 
manufacturer's instructions (BRL, Gaithersburg, MD). The following primers were 
used to sequence the entire coding region": sense direction: Tf1 (see above), NA-L 
(nt 106-125), P306 (nt 322-342) and Sn (nt 658-679); anti-sense direction: Tf2 (see 
above), P664 (nt 658-679) and NA-R (nt 329-348). 
FcyRl/IA gene-specific fragment amplification and FcyRl/IA genotyping 
Amplification of an FcyRlllA gene-specific fragment containing the site under 
investigation was achieved by means of an allele-specific primer annealing (ASPA) 
assay. The sense primer IIIA1 (5'-CAC AGT GGT nc ACA ATG AGA G-3') was 
compatible with NA2-FcyRIlIB and FcyRIlIA. The antisense primer IIIA2 (5'-CTG 
TAC TCT CCA CTG TGG TC-3') annealed completely to NA1-FcyRIIiB and 
FcyRIlIA. The PCR assay was performed with 1 tJg of genomic DNA, 150 ng of 
each primer, 200 tJmoliL of each dNTP and 2 U of Taq-DNA polymerase (Prome-
gal, diluted in a buffer recommended by the manufacturer in a total volume of 50 
tJL in a Perkin-Elmer Cetus Cycler (Norwalk, CT). The first cycle consisted of 5 
minutes of denaturation at 95 ·C, 1 minute of primer annealing at 64' C and 1 
minute of extension at 72 ·C. This was followed by 35 of these cycles in which the 
denaturation time was decreased to 1 minute. The final cycle was followed by 9 
minutes at 72 ·C to complete extension. 
The 91-bp product was electrophoresed in 10% polyacrylamide gels, stained 
with ethidium bromide and visualized with ultraviolet (UV) light. Cycle sequencing of 
the amplified fragments was performed with primer IIIA2 as described above. 
RESULTS 
Flowcytometry 
The PBMC of the patient contained 9% CD3-CD7. lymphocytes and 7% CD3-
CD56. lymphocytes, respectively, indicating that NK-cells are present in normal 
relative numbers (Figure 1). As shown in Figure 2, the CD3-CD7. lymphocytes 
Unusual FcyRllla on NK-cells 133 
patient control 
V~~-----'------------~C=O=7~ C07 
V~~-----'------------~C=O=3~ 
Figure 1. Siaining pattern of lymphocytes wilh CD3, CD7, and CD56 MoAbs. The 
lymphocyte gated mononuclear cells of the patient contained 9% CD3-CD7+ lymphocytes 
and 7% CD3-CD56+ lymphocytes, indicating that NK-cells are present in a relative number, 
which is comparable to that of the healthy, unrelated, age-matched control. 
stained minimally with the CD16 MoAb B73.1. Therefore, we tested several other 
CD16 MoAbs. CD3-CD7+ lymphocytes were positively stained with CLBFcRgran1, 
indicating that FcyRllla was expressed on the cell membrane. The results of the 
complete flow cytometric analysis of CD3-CD7+ lymphocytes of the patient, his 
family members, and a healthy, unrelated, control are summarized in Table 1. 
Except for Leu11c/B73.1, the CD3-CD7+ lymphocytes of the patient and his 
newborn brother stained positively with the applied CD16 MoAbs. NK-cells of both 
parents stained positively with B73.1, albeit with a somewhat lower fluorescence 
intensity compared with the control. Flow cytometric analysis of the patient's 
granulocytes showed a normal reactivity pattern with CD16 MoAbs and an 
NA(1+2+) phenotype, which was confirmed by genotyping. Granulocytes of his 
mother and brother were also NA(1+2+), his father had an NA(1-2+) phenotype. 
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Figure 2. Staining pattern of lymphocytes with C016 MoAbs. Staining pattern of lymphocytes 
of the patient and a healthy, unrelated, control with C016 MoAbs. With C016 MoAb B73.1 
followed by FITC-Iabeled goat antimouse Ig, staining of the C03- (C07+) subpopulation is 
severely decreased in comparison with the control. However, there is a clearly positive 
subpopulation when the C016 MoAb CLBFcRgranl is used. 
Cytotoxicity assays 
Spontaneous cytotoxicity of K562 target cells and ADCC of P815 targets 
measured by a "Cr release assay were normal for the patient and his younger 
brother, as compared with an age-matched healthy control (Figure 3). 
Sequence analysis 
Sequencing of the entire coding region of FcyRllla-encoding cDNA of the 
patient revealed a T to A nucleotide substitUtion at position 230 on both alleles. This 
substitution predicts a leucine to histidine change at amino acid position 48 in the 
first extracellular domain of FcyRllla. As shown in Figure 4, cycle sequencing of the 
FcyRIIIA-specific PCR products of the parents revealed that they both were 
heterozygous for this nucleotide substitution (FcyRIIIA-48L/H). Like the patient, the 
second son also had an FcyRIIIA-48H/H genotype (data not shown). 
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TABLE 1. Immunofluorescent staining of CD3-CD7+ celis with CD16 MoAbs' 
FcyRl/IA genotype 
48-H/H ~~alienQ 48-UH ~falherl 48-UH ~molher~ 48-HIH (brother~ 48-UL ~controll 
CD16MoAab %~s MFI %e2s MFI %e2s MFI %!:!os MFI %E05 MFI 
873.1 9 136 71 251 63 251 14 181 71 387 
ClBFcRgran1 62 1,372 92 1,703 72 1.643 48 1.276 78 1,899 
3G8 65 889 91 991 72 889 46 889 71 991 
leu·11a 55 432 87 374 66 1,027 43 416 77 556 
DJ130c 54 402 75 360 65 432 39 335 67 234 
BW209/2 63 858 90 1.231 74 1,231 37 827 79 1.474 
GRMl 61 889 88 1.372 67 1.276 49 1,104 76 1,529 
PENl 57 691 88 956 56 991 40 827 74 1,104 
1 Percentage of CD3·/CD?+ cells stained positively with the indicated C016 MoAbs and mean intensity of 
fluorescence (channel values, MFI: 4 log decade, relative linear units) of the patient, his family, and a healthy. 
unrelated, control. Staining of CD3-/CD7+ cells with MoAbs of irrelevant specificities was less Ihan 1.0% for Ihe 
mlgG1 and less Ihan 4.0% for the mlgG2a control MoAbs. 
DISCUSSION 
Only one patient with an absolute NK-cell deficiency has been described until 
now. This was an adolescent with recurrent life-threatening herpes-virus infections, 
who completely lacked CD16 andlor CD56 positive cells in vivo and NK-activity in 
vitro.'o Although NK-cell function is impaired in patients with Chediak-Higashi 
syndrome and Leucocyte Adhesion Deficiency disease, this impairment does not 
dominate their clinical course.' 
Here, we describe a patient with an as yet unknown FcyRIIIA-48H/H genotype, 
caused by a T to A nucleotide substitution at position 230 on both alleles. This 
particular genotype leads to an unusual phenotype, with loss of the Leu11c/B73.1 
epitope of the Fcy Receptor lila (CD16) on NK-cells (and, presumably, on 
macrophages). At nucleotide position 230 of the FcyRllIA gene a biallelic 
polymorphism (T or G) has recently been found, and further analysis, prompted by 
the findings in this patient, revealed that, in fact, a triallelic polymorphism (T, G or 
A) exists at this position, with gene frequencies in Caucasians of 86, 6, and 8%, 
respectively· With this frequency of the 230A allele, it can be predicted that 6.4 
FcyRIIIA-48H/H homozygotes per thousand individuals should be present in the 
Caucasian population. It is important to realize that this Leu11c/B73.1 negative 
phenotype will not be detected in most routine immunophenotyping procedures. 
NK-cells are mostly defined as the CD16 andlor CD56 positive and CD3 negative 
lymphocyte population. A CD16 (most frequently Leu11c) and a CD56 MoAb 
labeled with the same fluorescent dye are then used simultaneously. The lack of 
reactivity with Leu11c/B73.1 will remain unnoticed, as a large part of the NK-cell 
population is CD56 positive, as well. This can explain why this phenotype was not 
described before. 
The question of whether the unusual Fcy Receptor lila and the clinical 
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difference between 
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brother (0), and a 
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age-matched 
control ('). 
problems in this patient are causally related cannot be answered on the basis of 
the available data. Although the infectious problems of the patient described here fit 
into the postulated role of NK-cells in in vivo immune surveillance, the NK-cell 
activity as measured in vitro was not affected. In addition, the binding site of 
FcyRllia for IgG was described to be located at the second, membrane-proximal, 
extracellular Ig-like domain, whereas the Leu 11 c/B73.1 epitope is located at the 
first extracellular Ig-like domain of FcyRllla, albeit not at amino acid position 4B." 
The epitope recognized by 3GB and CLBFcRgran1 is located at the second 
extracellular Ig-like domain. On the other hand, it has also been described that 
B73.1 inhibits IgG binding to FcyRllla. 12 
The FcyRIIIA-4BH/H genotype with loss of the Leu11c/B73.1 epitope of the 
FcyRllta (CD16) on NK-cells was also present in the younger brother of the patient. 
He suffers from recurrent, mainly viral, upper respiratory tract infections as well. 
Also, he has food allergy and eczema. He has not yet come into contact with either 
Epstein-Barr or varicella zoster virus. Very recently, a 2-year old boy of Caucasian 
descent, not related to the patient described here, with the same geno- and 
phenotype was identified. He was born prematurely as one of a triplet and had 
suffered from food allergy and eczema, like the younger brother of the patient 
described here. This boy was tested after an unusually severe and prolonged 
infection that looked like chickenpox. Varicella zoster virus was not isolated, and 
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Figure 4. Sequence analysis of the FcyRlllA gene. A T to A nucleotide substitution at 
position 230 in the FcyRlllA gene predicts a leucine to histidine amino acid change at position 
48 of the first extracellular Ig-like domain of CD16, which contains the leu11 c1B73.1 epitope. 
The parents are heterozygous, and the patient is homozygous for this nucleotide substitution. 
he did not mount an antibody response to this virus. 
The identification of this unrelated boy with the same unusual Fcy Receptor lila 
and problems with combating an infection could make a causal relationship 
between the FcyRlIlA genotype and the clincial presentation described here more 
likely. Bearing in mind the relatively high allelic frequency of 8% in the Caucasian 
population, it could be that other intrinsic factors, besides FcyRlIIA-48H/H 
homozygosity, need to be present before these infectious problems occur. More 
elaborate analysis of the NK-cell function in vitro, and follow-up of the clinical 
course of newly traced FcyRllIA-48H/H homozygotes in the population is required 
to ascertain whether this genotype is really the cause of an NK-cell immuno-
deficiency. 
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NOTE ADDED IN PROOF 
While our report was being reviewed, another patient with FcyRIIIA-48H/H 
homozygosity was published by Jawahar et al. 13 
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ABSTRACT 
Two siblings, a boy and a girl, suffered from recurrent respiratory tract infections 
and episodes of intractable diarrhea associated with weight loss. The boy also 
suffered from severe varicella zoster virus pneumonia and Epstein-Barr virus 
related B-cell lymphoma. Immunological studies revealed lymphopenia and 
decreased proliferative response upon stimulation of lymphocytes in vitro. TCRall+ 
T -lymphocyte counts were low compared to age-matched controls, with 
CD4+/CD45RA+ "naive" helper T-Iymphocyte counts being most severely affected. 
We believe that these two siblings do not fit into any of the clinical syndromes 
reported to date, and that they might suffer from an as yet undescribed type of 
immunodeficiency disease. 
INTRODUCTION 
Knowledge of the clinical presentation, immunological characteristics and 
genetic defects of a large variety of primary immunodeficiency diseases has rapidly 
expanded in the past decade,1 and new clinical entities continue to be described.,g, 
Here, we present two immunodeficient siblings showing TCRall+ T-
lymphocytopenia with CD4+/CD45RA+ "naive" helper T-Iymphocytes being most 
severely affected. We believe that these children do not fit into any of the 
immunological syndromes reported to date. 
PATIENTS 
A boy, now aged 11 years, and his sister, now aged 8 years, were born to 
healthy non-consanguineous Caucasian parents. Both children were vaccinated 
without complications according to the regular Belgian schedule, including live-
attenuated oral poliovirus vaccination. Since early childhood, they suffered from 
recurrent bacterial otitis media and bronchitis. At 6 months of age, the girl was 
admitted with bacterial sepsis and skin abscesses. 
Both children showed difficulties in dealing with herpes viruses. At 4 years of 
age, the boy developed varicella zoster virus pneumonia and required mechanical 
ventilation as well as i. v. aciclovir. When he was 5 years of age, a high-grade B-cell 
lymphoma of the lung was diagnosed after he seroconverted to Epstein-Barr virus 
(EBV). This tumor was probably EBV-related, because EBV-mRNA (EBER) was 
detected in the tumor cells. The boy was treated successfully with cytostatic 
therapy according to the EORTC-CLCG 58881 ALL protocol after surgical 
resection of the tumor. At 3 years of age, the girl was evaluated for persistent 
generalized lymphadenopathy, but no malignancy was found. In the girl, 
cytomegalovirus could still be cultured from the throat and urine several years after 
seroconversion. IgM-VCA was still present in her serum several years after 
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TABLE 1. Immunological Investigations. 
Immunophenolyplng 
Total lymphocytes 
CD3+ T ·lymphocytes 
CD3+/CD4+ Th·subse~ 
C03+/CD8+ Ts/c-subset3 
CD19+ICD20+ B-Iymphocytes 
C03-/CD16+ andlor CDS6+ NK-cells 
T-lymphocy1es: %TCRy6+4 
%CD25+ 
CD4+ Th-subset: %CD45RA+ 
%CD45RO+ 
%HLA·DR+ 
%CD27+ 
CDS+ Ts/e-subset: %CD45RA+ 
%CD45RO+ 
%HLA·DR+ 
%CD27+ 
In vitro proliferation 
PHA 
PWM 
ConA 
Allo-Ag 
C03 
CD3 + rlL2 
Coaled CD3 alone 
+CD28 McAb 
+r1L2 
Coated C02 alone 
+CD28 McAb 
+r1L2 
PMA alone 
+CD28McA.b 
+rll2 
+Ca·lonophore 
I Age.matched reference values (3). 
2 Absolute counts (x 10 9/1). 
Boy 
(9 yrs) 
5.66 
9.7 
16.6 
5.6 
Boy (9 yrs) Girl (6 yrs) 
0.72 0.9 
0.4 0.8 
0.2 0.5 
0.1 0.2 
0.2 0.2 
0.1 0.2 
17 29 
9 1 
4 3 
99 98 
22 12 
34 49 
53 49 
76 71 
28 18 
29 9 
%of Girl 
controls (3.6 yrs) 
22 15.4 
36 10.2 
61 19.7 
143 8.2 
%of 
controls 
61 
38 
73 
210 
3 Th-subset = helper T·lymphocytes; Tsle-subset = suprressor/cytotoxic T-Iymphocytes. 
Normal range' 
1.1-5.9 
0.7-4.2 
0.3-2.0 
0.3-1.8 
0.2-1.6 
0,09·0.9 
Girl %of 
(4 yrs) controls 
0.7 5 
3.4 21 
2.5 39 
2.0 9 
4.2 22 
28.0 29 
12.0 14 
38.1 37 
38.7 41 
0.8 1 
33.1 32 
24.6 31 
0.9 7 
18.4 47 
10.8 45 
4 TCRyti is the alternative T-cell receptor, CD25 (ll2 receptor «-chain) and HLA-OR (class II) are markers of 
activation, CD45RA is expressed on "naive" T-Iymphocytes, C045RO Is expressed on "memory" T-Iymphocytes, C02 
es expressed on mature and activated T-Iymphocytes. 
53 H-thymld!ne Incorporation as a percentage of the mean response of two healthy adult controls investigated 
simultaneously. 
6 3H-thymidine incorporation (x 103 ) after stimulation of 40,000 peripheral blood mononuclear cells (mean of triplicate 
cultures). 
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seroconversion to EBV. 
Around 4 years of age, episodes of recurrent diarrhea of unknown origin with 
signs of malabsorption started to occur in both. Their were no signs of 
autoimmunity. The children are small for age (p, for weight and height). Their 
mental development and school performance are normal. 
Interestingly, the father suffers from recurrent mycotic dermatitis (T. rubrum) on 
a sharply demarcated area of the thigh. The mother has no infectious problems. 
IMMUNOLOGICAL INVESTIGATIONS 
Immunophenotyping of lymphocyte subpopulations (Table 1) showed TCRall+ 
T-Iymphocytopenia with CD4+/CD45RA+ "naive" helper T-Iymphocytes being most 
severely affected (Figure 1a). CD8+ suppressor/cytotoxic T-Iymphocyte counts 
were also decreased. No CD4+/CD8+ "double-positive" T-cells or CD1+ T-cells 
were present in the circulation. Il, micoglobulin (HLA class I) and HLA-DR (HLA 
class II) were expressed normally. 
Despite the high relative frequency of TCRyi5+ T-Iymphocytes, the absolute 
count of TCRy1i+ T-Iymphocytes was normal. PCR/heteroduplex analysis of 
V, 1N,2-J, 1 and V. 1N.2-J. 1 rearrangements as well as flow cytometric analysis of 
the pattern of V, and V. usage as compared to two age-matched controls, indicated 
the polyclonal composition of this cell population in both.'" 
The proliferative responses of peripheral blood mononuclear cells (Table 1) 
were low. They were similarly affected in the girl and the boy. Although the 
responses could be upregulated by the addition of recombinant interleukin-2 (rIL2) 
or CD28 monoclonal antibody (McAb), they remained low in comparison with 
controls. Normal proliferation was induced through bypassing of the CD3-TCR 
complex with PMA and Ca-ionophore. 
Serum immunoglobulin (Ig) levels were normal in the boy, but serum IgG 
decreased progressively in the girl (3.6 g/l at 6 years of age) with concomitant 
development of IgG1, IgG2 and IgG4 subclass deficiency. Serum Igs showed a 
restricted heterogeneity in the girl and a dominant homogeneous component (M-
component) in the boy (Figure 1 b). Both children showed a partial response to 
intramuscular booster immunization with diphteria, tetanus toxoid, and inactivated 
poliovirus and to Pneumovax immunisation (boy to tetanus, S. pneumoniae type 3 
and 9, and poliovirus, girl to S. pneumoniae type 3 and poliovirus). 
Chromosomal analysis showed a normal karyotype, and DNA-analysis gave no 
indications for the presence of deletions at chromosome 22q11 using the DGCR-
N25 probe. Adenosine deaminase and purine nucleotide phosphorylase enzyme 
levels in red blood cells were also normal. 
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Figure 1. Representative 
examples of the resulls of the 
immunological investigations. A, 
Decreased CD4+/CD45RA+ 
"naive" helper T-Iymphocytes. a, 
Serum immunoglobulin 
electrophoresis: standardized 
normal human serum (NHS; upper 
lane), a dominant homogeneous 
component in the boy (middle 
lane), and restricted heterogeneity 
In the girl (lower lane). 
The parents showed no quantitative abnormalities of IgM, total IgG, IgA, and IgG 
subclasses. TCRap+ T -lymphocytes were at the lower limit of normal in the father, 
and normal in the mother (0.7 x 10 'II and 1.7 x 10 'II, respectively). 
DISCUSSION 
The two siblings show a combined immunodeficiency disease (CI D) with 
possible autosomal recessive inheritance and a relatively mild clinical presentation. 
Their clinical course suggests a defect of cell-mediated immunity with fulminant 
varicella zoster virus pneumonia and EBV-related B-ceillymphoma in the boy, and 
episodes of intractable diarrhea with associated weight loss in both. This does not 
easily fit into the phenotype of commor) variable immunodeficiency.' The recurrent 
respiratory tract infections suggest an additional defect in their antibody production, 
probably secondary to impaired CD4+ helper T-Iymphocyte function. 
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This clinical picture is supported by the results of the immunological laboratory 
studies. Lymphopenia and decreased in vitro proliferation of lymphocytes were 
found in both children, confirming a defect in cell-mediated immunity. This was 
accompanied by limited specific antibody responses (both children), a 
homogeneous IgG component (boy), restricted serum Ig heterogeneity (girl), and 
IgG deficiency (girl), supporting a disturbance in the control of B-Iymphocyte activity 
by helper T -lymphocytes. 
The lymphopenia was mainly due to the low T-Iymphocyte count - caused by 
TCRap+ T-Iymphocytopenia - with B-Iymphocyte and NK-cell counts at the lower 
limit of normal. Initially, the high relative frequency of TCRy6+ T-Iymphocytes 
suggested an aberrant TCRyi5+ T-Iymphocytosis. This seemed to be confirmed 
because flow cytometric analysis of V, and V. usage differed from adult controls. 
However, the absolute count and the V, and V. usage of TCRyi5+ T-Iymphocytes 
were normal when compared to age-matched controls. This clearly illustrates the 
importance of adhering strictly to the use of absolute counts as well as age-
matched reference values"· in the analysis of lymphocyte subpopulations in 
immunodeficient patients. 
We can only speculate on the nature of the underlying molecular defect in 
these siblings. Although CD8+ suppressor/cytotoxic T-Iymphocyte counts were also 
decreased, CD4+/CD45RA+ "naive" helper T-Iymphocyte counts were most 
severely affected. According to recent models of T-cell development,7 either a 
defect in the nurturing capacity of the thymic micro-environment leading to a 
decreased output of "naive" cells, a "leaky" arrest in T-cell development, or 
premature death in the periphery could be the cause of the lymphopenia in these 
siblings. 
DNA-analysis showed no evidence of DiGeorge anomaly, the only thymic defect 
described in man, nor did the children suffer from any of the problems generally 
associated with DiGeorge anomaly (cardiac malformation, hypoparathyroidism). 
Mutations affecting the thymic stromal environment have been described in mice 
(winged-helix nude, ReIB, Hoxa-3).7 An as yet undescribed defect in the thymus or 
an equivalent of one of the mouse mutations is a possibility for the molecular defect 
in these siblings. 
A "leaky" developmental arrest caused by a defect situated in the T-
lymphocytes themselves is a distinct possibility. This defect would most likely be 
situated in the CD3 -TCR complex or associated phosphorylating enzymes, 
because lymphocyte proliferation could be upregulated substantially by rlL2 or 
CD28 McAb stimulation, and stimulation with PMAlionomycin elicited normal 
proliferation in vitro. Although the latter suggests ZAP70 deficiency, the 
immunophenotyping results and the clinical course in these siblings do not fit in with 
that diagnosis. In ZAP70 deficiency, a severe clinical course is associated with a 
selective absence of CD8+ T-Iymphocyles and abundant CD4+ T-Iymphocytes in 
the peripheral blood' 
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It has been described in mice that maintenance of a pool of "resting" T-
lymphocytes with a normal life-span requires permanent low-grade activation by 
continuing subtle stimulation of their TCR molecules by MHC. Mutations which 
disrupt these subtle signals (LKLF, Ets-1) cause a decrease in the numbers of 
"resting" T-Iymphocytes in mice.' Perhaps absence of such continuing subtle 
stimulation leads to apoptosis. Apoptotic depletion of CD4+ T-cells has been 
described in patients with idiopathic CD4+ T-Iymphocytopenia" The molecular 
defect in the here described siblings could be a human equivalent to one of the 
mouse mutations. 
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INTRODUCTION 
Recently, Seyama et ai' described twenty-eight unique mutations of the C040 
ligand (C040L) gene in forty-five X-linked hyper IgM syndrome (XHIM) patients 
from thirty unrelated families. Generally, peripheral blood mononuclear cells 
(PBMC) are screened for CD40L expression after activation with PMA and 
ionomycin to diagnose XHIM. Activated PBMC of most XHIM patients did not 
express functional CD40L (CD154): they failed to bind a CD40-lg fusion protein 
(bCD40-lg). The authors discerned five different CD40L staining patterns on 
cultured T-cells, using a polyclonal antiserum (pAb), four different monoclonal 
antibodies (McAb), and bCD40-lg. The type 1 pattern showed weak staining of 
CD40L with all reagents mentioned, the type 2-5 patterns successively showed loss 
of functional activity (bCD40-lg binding) and protein epitope expression (loss of 1-4 
McAb and finally pAb binding). A relationship between genotype and phenotype 
was suggested, with "milder genotypes" (resulting in staining pattern type 1 or 2) 
showing milder clinical phenotypes: in five out of ten patients from nine families with 
staining pattern type 1 or 2, symptoms started relatively late, and none of them 
suffered from opportunistic infections. Two patients with the 782C-H mutation, a 
missense mutation in exon 5, fitted into this group. 
We found the 782C-H XHIM mutation in four patients from two different 
families. Although they showed a favourable clinical course after immunoglobulin 
replacement therapy was started, the two index patients had symptoms from an 
early age onwards, including one who presented with Pneumocystis carinii 
pneumonia (PCP). The other two children were diagnosed shortly after birth 
because of the XHIM index patient in the family. 
PATIENTS 
The first index patient, patient No.1 (of family A) is a Dutch young man, now 
aged 19 years, who was treated with immunoglobulin replacement therapy from 
the age of two years onward because of hypogammaglobulinemia and frequent 
respiratory tract infections. Since then, the frequency of infections normalized. He 
never had an infection with an opportunistic pathogen, and never received 
prophylaxis with Co-trimoxazole. Recently, stimulation of his PBMC with PMA and 
ionomycin induced expression of the early activation marker CD69 (Leu-23, Becton 
Dickinson, San Jose, CAl on his CD3+ T-Iymphocytes, whereas CD40L (LL48, 
Schering-Plough, Dardilly, France) expression was absent (Figure 1). Fluorescent 
sequencing of the C040L gene revealed a 782C-H mutation (expected protein 
alteration T254M). The family was screened, and in patient No.2, his cousin now 
aged 2 years, XHIM was identified shortly after birth (Figure 2). At nine months of 
age, the serum IgG level had decreased to <0.5 gil. Although there were no clinical 
symptoms, immunoglobulin replacement therapy was started because of the 
increased risk of serious infections. 
The second index patient, patient No.3 (of family B) is a British boy, now aged 
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Figure 1. CD69 and CD40L expression on CD3+ T-Iymphocytes after stimulation of PBMC 
with PMA and ionomycin. A, Normal control. B, Patient No.1. 
11 years, who was diagnosed as having XHIM at 6 months of age when he 
presented with PCP. Following successful treatment of this infection, he has 
remained asymptomatic on immunoglobulin replacement therapy and Co-
trimoxazole prophylaxis except for one episode of a diarrhoeal illness at the age of 
seven years, which was of unknown etiology, lasted for two months and was 
associated with weight loss. Recent studies show no evidence of cholangiopathy on 
liver function tests, liver histology and endoscopic retrograde cholangio-
pancreatogram. His younger brother (patient No.4), now aged eight years, was 
diagnosed soon after birth based on the family history. He has remained 
completely well on immunoglobulin replacement therapy and Co-trimoxazole 
prophylaxis. His liver is also normal. The mutation in these boys has been 
previously reported (case 13 in Katz et al).' 
DISCUSSION 
In our opinion, the issue of a phenotype-genotype relation in XHIM remains 
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Figure 2. Single strand 
conformation 
polymorphism (SSCP) 
analysis of XHIM family A 
with T254M mutation. 
PCR products (198 bp) 
of exon 5 of the eD40L 
gene were denatured 
and run on a 12.5% 
polyacrylamide gel at 150 
Volts for 14 hours. The 
two control (e) lanes 
show the positions of the 
DNA strands of the 
unaffected X-
chromosome. The C-+ T 
mutation leads to a shift 
in the position of these 
bands as is shown in 
lane 1 (XHIM patient 
No.2). Carriers (lanes 2 
and 3) show both 
mutated and un mutated 
DNA strands. Non-
carriers (lane 4) only 
show the unmutated 
DNA strands. 
debatable. Not all patients with a staining pattern type 1 or 2 described by Seyama 
et ai' showed a mild clinical phenotype. Comparison of our two index patients with 
the 782C-H mutation with the two mild patients described by Seyama et ai' does 
not support a tight phenotype-genotype relation in XHIM patients, although our four 
patients all showed a favourable course after immunoglobulin replacement 
therapy. We agree that symptomatic PCP may occur in non immunocompromised 
infants, though this is very unusual. Nevertheless, we do not believe that the life 
threatening episode of PCP in our patient No.3 is compatible with a label of "mild 
phenotype". 
Furthermore, our XHIM cases also show that a favourable clinical course on 
immunoglobulin replacement therapy is compatible with a diagnosis of XHIM. This 
implies that testing of CD40L expression on activated PBMC should be considered 
in all patients with unexplained hypogammaglobulinemia. 
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INTRODUCTION 
Agammaglobulinemia with markedly reduced numbers of B-Iymphocytes - but 
normal T -lymphocytes - in the peripheral blood is the characteristic phenotype of X-
linked agammaglobulinemia (XLA) which is caused by a defect in the nonreceptor 
tyrosine kinase Btk.' However, only about 80% of patients with 
agammaglobulinemia with markedly reduced numbers of B-Iymphocytes in the 
peripheral blood are boys with a mutation in their BTK gene. In addition, 10% of 
patients with this phenotype are girls.' Therefore, a search was started for 
autosomal recessive disorders which result in an XLA-like phenotype. In this way, 
immunoglobulin (Ig) 11 heavy chain deficiency' and A 14.1 pseudo light chain 
deficiency' were found to be the defects in some of the patients. 
Normal B-cell differentiation in bone marr9w is a tightly regulated process. It can 
be studied by analysing the sequential appearance and disappearance of 
intracellular and cell surface markers (Table 1).'·7 Early B-cell progenitors express 
CD34, and subsequently B-cell specific markers like C010 and C019 are 
expressed,as .well as terminal deoxynucleotidyl transferase (TdT), which is 
necessary for nucleotide insertion during Ig gene rearrangement processes. Then 
cytoplasmic 1911 (CyI91l) and later surface membrane Igll (Smlgll) appear. Smlgll is 
first expressed as part of the pre-B-cell receptor (preBCR) on the cell surface (lgll 
with pseudo light chain), and later on as IgM molecule (lgll with IgK or IgA light 
chains) in both cases with C079a and C079b (Iga and 19P) as the anchoring and 
signaling molecules. Abnormal B-cell development is reflected by the disturbance 
of the relative frequencies or even absence of particular precursor-B-cell 
subpopulations in bone marrow.6.7 
We present a girl with agammaglobulinemia and absence of blood B-
lymphocytes. We compared the findings in this patient with those in patients with 
known defects, and present a plan for unraveling the molecular defect in this girl. 
PATIENT 
The patient, a girl now aged 11 years, is the only child of healthy first cousin 
Turkish parents. Noteworthy are her slight facial dysmorphism, eczema, short 
stature (3rd percentile), bronchial hyperreactivity, Wolf-Parkinson-Wight syndrome 
and mild subvalvular aortic stenosis. 
She was admitted directly after birth with wet lung and feeding problems. 
Consecutive white blood cell counts showed that the absolute neutrophil count 
decreased from 4.2 to 0.8 x 10 911 in the first week of life, but this did not attract 
attention at that time. At two months of age, she was readmitted for feeding 
problems, failure to thrive, and severe neutropenia «0.01 x 10 911). 
She was referred with agammaglobulinemia, absent blood B-Iymphocytes, and 
concomitant neutropenia (then 0.2 x 10 911) at nine months of age. After the onset of 
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Ig replacement therapy her neutropenia slowly improved (now around 1.0 x 10 9/1). 
At six years of age, she suffered from an episode of diarrhea and weight loss 
caused by Giardia Lamblia infection, which was treated successfully with tinidazole. 
Osteomyelitis of the right distal tibia caused by S. aureus was treated successfully 
with intravenous flu cloxacillin. 
IMMUNOLOGICAL INVESTIGATIONS 
CD19+ B-Iymphocytes were never detected in peripheral blood «1% of 
lymphocytes, < 0.01 x 10 9/1). The absolute counts of CD3+ T-Iymphocytes (1.9 x 
10 9/1), CD4+ helper T-Iymphocytes (1.2 x 1d' /I), CDB+ suppressor/cytotoxic T-
lymphocytes (0.61 x 10 9/1), and CD16+ and/or 56+ /CD3- NK-cells (0.15 x 10 ' /I) 
were normal for age.8 
At 5 months of age, IgG was 0.9 g/l, IgM 0.1 g/l, and IgA 0.1 g/I. After initiation of 
Ig replacement therapy, IgM and IgA remained undetectable. 
Detailed immunophenotyping of bone marrow with triple labelings (see also 
Table 1) showed that 20% of mononuclear cells (MNC) were B-lineage cells 
(CD19+ cells; Figure 1a). 2% of MNC were CD34+lTdT+/CD19+ and 
CD10+lTdT+/CD19+ early precursor-B-cells (Figures 1a and 1b). 13% of MNC 
were CyI9IJ+/SmlgM-/CD19+ pre-B-cells (Figure 1c). More mature B-cells 
(immature B) were low but present, and mainly had the Cylgw/SmlgM+/CD19+ 
immunophenotype (Figure 1c). As expected, cytoplasmic IgM, IgG and IgA 
containing plasma cells were completely absent. 
Chromosomal analysis of the patient showed a normal 46XX karyotype and 
uniparental disomy was not present. The mother showed random X-inactivation of 
her B-Iymphocytes. Both parents were healthy, and had normal serum Ig. Analysis 
of the BTK gene did not reveal any abnormalities (data not shown; kindly 
performed by R. Brooimans, Wilhelmina Children's Hospital, Utrecht). 
DISCUSSION 
This patient shows a phenotype that is "typical" for XLA (Btk deficiency). 
However, she is a girl, and chromosomal abnormalities that could explain XLA in a 
girl, like Turner's syndrome or uniparental disomy, were not present.9 Her mother 
was not a carrier of XLA, nor was her father an XLA-patient. Not surprisingly, her 
BTK gene was found to be completely normal. Bone marrow of 19IJ heavy chain 
deficient patients3 shows a marked decrease in CyI9IJ+ pre-B-cells that is not found 
in our patient. Bone marrow of the one patient described with }'14.1 pseudo light 
chain deficiency shows an even earlier developmental arrest, with most CD19+ 
cells being CD34+ precursor-B-cells.' The patient with the earliest defect in 
TABLE 1. Model of human B-<:ell development based on the literature ""'. G.T 
Stem cell 
CD34+ 
H germline 
Lgermline 
pro-a 
CD34+ 
H germ line 
Lgermline 
tjJL + (VpreB/A 14.1) 
TdT+ 
CyCD79a+ (Iga) 
CD10lo 
pre-a I 
CD34+ 
DJ, 
L gerrnline 
tjJL + (VpreB/h14.1) 
TdT+ 
CyCD79a+ (Iga) 
CD10+ 
CyCD79b+ (Ig~) 
CD19+ 
Large pre-a II 
VHDJH 
L germJine 
tjJL + (Vpre8lh 14.1) 
CyCD79a+ (Iga) 
CD10+ 
CyCD79b+ (Ig~) 
CD19+ 
Cylg~+ 
PreBCR+ 
Small pre-a /I 
Vt; DJH 
VLJL 
CyCD79a+ (Iga) 
CD10+ 
CyCD79b+ (Ig~) 
CD19+ 
Cylg~+ 
PreBCR+ 
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Abbreviations: H:. heavy chain gene; l = light chain gene; IpL:. pseudo light chain (composed ofVpre8 and J...14.1); Cy= cytoplasmic; (pre) BCR = (pre) B· 
cell receptor; Sm = surface membrane. 
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Figure 1. Immunophenotyping of bone marrow cells. Bone marrow mononuclear cells were 
stained for CD10 and CD19 (A) or CD34 and CD19 (B), followed by intracellular staining for 
TdT after permeabilization of the cells with FACS Lysing Solution (Becton Dickinson, San 
Jose, CAl. The third triple labeling (C) was performed by staining for CD19 and Smlg~, 
followed by intracellular Ig~ (Cylg~) staining, after permeabilization with IntraPrep 
(Immunotech, Marseille, France). All three triple labellngs were evaluated via two consecutive 
gating steps, i.e. gating on the "Iympho-gate" (left panels) based on light scatter 
characteristics, and subsequent gating on CD19 positivity (middle panels). These analyses 
showed that the vast majority of CD19+ precursor-B-cells are positive for CD10, but negative 
for the more immature markers CD34 and TdT. Furrthermore, most precursor-B-cells 
expressed Cylg~ and a small part also expressed Smlg~. The combined data indicate that the 
precursor-B-cell compartment in bone marrow In this patient mainly consists of more mature 
precursor-B-cells, whereas no mature B-Iymphocytes are found in peripheral blood. This 
implies that the differentiation blockade probably occurs just before the early B-Iymphocyte 
stage. 
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B-cell development - of which the molecular defect is as yet unidentified - shows 
complete absence of Cylg/.l, and very low levels of CD19+ cells in bone marrow.'·'o 
Both bone marrow immunophenotypes are not comparable to the 
immunophenotype found in our patient. So, Btk-deficiency has been ruled out, and 
Ig/.l heavy chain deficiency, A 14.1 pseudo light chain deficiency, or the above 
mentioned early pro-B-cell blockage are not likely explanations for the B-
lymphocyte deficiency in this girl. 
Other disorders that result in agammaglobulinemia with a selective B-
lymphocyte deficiency in humans have not been described as yet. However, 
several mouse models have been created in which genes have been knocked out 
that are supposed to be important in B-cell development. Some of them show a 
phenotype that is reminiscent of the "typical" XLA phenotype.,·11 In order to find the 
molecular defect in patients like the one we describe here, it might be useful to 
screen for defects that have already been engineered in the mouse. Our patient 
only has a B-cell defect in Jhe presence of a completely normal T-cell 
compartment. Therefore, defects in molecules that are indispensable for common 
lymphoid progenitors or that have an important role in T-cell development as well 
as in B-cell development are unlikely. B-cell specific molecules like CD79a and 
CD79b are interesting candidates, as are tyrosine kinases that are linked to the Btk-
pathway.,·11." 
We propose the following plan for future research towards the underlying 
molecular defect in this girl: 
1. Determine the integrity of the genes for Ig/.l and pseudo light chain (VpreB and 
A 14.1), because it is not yet fully clear whether genotype and phenotype are closely 
related in these disorders. 
2. Perform more detailed immunophenotyping of the patient's bone marrow, 
including expression of CD79a and CD79b, to determine the exact position of the 
arrest in B-cell development. 
3. Examine the integrity of other genes, including the CD79A, CD79B, PAX5, SYK, 
and possibly SOX4 and BLK genes, dependent on the results of the additional 
immunophenotyping of the bone marrow and comparison of these results with 
those from the relevant knock-out mice. 
If we succeed in unraveling the molecular defect in this girl, this will not only 
help her family (prenatal diagnosis and identification of carriers), but it will also lead 
to a further understanding of normal and abnormal human B-Iymphocyte 
development. 
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GENERAL DISCUSSION 
In the past two decades, knowledge of the human immune system has 
increased dramatically due to the expanding technical possibilities, of which flow 
cytometric immunophenotyping of leukocytes is a prominent example. Around 25 
years ago, T-Iymphocytes were defined by their capability of forming rosettes with 
sheep erythrocytes, and B-Iymphocytes by the presence of immunoglobulins on 
their surface membrane.'·' Nowadays, more than 100 different cell surface and 
intracellular markers can be analyzed by detailed multipara meter flow cytometry to 
define T-Iymphocytes, B-Iymphocytes, NK-cells and their various subpopulations.' 
These findings can be coupled to functional characteristics of the different subsets, 
many of which can also be determined by flow cytometry.4 
Because adult blood is more easily available than infant blood, most studies on 
flow cytometric immunophenotyping of leukocytes have been performed in adults. 
The technical experiences and reference valu~s \ collected with adult blood 
samples, were applied to blood samples from neonates and infants to investigate 
normal lymphocyte development in the first years of life 7 as well as the 
pathophysiology of congenital and acquired immunodeficiencies." 
However, several problems and pitfalls are encountered when analyzing 
lymphocytes in pediatric samples (Chapters 4 and 5), like the limited amount of 
available blood in neonates and infants, the presence of normoblasts and Iysis-
resistant erythrocytes in neonatal cord blood, the variability in staining patterns of 
some fluorochrome-conjugated antibodies (McAb) combinations in neonates, and 
the higher lymphocyte counts in neonates and infants, which render comparative 
Iymphocyle studies between neonates, infants, and adults less informative if 
relative frequencies of lymphocytes are used. 
Technical aspects of immunophenotyplng of lymphocytes in children 
This thesis shows that it is possible to overcome the above mentioned problems 
and pitfalls and to acquire accurate absolute counts of Iymphocyle subpopulations 
in neonates and infants. 
When microassays are used for immunological studies, the limitations in the 
available volume of blood in neonates and infants is no longer a problem. We 
showed that it is possible to develop a reliable microassay for immunophenotyping 
of lymphocytes in neonates and infants (Chapter 3). It is desirable, and potentially 
possible, to develop other microassays for immunological investigations in children 
in the future, e.g. for studies on lymphocyte function. 
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The normoblasts and unlysed erythrocytes within the flow cytometric "Iympho-
gate" of neonatal samples can be identified using the cluster of differentiation 
(CD)71/GpAlCD45 triple immunostaining (Chapter 3): the transferrin receptor 
CD71 is expressed by erythroid precursors, glycophorin A (GpA) is expressed by all 
ery1hroid cells, and CD45 is expressed by all leukocytes. After identification of these 
normoblasts and unlysed erythrocytes, a correction for their presence can be 
made. 
This technique can also be used for rapid prenatal diagnosis of congenital 
immunodeficiencies by flow cytometric immunophenotyping in fetal blood samples, 
which contain a very large amount of normoblasts.' 
The imporlance of using absolute counts instead of relative frequencies was 
illustrated by our finding that the absolute counts of CD45RO+ T-Iymphocytes are 
Similar in healthy neonates, infants, and adults, despite higher relative frequencies 
of CD45RO+ T-Iymphocytes in adults (Chapter 7) and that the high percentage of 
T-cell receptor (TCR)yi5+ T -lymphocytes in the two siblings with abnormal cell-
mediated immunity was due to TCRap+ T-Iymphocytopenia with normal absolute 
counts of TCRyi5+ T-Iymphocytes (Chapter 11). 
, 
Using detailed multiparameter flow cytometry, we and others showed that 
immature "thymocyte-like" T-cells are not present in the neonatal circulation. These 
cells were assumed to be present, based on single CD1, CD4, CD8, and CD71 
immunostainings in the pas!."'" Now, it has become clear that CD71+ cells are 
mainly normoblasts (notthymocytes) (Chapters 4 and 5), that CD1+ cells represent 
CD1c+ B-Iymphocytes and not CD1a+ thymocytes (Chapters 4 and 7 and ref 13), 
and that CD4+/CD8+ "double-positive" thymocytes are not present (Chapters 4 and 
7 and ref 14), but that the high CD8+ count is due to the high CD8+/CD3- NK-cell 
count (Chapters 4 and 7) and that CD4+/CD3- cells are in fact CD14+ small 
monocytes, not immature T-cells (Chapter 4). 
We (Chapters 5, 6, and 7) and others 15 have shown differences in lymphocyte 
subpopulations between neonates, infants and adulls. This implies that the 
available adult reference values cannot be used in children. In our studies, this was 
clearly illustrated by the analysis of Vy and V. gene usage in the two siblings with 
TCRap+ T-Iymphocytopenia (Chapter 11), and by the analysis of NK-cell function 
in the children with loss of the B73.1 (CD16) epitope (Chapter 10). In the near 
future, reference values for all pediatric age groups will have to be established for 
relative frequencies as well as absolute counts of specific lymphocyte 
subpopulations (e.g. CD45RA+ and CD45RO+ T-Iymphocyte subpopulations), and 
also for functional tests like lymphocyte proliferation assays, and analyses of 
cytokine production by different subsets. 
Immunophenotyping of lymphocytes In healthy neonates and infants 
With detailed multipara meter flow cytometry, reference values of pediatric 
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lymphocytes can be accurately determined in cross-sectional studies. '6 However, 
external factors that influence lymphocyte development, like exposure to specific 
antigens, will not happen at exactly the same time-points in each child. Therefore, 
longitudinal follow-up studies of individual children will give additional information 
on lymphocyte development in the first years of life. 
In this thesis, we show that trends in lymphocyte subpopulation changes found 
in populations in cross-sectional studies 16 are confirmed when following individual 
children longitudinally: T - and B-Iymphocyte absolute counts increase at one and 
six weeks of age, respectively, whereas NK-cell counts show a sharp decline 
directly after birth. The latter is mainly due to a decline in CD8+ NK-cells. The high 
CD4/CD8 ratio in infants is mainly due to the very high CD4+ T-Iymphocyte counts 
(Chapters 6 and 7). 
The comparison of absolute counts of lymphocyte subpopulations gave new 
inSight into lymphocyte development in infants, when compared to previous studies 
which only used relative frequencies. '.9.17 Large amounts of naive "untriggered" 
cells (e.g. CD45RA+ T-Iymphocytes) are present in neonates, and further increase 
during the first year of life, whereas "memory" cells (CD45RO+ T-Iymphocytes) are 
present in similar amounts in neonates, infants, and adults, a finding that will be 
missed if only relative frequencies are considered. 
These findings alter the perspective on the development of the infant immune 
system considerably: neonates and infants do not lack mature cells, but they have 
large amounts of "untriggered" naive cells, probably being ready to be primed in 
primary immune responses. However, the "memory" T -lymphocytes in neonates 
and infants did show differences in comparison with adult cells: the fluorescence 
intensity of CD45RO staining was lower in neonates and infants than in adults (Le. 
fewer molecules were present per cell), and more neonatal and infant cells carried 
CD38 on their surface, probably as a sign of greater metaboliC need due to 
continuous encounters with antigen in primary immune responses (Chapter 7). 
Functional studies are needed to assess whether the seemly "mature" cell 
populations in neonates and infants that show phenotypic differences with their 
adult counterparts are truly mature, or whether they harbor some kind of "functional 
immaturity" that is gradually overcome during maturation processes in the first few 
years of life. 
Immunophenotyplng of lymphocytes in Immunodeficient children 
Knowledge of lymphocyte subpopulations in healthy children enables the 
interpretation of results obtained in immunodeficient children. Despite the rapid 
developments in genetic research,18 immunophenotyping remains an important tool 
in the diagnosis of congenital immunodeficiency states in children because it is 
reliable, rapid and easy-to-use. It is also important for follow-up of children with 
acquired immunodeficiency states, e.g. after bone marrow transplantation. In this 
thesis, this is illustrated by immunophenotyping studies in patients with a variety of 
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underlying conditions. 
We (Chapter 9) and others,gf9 found that the reconstitution of lymphocyte 
subpopulations after bone marrow transplantation does not resemble normal 
ontogeny as far as T-Iymphocytes are concerned. Especially the very slow 
reconstitution of CD45RA+ cells does not resemble T-cell development in the first 
year of life. B-Iymphocyte reconstitution does seem to follow normal ontogeny with 
high values being reached after six months posttransplant. When age-matched 
reference values are used to define reconstitution, it becomes clear that CD4+ T-
lymphocyte absolute counts recover slowly in children, as has been described in 
adults. f9 Unexpectedly, the reconstitution of CD4+ T-Iymphocyle absolute counts is 
faster in children with CMV-reactivation (Chapter 9). 
Immunophenotyping of lymphocytes is essential for focussing the molecular 
diagnostic studies in congenital immunodeficiency diseases in order to prevent that 
too many genes have to be analysed for the presence of mutations. In this thesis, 
this is illustrated by the B73.1 (CD16) epilope loss in the children with F,yRIIIA48-
H/H homozygosity (Chapter 10), and by the absence of CD40 ligand expression on 
activated T-Iymphocytes in the patients with X-linked hyper IgM syndrome (Chapter 
12). Furthermore, immunophenotyping can reveal the presence of an immune 
disturbance of which the molecular defect cannot be defined as yet, as is illustrated 
in the two siblings with TCRap+ T-Iymphocytopenia (Chapter 11). It is important to 
realize, however, that an immune disturbance can be present without detectable 
abnormalities in immunophenotyping of lymphocytes. 
Immunophenotyping of bone marrow cells can direct the search towards the 
underlying molecular defect in B-cell immunodeficiencies by identifying the 
developmental block, as is shown in the girl with agammaglobulinemia and absent 
blood B-Iymphocytes (Chapter 13). 
Even if the molecular defect of an immunodeficiency is already established, 
immunophenoptyping of lymphocytes enables pathogenetic studies of the defect by 
analyzing subsets according to e.g. their status of activation, expression of 
adhesion molecules, or intracellular expression of cytokines. f9 
In conclusion, immunophenotyping of lymphocytes proofs to be a valuable tool 
for pediatricians in the care of immunodeficient children for many years to come. 
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SUMMARY 
At birth, the "naive" immune system is suddenly challenged with many 
environmental antigens. In this process, T-Iymphocytes and B-Iymphocytes playa 
central role. The "naive" immune system gradually builds up a pool of competent 
"memory" cells during the first two years of life by its encounters with antigens. It is 
to be expected that this process is reflected in the distribution of lymphocyte 
subpopulations, and that such processes will be disturbed in certain 
immunodeficiency diseases. 
The aim of this thesis was to study development of lymphocytes with 
immunophenotyping in healthy as well as immunodeficient children. This 
information can lead to a better understanding of the immaturity of the immune 
system in infants and their higher susceptibility to infections. Also, the improved 
knowledge of the normal development of the immune system can lead to a better 
interpretation of results obtained in studies of immunodeficient patients. The 
technical developments in the past decade have greatly improved the possibilities 
for such studies: nowadays, rapid and accurate multipara meter flow cytometric 
immunophenotyping of lymphocytes enables detailed studies of lymphocyte 
subpopulations. By incubating the unprocessed blood sample wilh monoclonal 
antibodies (McAb) coupled to a fluorochrome, and analysing after osmotic lysis of 
the erythrocytes - the lysed whole blood technique - differential loss of 
subpopulations and aspecific binding of McAb are minimized (Chapter 2). 
However, several problems and pitfalls are encountered when 
immunophenotyping of Iymhocytes is undertaken in children (Chapter 4). Firstly, 
the limited amount of blood available hampers the possibilities for detailed studies 
in smaller children. This can be overcome by developing microassays (Chapter 3). 
Secondly, the analysis of lymphocytes within the flow cytometric "Iympho-gate" -
defined on the basis of size and cellular characteristics of the cells - can be biased 
by contamination of this "Iympho-gate" wilh erythroid cells which can be present in 
large numbers in neonatal cord blood (median around 30% in preterm neonates 
and 10% in term neonates). This leads to underestimation of the relative 
frequencies of lymphocyte subpopulations. Also, neonatal erythrocytes are 
relatively resistant to osmotic lysis, and are sometimes large enough to be located 
within the "Iympho-gate" as well (>1 % in about half of term neonates and in most 
preterm neonates). This can be overcome by using the cluster of differentiation 
(CD)71/GpNCD45 triple immunostaining to identify normoblasts 
(CD71+/GpA+/CD45- cells) and unlysed erythrocytes (CD71-/GpA+/CD45- cells) 
within the "Iympho-gate", and to correct for their presence by calculating the correct 
percentage of lymphocytes within the "Iympho-gate" (Chapter 3). 
In the past, the limited technical possibilities lead to erroneous interpretation of 
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immunophenotyping results, e.g. the assumption that immature "thymocyte-like" T-
cells are present in the neonatal circulation. Those past conclusions have now 
been adapted gradually with the aid of more detailed mulliparameter analysis of 
lymphocyte subpopulations (Chapter 4). 
An additional problem is encountered with immunophenotyping of lymphocytes 
in neonates: some McAb like CD45RA and CD45RO show greater overlap in 
positive and negative populations than in adults, which renders the interpretation of 
results difficult. We preferred the use of phycoerythrin (PE) conjugated CD45RA 
and CD45RO McAb, because the greater staining Intensity of the PE fluorochrome 
enabled us to define the quadrant settings more accurately (Chapter 5). 
Healthy children 
After addressing the above described technical problems, we were able to 
obtain accurate absolute counts of blood lymphocyte subpopulations in neonates 
and infants. This was important, because total lymphocyte counts per ml of blood 
are essentially higher in neonates and infants than in adults. Therefore, differences 
in the relative frequencies of lymphocyte subpopulations do not show the 
differences in the actual sizes (i.e. the absolute counts) of these subpopulations 
(Chapters 4-7). This is illustrated clearly with our findings in neonatal cord blood 
samples: we found that "mature" lymphocyte subsets - CD45RO+ T-Iymphocytes, 
CD1c- and CD5- B-Iymphocytes - are similar in size in neonates and adults. "Naive" 
subsets - CD45RA+ T-Iymphocytes, CD1c+ and CD5+ B-Iymphocytes - are larger in 
neonates than in adults: a large pool of naive as yet "untriggered" cells seems to be 
stand-by for participation in primary immune responses. This was not the case in 
some preterm neonates, which might explain their greater susceptibility to 
infections (Chapter 5). 
Age-matched reference values have been determined in cross-sectional 
studies, but patients are generally followed longitudinally. Also, changes in 
lymphocyte subpopulations will not occur at exactly the same time-points in all 
children, and will therefore be leveled off in cross-sectional studies. Therefore, we 
performed a longitudinal study of lymphocyte subpopulations in healthy infants 
followed from birth to one year of age. We found that T - and B-Iymphocytes 
increased at one and six weeks of age respectively, whereas NK-cells showed a 
sharp decline directly after birth. These resulls confirmed the findings we reported 
before in a cross-sectional study. The high CD4/CD8 ratio was mainly caused by 
very high CD4+ T-Iymphocyte counts (Chapter 6). During the first year of life, the 
"naive" CD45RA+ T-Iymphocyte subset increased in number; the "memory" 
CD45RO+ T-Iymphocytes remained similar in size, the "mature" CD1c- and CD5-
B-Iymphocytes increased. We found no indication for the presence of immature 
"thymocyte-like" T-cells, nor for the presence of precursor-B-cells in the circulation. 
The functional maturation of T-Iymphocytes in the periphery through triggering with 
antigen was reflected in the loss of CD38 expression and the increase of the 
intensity of expression of CD45RO per cell. The high NK-cell count at birth was 
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mainly accounted for by CD8+ NK-cells. The meaning of this finding is not clear. 
Interestingly, subpopulations of CD7-, CD38-, and CD45RO- NK-cells were present 
shortly after birth, whereas CD57+ NK-cells were absent. a phenotype which fits in 
with an activated state of these NK-cells. This finding can support the theory that 
NK-cells are engaged in the maintenance of pregnancy at the immunological 
interface in the placenta (Chapter 7). 
Immunodeficient children 
Immunophenotyping of lymphocytes plays an important role in the diagnosis 
and follow-up of primary and acquired immunodeficiencies. Enumeration of 
absolute counts of blood lymphocyte subpopulations enables diagnosis of 
congenital immunodeficiencies, follow-up of HIV-infection, and monitoring of 
immunological reconstitution after bone marrow transplantation. Also, in congenital 
immunodeficiencies the block in lymphocyte development can be determined by 
analysis of intracellular and surface antigen expression in blood and bone marrow 
cells (Chapter 8). 
We studied twenty-two children who underwent allogeneic bone marrow 
transplantation (BMT) for a hematological malignancy, and compared the 
reconstitution of their lymphocyte subpopulations - defined as reaching the P5 of 
age-matched reference values - to normal ontogeny. We found a relatively fast 
reconstitution of B-Iymphocytes, with high values (>P95 of age-matched reference 
values) being reached from six months after BMT onwards, mimicking normal 
ontogeny. Unlike normal ontogeny, T-Iymphocyte reconstitution was slow. The 
reconstitution of CD4+ helper T-Iymphocytes was very slow (> 6 months after 
BMT), as was reported before in adults. Unexpectedly, CMV-reactivation enhanced 
CD4+ helper T-Iymphocyte reconstitution. CD45RA+ T-Iymphocyte absolute counts 
increased only slowly after BMT; CD45RO+ T-Iymphocyte absolute counts 
remained similar during the entire follow-up period, despite the high relative 
frequency of CD45RO+ T-Iymphocytes in the first three months after BMT. Like in 
adults, we found that a high percentage of T-Iymphocytes was negative for the CD7 
antigen in the first three months after BMT. However, CD7- T-Iymphocyte absolute 
counts were similar during the entire follow-up period. These findings again 
illustrate the importance of using absolute counts instead of relative frequencies for 
investigating the development of lymphocyte sub populations (Chapter 9). 
In a child with recurrent - probably viral - respiratory tract infections and 
problems with BCG vaccination and infection with Epstein-Barr virus and varicella 
zoster virus, immunophenotyping of lymphocytes showed lack of staining with the 
CD16 (B73.1) epitope (CD16 is the Fcy receptor type Ilia). CD3-/CD7+ NK-cells 
were present, however, and other CD16 McAb like 3G8 and CLBFcRgran1 did 
stain the patient's NK-cells. NK-cell function (K562 lysis and P815 ADCC) was 
normal as compared to an age-matched control, though lower than in adult 
controls. This CD16 (B73.1) epitope loss in the first extracellular domain of the 
CD16a molecule led to the finding of FcyRIIIA48-H/H homozygosity. The 
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importance of this finding is not yet clear, because the expected frequency of 
homozygotes is 6.4 per thousand Caucasians based on the allelic frequency found 
in healthy blood donors. No other homozygous individuals were identified until now 
(Chapter 10). 
In several other immunodeficient patients, immunophenotyping proved to be 
useful for establishing the diagnosis or classification of their disease. In that way, 
the absence of CD40 ligand expression on activated T-Iymphocytes could rapidly 
be shown in several patients with hyper IgM syndrome (Chapter 12), and the T-cell 
deficiency in two siblings with recurrent severe - mainly viral - infections could be 
further characterized (Chapter 11). Also, the exact position of the developmental 
blockage in B-cell differentiation could be determined in the bone marrow of a girl 
with agammaglobulinemia (Chapter 13). So, the current technical possibilities and 
available experience in flow cytometric immunophenotyping are very useful for the 
care of children with an immunodeficiency. 
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Bij de geboorte wordt het "naieve" immuunsysteem plotseling geconfronteerd 
met de vele antigen en uit de omgeving. Hierbij spelen de T - en B-Iymfocyten een 
centrale rol. Het "naieve" immuunsysteem bouwt gedurende de eerste twee 
levensjaren geleidelijk een verzameling competente "geheugen" cellen op door de 
ontmoetingen met antigenen. Het is te verwachten dat dit proces wordt 
weerspiegeld in de verdeling van de Iymfocytensubpopulaties, en dat dergelijke 
processen gestoord zullen zijn bij bepaalde immunodeficienties 
(afweerstoornissen). 
Het doel van dit proefschrift was om met behulp van immunofenotypering de 
ontwikkeling van Iymfocyten te bestuderen bij gezonde kinderen en kinderen met 
een afweerstoornis. De informatie verkregen uit een dergelijke studie kan leiden tot 
een beter begrip van de rijping van het immuunsysteem in jonge kinderen en van 
hun verhoogde gevoeligheid voor infecties. Daarnaast kan verbeterde kennis van 
de normale ontwikkeling van het immuunsysteem bijdragen aan de interpretatie 
van bevindingen uit studies bij immunodeficiente palienten. De technische 
ontwikkelingen van de afgelopen decade hebben de mogelijkheden voor dergelijke 
studies sterk verbeterd: tegenwoordig kan snel en nauwkeurig onderzoek van de 
Iymfocytensubpopulaties plaatsvinden met behulp van multipara meter 
flowcytometrische immunofenotypering. Door het onbewerkte bloedmonster te 
incuberen met monoclonale antistoffen (McAb) die direct aan een fluorochroom 
zijn geconjugeerd, en te analyseren na osmotische lysis van de erytrocyten - de 
"gelyseerde vol bloed methode" - kan differentieel verlies van subpopulaties en 
aspecifieke binding van antistoffen veelal worden voorkomen (Hoofdstuk 2). 
Echter, als immunofenotypering van Iymfocyten bij kinderen wordt toegepast, 
komen diverse problemen en valkuilen aan het licht (Hoofdstuk 4). Allereerst 
bemoeilijkt het beperkte bloedvolume de mogelijkheden v~~r gedetailleerde 
studies bij kinderen. Met de ontwikkeling van micro-bepalingen kan dit probleem 
worden opgelost (Hoofdstuk 3). Ten tweede kan de analyse van Iymfocyten 
binnen de flowcytometrische "Iymfo-gate" - gedefinieerd op basis van de celgrootte 
en de onregelmatigheid van de cellen - worden verstoord door verontreiniging van 
deze "Iymfo-gate" met erytroide cellen die in grote aantallen in neonataal 
navelstrengbloed aanwezig kunnen zijn (mediaan rond 30% bij prematuren, en 
rond 10% bij a terme neonaten). Dit leidt tot onderschatting van de relatieve 
frequenties van de Iymfocytensubpopulaties. Daarnaast zijn neonatale erytrocyten 
relatief resistent voor osmotische lysis, en daarbij soms groot genoeg om ook 
binnen de "Iymfo-gate" te vallen (>1% van de "Iymfo-gate" bij ongeveer de helft van 
de a terme neonaten, en bij de meeste prematuren). Dit probleem kan worden 
opgelost door de differentiatie-cluster (CD)71/GpNCD45 drievoudige labeling te 
gebruiken ter identificatie van normoblasten (CD71+/GpA+/CD45- cellen) en 
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ongelyseerde erylrocylen (CD71-/GpA+/CD45- cellen) binnen de "Iymfo-gate", en 
door daarmee het correcte percentage Iymfocyten binnen de "Iymfo-gate" te 
berekenen (Hoofdstuk 3). 
In het verleden hebben de beperkte technische mogelijkheden geleid tot 
onjuiste interpretaties van immunofenotyperingsresultaten, bijvoorbeeld tot de 
aanname dat onrijpe "thymocyt-achtige" T-cellen aanwezig zouden zijn in de 
neonatale circulatie. Dergelijke conclusies uit het verleden zijn geleidelijk 
aangepast met behulp van verfijnde analysemogelijkheden van 
Iymfocylensubpopulaties met multiparameter flowcylometrie (Hoofdstuk 4). 
Een exira probleem bij immunofenotypering van Iymfocyten bij neonaten is het 
feit dat sommige McAb zoals CD45RA en CD45RO een grotere overlap tussen 
positieve en negatieve populaties laten zien dan bij volwassenen, wat de 
interpretatie van studieresultaten lastig maakt. Wij gaven de voorkeur aan het 
gebruik van phycoerythrine (PE) geconjugeerde CD45RA en CD45RO McAb, 
omdat de hogere kleuringsintensiteil van het PE-fluorochroom het ons mogelijk 
maakte om nauwkeuriger de grenzen tussen positieve en negatieve populaties vast 
te stell en (Hoofdstuk 5). 
Gezonde klnderen 
Na het aanpakken van de hierboven beschreven problemen waren wij in staat 
om de absolute aantallen van Iymfocytensubpopulaties bij neonaten en jonge 
kinderen nauwkeurig te bepalen. Dit was belangrijk omdat het totaal aantal 
Iymfocyten per ml bloed bij neonaten en jonge kinderen hoger is dan bij 
volwassenen. Dat betekent dat verschillen tussen relalieve frequenties van 
Iymfocytensubpopulaties niet de verschillen in daadwerkelijke grootte (d.w.z. 
absolute aantallen) van deze subpopulaties laten zien (Hoofdstukken 4-7). Dit 
wordt duidelijk ge'illustreerd door onze bevindingen in neonataal navelstrengbloed: 
we von den dat "rijpe" Iymfocytensubpopulaties - CD45RO+ T-Iymfocyten, CD1c- en 
CD5- B-Iymfocyten - een vergelijkbare grootte hadden bij neonaten en 
volwassenen."Naieve" subpopulaties - CD45RA+ T-Iymfocyten, CD1c+ en CD5+ B-
Iymfocyten -waren in veel grotere aantallen aanwezig bij neonaten dan bij 
volwassenen: een grote verzameling naieve nog niet "getriggerde" cellen lijkt klaar 
te staan voor deelname aan primaire immuunreacties. Dit werd echter niet bij aile 
prematuren gevonden, wat hun grotere gevoeligheid voor infecties zou kunnen 
verklaren (Hoofdstuk 5). 
Leeftijdsgerelateerde referentiewaarden worden veelal bepaald in transversale 
studies, terwijl pati8nten longitudinaal worden vervolgd. Daarnaast zullen 
veranderingen in Iymfocytensubpopulaties niet bij aile kinderen op exact dezelfde 
tijdstippen optreden, waardoor ze worden afgevlakt in transversale studies. Wij 
verrichtten daarom een longitudinale stu die naar het verloop van de 
Iymfocytensubpopulaties bij gezonde kinderen die werden vervolgd van hun 
geboorte tot de leeftijd van een jaar. We vonden dat T - en B-Iymfocyten toenamen 
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in aantal vanaf de leeftijd van respectievelijk een en zes weken, terwijl de NK-
cellen juist sterk daalden na de geboorte. Deze resultaten bevestigden onze 
bevindingen uit een transversale studie die we al eerder rapporteerden. De hoge 
CD4/CD8 ratio werd voornamelijk veroorzaakt door de zeer hoge absolute 
aantallen CD4+ T-Iymfocylen (Hoofdstuk 6). Gedurende het eerste levensjaar 
stegen de "naieve" CD45RA+ T-Iymfocyten in aantal; de "memory" CD45RO+ T-
Iymfocyten bleven gelijk in aantal, de "rijpe" CD1c- en CD5- B-Iymfocylen stegen in 
aantal. We vonden geen aanwijzingen voor de aanwezigheid van onrijpe 
"thymocyt-achtige" T-cellen of voorloper B-cellen in de circulatie. De functionele 
rijping van T-Iymfocyten in de periferie door antigene stimulatie werd weerspiegeld 
door het afnemen van de CD38 expressie en het toenemen van de intensiteit van 
de CD45RO expressie. De hoge aantallen NK-cellen bij de geboorte waren voor 
een groot deel CD8+ NK-cellen. De betekenis hiervan is niet duidelijk. Opvallend 
was de aanwezigheid van CD7-, CD38-, en CD45RO- NK-cellen kort na de 
geboorte, en de afwezigheid van CD57+ NK-cellen, een fenotype dat kan pass en 
bij een geactiveerde status van deze NK-cellen. Deze bevinding kan de theorie 
ondersteunen dat deze ongebruikelijke NK-cellen actief zijn bij het behoud van de 
zwangerschap op het immunologische scheidingsvlak in de placenta (Hoofdstuk 
7). 
Klnderen met een afweerstoornis 
Immunofenotypering van Iymfocyten speelt een belangrijke rol bij de 
diagnostiek en het vervolgen van primaire en verkregen immunodeficienties. Het 
nauwkeurig vaststellen van de absolute aantallen van de Iymfocytensubpopulaties 
in het bloed maakt de diagnostiek mogelijk van congenitale immunodeficienties, 
het vervolgen van HIV-infectie, en het monitoren van het immunologisch herstel na 
beenmergtransplantatie. Tevens kan bij congenitale immunodeficienties de 
blokkade in de ontwikkeling van de Iymfocyten worden vastgesteld door middel van 
analyse van de expressie van intracellulaire en oppervlakte moleculen van cellen in 
bloed en beenmerg (Hoofdstuk 8). 
Wij bestudeerden het herstel van de Iymfocytensubpopulaties - gedefinieerd als 
het bereiken van de P5 van leeftijdsgerelateerde normaalwaarden - bij 
tweeentwintig kinderen die een allogene beenmergtransplantatie (BMT) 
ondergingen voor een hematologische maligniteit, en vergeleken de resultaten met 
de normale Iymfo'ide ontwikkeling. We vonden een relatief snel herstel van de 
aantallen B-Iymfocyten, waarbij hoge waardes (>P95 van leeftijdsgematchte 
normaalwaarden) werden bereikt vanaf zes maanden na BMT, zoals in de normale 
ontwikkeling ook gebeurt. In tegenstelling tot de normale ontwikkeling was het 
herstel van de aantallen T-Iymfocyten traag. Het herstel van de aantallen CD4+ 
helper T -Iymfocyten was zelfs zeer traag (> zes maanden na BMT), zoals al eerder 
voor volwassenen werd beschreven. Onverwachts von den we een duidelijk positief 
effect van CMV-reactivatie op het herstel van de aantallen CD4+ helper T-
Iymfocyten. De aantallen CD45RA+ T-Iymfocyten stegen slechts langzaam na 
BMT; de aantallen CD45RO+ T-Iymfocyten bleven gedurende de gehele follow-up 
178 Samenvatling 
periode gelijk, ondanks de hoge relatieve frequentie van CD45RO. T -Iymfocyten in 
de eerste drie maanden na BMT. Net als bij volwassenen vonden we dat een hoog 
percentage van de T -Iymfocyten in de eerste drie maanden na BMT negatief was 
voor het CD7 molecuul. De absolute aantallen CD7- T-Iymfocyten waren echter 
gedurende de gehele follow-up periode gelijk. Dit illustreert opnieuw het be lang 
van het gebruik van absolute aantallen in plaats van relatieve frequenties bij 
onderzoek naar de ontwikkeling van Iymfocytensubpopulaties (Hoofdstuk 9). 
Bij een kind met recidiverende - waarschijnlijk virale - luchtweginfecties en 
problemen met BCG-vaccinatie en infectie met Epstein-Barr virus en varicella 
zoster virus toonde immunofenotypering van de Iymfocyten een afwezigheid van 
het CD16 (B73.1) epitoop aan (CD16 is de Fcy receptor type lila). CD3-/CD7. NK-
cellen waren echter wei aanwezig, en andere CD16 McAb zoals 3G8 en 
CLBFcRgran1 kleurden de NK-cellen van de patiEint wei aan. De NK-cel functie 
(K562 lysis en P815 ADCC) was normaal in vergelijking met een 
leeftijdsgerelateerde controle; overigens was dat wei lager dan bij volwassen 
controles. Dit CD16 (B73.1) epitoopverlies in het eerste exlracellulaire domein van 
het CD16a molecuulleidde tot de ontdekking van FcyRIIIA48-H/H homozygotie in 
de patiEint. Het belang van deze bevinding is nog niet duidelijk, aangezien de 
verwachte frequentie van homozygoten 6.4 per duizend CaucasiEirs is, gebaseerd 
op de gevonden allelfrequentie bij gezonde bloeddonoren. Tot nu toe werden nog 
geen additionele homozygote individuen ge'identificeerd (Hoofdstuk 10). 
Ook bij diverse andere patiEinten met een immunodeficiilntie bleek 
gedetailleerde immunofenotypering waardevol te zijn voor het stellen van de 
diagnose of voor het nauwkeurig definiEiren van het ziektebeeld. Zo kon op snelle 
wijze de CD40 ligand deficiilntie worden aangetoond op geactiveerde T-Iymfocyten 
bij patiEinten met hyper IgM syndroom (Hoofdstuk 12), en kon het type T-cel 
deficiEintie nauwkeurig worden vastgesteld bij een broer en zus met ernstige 
recidiverende infecties van vooral virale oorsprong (Hoofdstuk 11). Tenslotte kon de 
precieze positie van de blokkade in de B-cel differentiatie worden bepaald in het 
beenmerg van een meisje met agammaglobulinemie (Hoofdstuk 13). Kortom, de 
huidige technische mogelijkheden en de beschikbaar gekomen kennis en ervaring 
op het gebied van flowcytometrische immunofenotypering zijn zeer waardevol in de 
zorg voor kinderen met een immunodeficiEintie. 
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Dit proefschrift is in de afgelopen zeven jaar tot stand gekomen naast een 
drukke klinische baan op diverse plaatsen: Rotterdam, Leiden en 's-
Hertogenbosch. Het kan niet anders dan dat vele mensen daaraan op enigerlei 
wijze hun bijdrage hebben geleverd. Het is onmogelijk een ieder daar persoonlijk 
voor te bedanken, een aantal van hen wil ik er echter in het bijzonder uitlichten. 
Zonder hen zou dit proefschrift er nooit gekomen zijn. 
Allereerst uiteraard professor Dr. J.J.M. van Dongen, mijn promotor. Beste 
Jacques, zonder jouw enthousiasme, jouw onvoorwaardelijke steun in moeilijke 
tijden, jouw bezielende leiding en ongezouten kritiek was ik nooit daar gekomen 
waar ik nu ben. Toen ik v~~r het eerst bij je kwam met mijn plannen heb je je 
ernstige twijfels uitgesproken: een dokter die in het lab wil komen werken? Aan een 
onderzoek dat nog vanaf de aliereerste gedachte moet worden opgezet? Die moet 
zich eerst maar eens komen bewijzenl Jouw grote verdienste is dat als je eenmaal 
met iemand afspraken maakt je je daar ook aan houdt, en je een grote steun en 
stimulator betoont. Ik ben je veel dank verschuldigd en hoop de samenwerking met 
jou - nu vanuit Den Bosch - nog lang te kunnen voortzetten. 
Zonder de steun van professor Dr. R. de Groot was mijn onderzoek al in een 
vroege fase - na de afwijzing van mijn eerste subsidieaanvraag - blijven steken. 
Beste Ronald, jij hebt je altijd voor mijn plannen ingezet, al is dat de laatste jaren 
wat meer op afstand geworden. V~~r jouw steun wil ik je bij deze ook hartelijk 
bedanken. 
Mijn eerste schreden op het pad van de wetenschap zeUe ik in 1988 onder 
lei ding van Dr. M.J.D. van Tol. Beste Maarten, ik ben je zeer erkentelijk voor mijn 
eerste lessen in de immunologie en het laboratoriumwerk, maar ook voor de 
inmiddels jarenlange samenwerking die wij verder hebben uitgebouwd in de jaren 
dat ik als staflid op de afdeling IHOBA in Leiden werkzaam was. Inmiddels hebben 
wij de samenwerking al weer uitgebreid naar de "Bosche" populatie, en ik hoop dat 
wi] dat nog lang zo zullen doen. 
Professor Dr. J.M.J.J. Vossen, medepromotor, beste Jaak, wij hebben moeilijke 
tijden meegemaakt. Ik ben blij dat wij nu een goede werkrelatie hebben gevonden. 
Ik dank je voor de mogelijkheden die je bood om mijn werk aan de 
immunodeficilinte Leidse patienten ook na mijn vertrek naar Den Bosch af te 
maken, zodat dat werk onderdeel van dit proefschrift kon zijn. 
Professor Dr. H.J. Neijens, beste Herman, mijn dank voor je aliijd 
belangstellende houding, en voor het doorwerken van dit manuscript in korte tijd. 
Professor Dr. R. Benner dank ik voor zijn bereidwilligheid zitting te nemen in de 
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"kleine" promotiecommissie, en in korte tijd een flinke stapel manuscripten voor mij 
door te werken. 
Marieke Comans-Bitler en Sandra de Bruin-Versteeg waren de analisten die mij 
steunden op het Rotlerdamse immunologisch laboratorium. Marieke, ik ben je 
aileen al dankbaar dat je mij hebt "geschiktbevonden" voor het doen van 
laboratoriumwerk, bovendien heb ik ontzetlend veel van je geleerd. Sandra, zonder 
jou was de enorme bulk aan immunofenotyperingswerk voor de longitudinale 
studie bij gezonde kinderen nooit afgekomen. Jij was mijn paranimf, niet aileen op 
de dag zelf! 
Analisten van het immunologisch laboratorium in Leiden, ik ben dankbaar voor 
mijn eerste lessen over immunologisch laboratoriumwerk die ik van jullie kreeg. 
Renee Langlois van den Bergh en Jacqueline Waaijer, jullie wit ik ook bedanken 
voor al het immunofenotyperingswerk van de kinderen na beenmergtransplantatie, 
en de rompslomp die dat met zich meebracht. 
Dr. F.K. Lotgering, gynaecoloog, en Dr. G.J.M. Boerma, klinisch chemicus, ik 
dank jullie voor jullie bereidwillige medewerking bij het verzamelen en bewerken 
van de monsters voor de longitudinale studie van gezonde kinderen. Datzelfde 
geldt voor de verpleegkundigen van de verloskamers van het Dijkzigt Ziekenhuis, 
en de analisten van het hematologisch laboratorium van het Sophia 
Kinderziekenhuis. 
Dr. W. C. J. Hop, mijn dank voor de hulp bij de statistische verwerking van de 
resultaten uit de longitudinale stu die bij gezonde kinderen. Professor Dr. P.J.J. 
Sauer, beste Pieter, mijn dank voor de tijd die je mij gaf om in het laboratorium 
bezig te zijn toen ik als staflid neonatologie bij je werkte. Dr. J. Hermans, mijn dank 
voor de hulp bij de statistische verwerking van de resultaten uit de studie naar het 
immunologisch herstel na beenmergtransplantatie. Dr. M. de Haas, beste Masja, 
mijn dank voor de vruchtbare samenwerking rondom het B73.1/CD16 werk. J.G. 
Noordzij, beste Jeroen, ik hoop dat we nog verder weten te komen met het werk 
rond het meisje dat geen XLA heeltl 
Dr. C. Weemaes, beste Corry, hartelijk dank voor je interesse en 
ondersteuning; ik hoop dat wij de vruchtbare samenwerking in het Bosch-Nijmeegs 
overleg verder zullen uit bouwen. Professor Dr. W. Kuis en dr. H. Hooijkaas, mijn 
dank voor het plaats nemen "achter de tafel". 
Tar van Os mijn dank voor het maken van vele fraaie figuren, en DaniEilie 
Korpershoek voor het afwerken van diverse manuscripten. 
Mijn collega's op de diverse plaatsen waar ik heb gewerkt - de Rotlerdamse 
neonatologie, de Leidse IHOBA subafdeling, de Bosche kindergeneeskunde - ben 
ik dankbaar voor hun bereidwilligheid te accepteren dat ik af en toe met mijn 
aandacht wei erg veel bij mijn proefschrift was. Vooral bij het afronden daarvan 
werd de last weleens te zwaar, hetgeen mijn humeur niet altijd ten goede kwaml 
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Mijn ouders ben ik dankbaar v~~r hun stimulerende houding vanaf mijn eerste 
stapjes. Ik ben blij dat jullie er bij zijn om te zien waar dat allemaal toe heeft geleid. 
Mijn zus Laura, jij hebt vaak je steentje bijgedragen door op de kinderen te passen. 
Ik heb jou in je studies vaak "achter de broek gezeten" de laatste jaren - met goed 
resultaat! - en dat hielp mij ook weer verder. Onze goede verstandhouding mondt 
daarom vanzelfsprekend uit in jouw plaats als paranimf op deze "grote dag". 
Arjan, jij hebt al heel wat te stellen gehad met die kinderarts-immunoloog en 
wetenschapper die ook nog jouw vrouw is! Hopelijk komt er nu eindelijk eens wat 
meer tijd. En dat geldt ook voor jullie, Sascha en Robin, die mama zat wei altijd 
achter de computer de laatste tijd. Jullie vrolijke en gezellige aanwezigheid maakte 
het allemaal de moeite waard. En jij, Sascha, verzorgde al vele iIIustralies voor mij, 
ook de kafl van dit proefschrifl, en was zelfs al eens een "Ieeflijdsgematchte 
controle". Fantastisch! 
Vught, april 1999. 
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